Document:

EX-10.31

 Exhibit 10.31 

 

									
	

	  	4 Park Plaza, Suite 300	  	TEL: 949.263.3880	  	info@celticleasing.com
	  	Irvine, CA 92614	  	FAX: 949.263.1331	  	www.celticleasing.com

 January 19, 2018 

Mr. Kamal Adawi 
 CFO 

Exagen Diagnostics, Inc., 
 1261 Liberty Way, 

Vista, CA 92081 
  

	RE:	 Lease Schedule(s) No. 3861A01 to 

Celtic Master Lease No. CML-3861A 

Dear Mr. Kamal: 
 This letter shall serve as formal
notification that the above referenced transaction has been approved as set forth herein and in the paperwork enclosed as follows: 
  

	1)	 Master Lease No. CML-3861A; 

 

	2)	 Corporate Certificate (of Lessee); 

 

	3)	 Lease Schedule No. 3861A01; 

 

	4)	 Letter Agreement acknowledging a five percent restock Fee; 

 

	5)	 Misdirected Invoice/Assignment of Invoice/Bill of Sale document; 

 

	6)	 Intercreditor Agreement/Subordination form (to be executed by creditor prior to
funding) 

  

	7)	 Notarization of Signature; 

 

	8)	 Insurance Authorization form; and 

 

	9)	 Auto Debit Authorization Form. 

In addition to having the above listed items duly completed and returned, please also note the following: 

 

	A)	 It is Celtic’s understanding that all of the Equipment has been delivered to and is usable by Lessee. In
consideration of Celtic approving and subsequently funding this Transaction, Lessee and Celtic mutually agree that the Final Commencement Date shall be the Date of Funding (the date that Celtic and/or its Assignee reimburses Lessee for equipment)
and billing from this date, pursuant to Section 4. RENT of the Lease, is appropriate. 

  

	B)	 Please be advised that prior to final funding, a physical inspection of the equipment will be conducted

  

	C)	 If applicable, provide us with proper sales/use tax exemption documentation—otherwise, a lump sum sales
tax charge will need to be paid upfront and/or added to the lease stream, as applicable. 

 This approval and related funding(s) may, at
Lessor’s sole discretion, be subject to: no adverse material changes in the financial condition of Lessee or Guarantor(s), if any; approval of the 
  

					
	 L:\APLTRNUL
	 	THE PERSONAL SIDE OF BUSINESS	  	

 Exagen Diagnostics, Inc. 

January 19, 2018 
 Page 2 

subject equipment and related vendors; a UCC Search and obtainment of any UCC Releases or Subordinations required as a result thereof; obtainment of
acceptable Certificates of Insurance; final legal review and approval of the subject documentation; and rent adjustment to reflect any increase in 4 year interest rate swaps from a base rate of 2.17% through the day of final funding by Lessor or our
assignee. Please note that the approval as set forth herein and in the enclosed paperwork is the entire agreement between the parties with respect to the subject equipment and shall supersede any and all prior proposals, letters of intent,
negotiations and/or other communications. It is our understanding that all items of equipment have already been delivered to and accepted by Lessee, and that funding is therefore expected to be imminent. Should the funding of the Transaction be
delayed, an update of this approval may be required 
 Thank you for your business and please don’t hesitate to call the undersigned or your account
representative, Hunter Bestard, if you have any questions or comments. 
  

					
	CELTIC LEASING CORP.	 		 	
	 /s/ Valerie Caron
	 		 	
	Sincerely,	 		 	
	CELTIC LEASING CORP.	 		 	

  

											
		 		 	 READ, ACKNOWLEDGED, AND AGREED: 

Exagen Diagnostics, Inc.

	 Valerie Caron
 Funding
Administrator
	 		 	By:	 	/s/ Kamal Adawi
		 		 		 	Name:	 	Kamal Adawi	 	
		 		 		 	Title:	 	CFO	 	Date: 2-1-2019

					
	

	  	MASTER LEASE	  	Number CML- 3861A
	  	CELTIC LEASING CORP.—Lessor
	  	4 Park Plaza, Suite 300 • Irvine. CA 92614
	  	866.323.5842 • 949.263.3880 • Fax: 949.263.1331

 Lessee: Exagen Diagnostics, Inc.  

Address: 1261 Liberty Way, Vista, CA 92081 

This is a MASTER LEASE AGREEMENT (herein called “Lease”). Lessor hereby agrees to lease to Lessee, and Lessee hereby agrees to
lease from Lessor, the items of tangible and/or intangible property (collectively called “Equipment” and individually called “Item”) described on any Lease Schedule(s) (“Schedule”) now or in the future annexed hereto
and made a part hereof, subject to the terms and conditions set forth herein. Each Schedule annexed hereto incorporates the terms of this Lease and is independent and enforceable as a separate transaction. 

1. QUIET ENJOYMENT: So long as Lessee is not in default hereunder. Lessor shall not disturb Lessee’s quiet enjoyment of the Equipment,
subject to the terms and conditions of this Lease. 
 2. NO WARRANTIES AND UNIFORM COMMERCIAL CODE ACKNOWLEDGMENT: Lessee acknowledges that
Lessor is not the manufacturer, vendor, developer, distributor, publisher or licensor (for purposes of this Lease, all of which arc called “Manufacturer”, both collectively and individually) of the Equipment. Lessee further acknowledges
and agrees that LESSOR MAKES NO WARRANTY OR REPRESENTATION, EXPRESS OR IMPLIED, AS TO THE MERCHANTABILITY, FITNESS FOR ANY PURPOSE, CONDITION, DESIGN, CAPACITY, SUITABILITY OR PERFORMANCE OF ANY OF THE EQUIPMENT, OR ANY OTHER REPRESENTATION OR
WARRANTY WITH RESPECT THERETO, IT BEING AGREED THAT THE EQUIPMENT IS LEASED “AS IS”. LESSEE FURTHER REPRESENTS THAT ALL ITEMS OF EQUIPMENT ARE OF A SIZE, DESIGN AND CAPACITY SELECTED BY IT, AND THAT IT IS SATISFIED THE SAME IS SUITABLE
FOR LESSEE’S PURPOSES. Lessor assigns to Lessee any and all Manufacturer warranties, to the extent assignable, for the term of the Lease. Lessor shall have no liability to Lessee or anyone claiming through Lessee for the breach of any such
warranty or for any claim, loss, damage or expense of any kind or nature resulting, directly or indirectly, from the delivery, installation, use, operation, performance, or lack or inadequacy thereof, of any Items of Equipment. This Lease is a
“Finance Lease” as defined in, and for the purpose only of Division 10 of the California Commercial Code and not necessarily for any accounting purpose or otherwise. Lessee acknowledges that Lessor has informed or advised Lessee, either
previously or by this Lease, of the following: (i) the identity of the “Supplier”, (ii) that Lessee may have rights under the “Supply Contract”, and (iii) that Lessee may contact the Supplier for a description of any
such rights. (The terms “Finance Lease”, “Supplier” and “Supply Contract” as used herein have the meanings ascribed to them under Division 10 of the California Commercial Code.) 

3. TERM: The “Commencement Date” for each Item shall be the day that the Item has been delivered to and is usable by Lessee as evidenced by
an Acceptance Certificate duly executed by Lessee or. in the absence thereof, the Manufacturer’s delivery certification. The “Base Term” as indicated on any Schedule shall be the period beginning on the first day of the calendar
quarter (January 1, April 1, July 1 or October 1) following the final Commencement Date (“Final Commencement Date”) of the Schedule or. if the Final Commencement Date falls on the first day of a calendar quarter, then that day. and
continuing for the number of months specified on the Schedule. This Lease with respect to any Schedule may be terminated as of the last day of the Base Term by either party giving the other party at least six months but not more than twelve months
prior written notice of such termination. Otherwise, the “Term” (as defined below) with respect to any Schedule shall automatically be extended in successive one year intervals [“Extension Term(s)”] at the rental amount in effect
as of the last billing cycle of the Base Term. Any such Schedule may be terminated as of the last day of any Extension Term by either party giving the other party at least six months, but not more than twelve months, prior written notice of such
termination. Any termination notice given by Lessee shall stipulate whether Lessee chooses to purchase the Equipment or renew the Lease as provided in Section 6. Fair Market Value Purchase Option / Renewal Option. or return the Equipment as
provided in Section 7. Return of Equipment. The “Term” of each individual Schedule is hereby defined as the period beginning on the first Commencement Date that occurs with respect to all Items subject to the Schedule and continuing
through the Base Term and all Extension Terms, if any. Each Schedule now or in the future annexed hereto shall be deemed to incorporate therein these specific terms and conditions and shall have an independent Term. 

4. RENT: The monthly rent as shown on each Schedule shall be due and payable by Lessee in the amount of the monthly rent multiplied by the
number of months in the billing cycle indicated on the respective Schedule (one month in a monthly billing cycle, three in a quarterly cycle, six in a biannual cycle, etc.) on the first day of the Base Term and on the first day of each billing cycle
thereafter, for the remainder of the Term. For Items having a Commencement Date prior to the first day of the Base Term, rent shall be due on a pro rata basis only in the amount of one-thirtieth of the
Item’s proportional monthly rent for each day from the Item’s Commencement Date until, but not including, the first day of the Base Term and shall be payable by Lessee five days after receipt of invoice from Lessor. If any rental or other
amounts payable hereunder are not paid within five days of their due date then Lessee shall pay to Lessor upon demand “Delinquency Charges” which shall equal interest compounded monthly at the rate of eighteen percent per annum (or the
highest rate allowable by law whichever is less) on the delinquent balance from the date due until the date paid plus a monthly administrative fee of five percent of the cumulative delinquent balance to offset Lessor’s collection and accounting
costs. Any deposit paid by Lessee to Lessor shall be refundable if the Schedule is not accepted by Lessor. THIS IS A NET LEASE AND LESSEE’S OBLIGATION TO PAY ALL RENTAL CHARGES AND OTHER AMOUNTS DUE HEREUNDER SHALL BE ABSOLUTE AND UNCONDITIONAL
UNDER ALL CIRCUMSTANCES AND SHALL NOT BE SUBJECT TO ANY ABATEMENT, DEFENSE, COUNTERCLAIM, SETOFF, RECOUPMENT OR REDUCTION FOR ANY REASON WHATSOEVER EXCEPT AS OTHERWISE PROVIDED HEREIN, IT BEING THE EXPRESS INTENT OF LESSOR AND LESSEE THAT ALL RENTAL
AND OTHER AMOUNTS PAYABLE BY LESSEE HEREUNDER SHALL BE AND CONTINUE TO BE PAYABLE IN ALL EVENTS. LESSEE HEREBY WAIVES ALL RIGHTS IT MAY HAVE TO REJECT OR CANCEL THIS LEASE, TO REVOKE ACCEPTANCE OF ANY OF THE EQUIPMENT, AND OR TO GRANT A SECURITY
INTEREST IN ANY OF THE EQUIPMENT FOR ANY REASON EXCEPT AS REQUIRED HEREIN. 
 5. USE, MAINTENANCE AND LOCATION: Lessee at its own
expense shall properly use the Equipment, keep the Equipment in good working order, repair and condition, comply with all Manufacturer’s instructions as to use and operation, and comply with all applicable laws, rules, regulations or orders of
any governmental agency with respect to the use, operation, maintenance, care, storage, or location of the Equipment. During the Term, Lessee shall keep in force the best standard maintenance agreement with the Manufacturer, or such other qualified
party including qualified self-maintenance by Lessee, as is reasonably acceptable to Lessor, that will ensure: the Equipment is maintained to all current engineering specifications; all repairs, adjustments and replacements are properly made; and
all upgrades, enhancements and changes that are available from time to time from the Manufacturer are made to the Equipment. Lessee shall not relocate the Equipment 
  

					
	CELTIC LEASING CORP. (CMLR 3/03)	  	Initials: KA	  	

 
without Lessor’s prior written consent. Lessee shall pay all costs associated with the delivery, installation, use, relocation, and Lessor’s inspection of the Equipment. If Lessor
requests, Lessee shall affix in a prominent place labels or tags to the Equipment stating that the Equipment is owned by Lessor. Lessee shall permit Lessor to inspect the Equipment from time to time as reasonably determined by Lessor. 

6. FAIR MARKET VALUE PURCHASE OPTION / RENEWAL OPTION: Lessee may purchase, or renew this Lease for, all but not less than
all of the Equipment subject to any Schedule, provided Lessee is not in default and upon proper written notification to Lessor, as of the expiration of the Term of said Schedule. In the event Lessee notifies Lessor it elects to purchase the
Equipment, the purchase price shall be the “Fair Market Value” of the Equipment. For the purpose of this Lease. “Fair Market Value” is defined as the total cost(s) it would take to replace the Equipment on an in-place, installed basis, including all current cost(s) and expense(s) for the purchase, assembly, installation, delivery, freight, consulting, training, site preparation and any other services that would be
required to render such Equipment fully installed, ready and acceptable for use by an end user as of the termination of the Term. If Lessor and Lessee can not agree on a purchase price then the purchase price shall be determined by the average of
two Senior Appraisers accredited by the American Society of Appraisers, one chosen by Lessor and one by Lessee, both using the definition of Fair Market Value hereunder in determining their purchase price, the cost of which shall be borne by Lessee.
In the event Lessee notifies Lessor it elects to renew, the renewal shall be based upon the Fair Market Value of the Equipment, the then prevailing market conditions. Lessee’s credit worthiness and such other terms and conditions to be mutually
agreed upon by Lessee and Lessor. If Lessee has properly elected to purchase or renew any given Schedule, but neither a Fair Market Value purchase price nor the terms and conditions of a renewal have been determined at least thirty days prior to the
expiration of the Term, then the Term of the Schedule shall continue on a month to month basis at the rental that was in effect at the end of the Base Term, until such time that either a Fair Market Value purchase price or the terms and conditions
of a renewal have been determined. 
 7. RETURN OF EQUIPMENT: If the Equipment is to be returned upon termination of the Term with respect to
any Schedule or if for any other reason. Lessee shall immediately discontinue all use of the Equipment and at its own cost, de-install, pack and ship the Equipment to a location(s) within the United States,
all in accordance with instructions provided by Lessor. In the case of Equipment which is software. Lessee will also certify in a written form acceptable to Lessor that: (i) all tangible software has been delivered to Lessor; (ii) all
tangible records and intangible software have been destroyed; (iii) Lessee has not retained the software in any form; (iv) Lessee will not use the software after termination; and (v) Lessee has not received from Manufacturer anything
of value relating to or in exchange for Lessee’s use, rental, or possession of the software during the duration of the Lease (including a trade-in, substitution or upgrade allowance). Upon return of the
Equipment. Lessee shall take all actions necessary to ensure that the Equipment will be eligible for the best standard Manufacturer Maintenance Contract and shall pay all fees, charges and expenses for maintenance certification or recertification by
the Manufacturer and for all costs for repair or replacement of damaged Equipment. Until Lessee has complied with all of the requirements of this Section, rent payment obligations will continue on a month to month basis at the monthly rent
delineated on the Schedule. Lessee shall allow Lessor to inspect, at Lessee’s cost, all of Lessee’s locations to ensure compliance hereunder. 

8. TITLE; PERSONAL PROPERTY: Except as otherwise provided in this Lease or any Schedule, title to the Equipment shall remain in Lessor. Lessee
shall at all times keep the Equipment free and clear of all liens, claims, levies, and legal processes, and shall at its expense protect and defend Lessor’s title and/or license rights in the Equipment. In the event any of the Equipment is
software governed by a software license. Lessee shall keep said license current for the entire Term and to the extent the license allows title to the software to pass to licensee, such title shall vest and remain in Lessor. Lessee acknowledges that
the license to use the software is being provided by the Manufacturer solely because of payments made by Lessor and in consideration therefor Lessor has obtained Lessee’s interest in the License. Lessee forgoes any future claim to the software,
including any right to purchase and/or use the software beyond the Term, except as otherwise provided in this Lease. Lessee hereby agrees and does hereby appoint Lessor or its assigns its true and lawful attorney-in-fact to prepare UCC’s or other instruments necessary, and authorizes Lessor to cause this Lease or other instruments in Lessor’s determination, to be filed or recorded at Lessee’s
expense in order to protect Lessor’s interest in the Equipment, and grants Lessor the right to execute and deliver such instruments for and on behalf of Lessee. If requested by Lessor, then Lessee agrees to execute and deliver any such
instruments and agrees to pay or reimburse Lessor for any searches, filings, recordings, inspections, fees, taxes or any other costs incurred as necessary to protect Lessor’s interest in the Equipment. Lessee also authorizes Lessor to insert on
any Schedule and on related supplemental lease documentation information commonly determined after execution by Lessee such as: serial numbers and other Equipment identification data, Equipment locations. Commencement Dates, and Final Commencement
Date. Lessee shall take all steps necessary to ensure that the Equipment is and remains personal properly. 
 9. ALTERATIONS: Lessee shall
make no alterations, modifications, attachments, improvements, enhancements, revisions or additions to any of the Equipment (collectively called “Alterations”), without Lessor’s prior written consent. All Alterations that are made
shall become part of the Equipment and shall be the property of Lessor. Equipment which is software shall include all updates, revisions, upgrades, new versions, enhancements, modifications, derivative works, maintenance fixes, translations,
adaptations, and copies of the foregoing or of the original version of the software whether obtained from the Manufacturer or from any source whatsoever, and references in this Lease to software will be interpreted as references to any and all of
the foregoing. 
 10. TAXES: Lessee shall pay all fees, assessments and taxes (except for income taxes based solely on Lessor’s net
income assessed by the U.S. Internal Revenue Service and/or any member State of the United States of America), including but not limited to, sales, use, property, excise, intangibles, single business, stamp, documentary and any other costs imposed
by any authority, with respect to the use, delivery, rental/lease, possession, purchase, ownership or sale of the Equipment and shall at its own cost and expense keep the Equipment free and clear of all levies, liens or encumbrances arising
therefrom. Lessee shall file all required personal property tax returns relating to the Equipment. In the event Lessor files appropriate properly tax returns or other reports. Lessee shall upon demand immediately reimburse Lessor for all amounts
paid by Lessor, plus processing costs. 
 11. LOSS OR DAMAGE: Lessee shall bear the entire risk of loss, damage, theft, destruction,
confiscation, requisition, inoperability, erasure, or incapacity, for or from any cause whatsoever, of any or all Items during the period the Equipment is in transit to or from, or in the possession of, Lessee (“Event of Loss”) and shall
hold Lessor harmless against same. Immediately upon its discovery, Lessee shall fully inform Lessor of an Event of Loss. Except as provided herein, no Event of Loss shall relieve Lessee of any obligation hereunder, and all Schedules shall remain in
full force and effect without any abatement or interruption of rent. In an Event of Loss, Lessee at its option provided no event of default has occurred hereunder, shall: (a) continue to timely make all rental payments and pay all other amounts
due under the Lease and within a commercially expedient time frame, place the Equipment in good working order, repair and condition, or replace the affected Equipment with identical equipment with documentation creating clear title thereto in
Lessor; or (b) terminate the Lease with respect to the affected Schedule by paying to Lessor within thirty days the “Casualty Value” which is defined as the sum of: (i) the present value of the unpaid balance of the aggregate rent
reserved under the related Schedule calculated using a discount rate of two percent per annum, plus (ii) all accrued but unpaid rentals, taxes. Delinquency Charges, penalties, interest and all or any other sums then due and owing under the
related Schedule, plus (iii) the amount of any applicable end of Term purchase option or other end of Term payment or, in the absence thereof, the Fair Market Value of the Equipment plus (iv) an amount reasonably determined by Lessor to
make Lessor whole on an after tax basis for any loss, recapture, or unavailability of any tax credit and/or deduction. 
  

					
		  	Initials: KA	  	CELTIC LEASING CORP.(CMLR 3/03)

 12. INSURANCE: Lessee, at its expense, shall provide and maintain in full force and effect at
all times that this Lease is in force such casualty, property damage, comprehensive public liability and other insurance in such form and amounts as is and with such companies as shall be satisfactory to Lessor. All such insurance shall provide that
it may not be canceled or materially altered without at least thirty days prior written notice to Lessor, shall name Lessor as additional insured and loss payee, and shall not be rescinded, impaired or invalidated by any act or neglect of Lessee.

 13. INDEMNITY: Lessee shall indemnify, defend, protect, save and hold harmless Lessor, its employees, officers, directors, agents, assigns
and successors from and against any and all claims, actions, costs, expenses (including reasonable attorneys’ fees), damages (including any interruption of service, loss of business or other consequential damages), liabilities, penalties,
losses, obligations, injuries, demands and liens (including any of the foregoing arising or imposed under the doctrines of “strict liability” or “product liability”) of any kind or nature arising out of. connected with, relating
to or resulting from the manufacture, purchase, sale, lease, ownership, installation, location, maintenance, operation, condition (including latent and other defects, whether or not discoverable), selection, delivery, return, or any accident in
connection therewith, of any Item or Items of Equipment, or by operation of law (including any claim for patent, trademark or copyright infringement), regardless of where, how or by whom operated the provisions of this paragraph shall survive
termination or expiration of this Lease. 
 14. AUTHORITY OF LESSEE TO ENTER LEASE: With respect to this Lease and each Schedule now or in the
future annexed hereto. Lessee hereby represents, warrants and covenants that: (i) the execution, delivery and performance thereof have been duly authorized by Lessee; (ii) the individuals executing such have been duly authorized to do so:
(iii) the execution and or performance thereof will not result in any default under, or breach of. any judgment, order, law or regulation applicable to Lessee, or of any provision of Lessee’s articles of incorporation, bylaws, or any
agreement to which Lessee is a party: and (iv) all financial statements and other information submitted by Lessee herewith or at any other time is true and correct without any misleading omissions. 

15. ASSIGNMENT: Lessee hereby agrees and acknowledges that Lessor may without notice to Lessee, assign all or any part of Lessor’s rights,
title and interest in and to this Lease, any Schedule, the Equipment, and any of the rentals or other sums payable hereunder, to any assignee (“Assignee”) provided any such assignment shall be made subject to the rights of Lessee herein.
Lessee hereby acknowledges that any such assignment does not change the duties of. nor the burden of risk imposed on the Lessee and that Lessee shall not look to Assignee to perform any of Lessor’s obligations hereunder and shall not assert
against Assignee any defense, counterclaim or setoff it may have against Lessor. Lessee agrees that after receipt of written notice from Lessor of any such assignment Lessee shall pay. if directed by Lessor, any assigned rental and other sums
payable hereunder directly to Assignee and will execute and deliver to Assignee such documents as Assignee may reasonably request in order to confirm the interest of Assignee in this Lease. WITHOUT LESSOR’S PRIOR WRITTEN CONSENT, LESSEE
SHALL NOT ASSIGN, TRANSFER, ENCUMBER, SUBLET OR SELL THIS LEASE. ANY SCHEDULE, ANY OF THE EQUIPMENT, OR ANY OF ITS INTEREST THEREIN, IN ANY FORM OR MANNER. 

16. FURTHER ASSURANCES: Upon Lessor’s request. Lessee, promptly and at its expense, shall execute and or deliver such documents,
instruments and/or assurances, and shall take such further action, as Lessor deems prudent in order to establish and/or protect the rights, interests and remedies of Lessor, and for the confirmation, assignment and or perfection of this Lease and
any Schedule hereto, and for the assurance of performance of Lessee’s obligations hereunder, such as (but not limited to): a secretary’s certificate certifying the authority of the person(s) signing, and/or the resolutions authorizing,
this Lease and/or any Schedule: delivery and or acceptance certificates, insurance certificates: an opinion of Lessee’s counsel; financial statements and other credit information as reasonably requested by Lessor; intercreditor agreements;
subordinations; and a landlord/mortgagee waiver of rights and interests in the Equipment. If Lessee fails to complete when due any such requested item. Lessor, at its sole discretion and notwithstanding the provisions of Section 3. Term herein,
may elect to delay the Final Commencement Date of the affected Schedule until any or all such requested items are completed. Until duly executed by an authorized officer of Lessor. Lessee agrees that this Lease and any Schedule executed by Lessee
shall constitute an offer by Lessee to enter into the Lease with Lessor. 
 17. DEFAULT: The occurrence of any of the following shall
constitute an event of default hereunder (“Event of Default”): (a) Lessee fails to pay when due any installment of rent or any other amount due hereunder and such failure continues for a period of ten days after receipt of written notice
thereof; (b) any financial or other information or any other representation or warranty given to Lessor herein or in connection herewith (including information provided by or on behalf of any Guarantor), proves to be false or misleading:
(c) Lessee assigns, transfers, encumbers, sublets or sells this Lease, any Schedule, any of the Equipment, or any of its interest therein, in any form or manner, without Lessor’s prior written consent: (d) Lessee fails to observe or
perform any other covenant, condition or obligation to be observed or performed by it under this Lease and such failure continues for a period of fifteen days after receipt of written notice thereof: (e) any transaction or series of
transactions that results in an ownership change of fifty percent or more of the equity interests of Lessee or any Guarantor of this Lease; (f) Lessee or any Guarantor of this Lease consolidates with or merges into, or sells or leases fifty
percent or more of its assets to any individual, corporation, or other entity; (g) Lessee, or any Guarantor of this Lease, ceases doing business as a going concern, dies, makes an assignment for the benefit of creditors, admits in writing its
insolvency, files a voluntary petition in bankruptcy, is adjudicated bankrupt or insolvent, files a petition seeking for itself any reorganization, liquidation, dissolution or similar arrangement under any present or future statute, law or
regulation, or files an answer admitting the material allegations of a petition filed against it in any such proceedings, consents to or acquiesces in the appointment of a trustee, receiver, or liquidator of it or of any substantial part of its
assets, or if its shareholders take any action looking to its dissolution or liquidation: or (h) within sixty days after the commencement of any proceeding against Lessee or any Guarantor of this Lease, seeking reorganization, liquidation,
dissolution or similar relief under any present or future statute, law or regulation, such proceedings shall not have been dismissed, or if within sixty days after the appointment without Lessee’s consent or acquiescence of any trustee,
receiver or liquidator of it or of any substantial part of its assets, such appointment shall not be vacated. 
 18. REMEDIES: If an Event of
Default shall occur. Lessor may, in addition to all available remedies it may have at law or in equity, do any or all of the following: (a) proceed, by appropriate court action, to enforce performance by Lessee of the applicable covenants of
this Lease and to recover damages for the breach thereof: (b) by written notice to Lessee, terminate this Lease and/or all or any Schedules hereto and Lessees rights hereunder and/or thereunder; (c) personally or by its agents enter the
premises where any of the Equipment is located and take immediate possession of the Equipment without court order or other process of law and free from all claims by Lessee: (d) nullify any end of Term purchase or renewal option; and or
(e) recover all unpaid amounts then due and owing including applicable late charges, plus, as liquidated damages for loss of a bargain and not as a penalty, accelerate and declare to be immediately due and payable the unpaid balance of the
aggregate rent and other sums reserved hereunder plus the Fair Market Value of the Equipment, without any presentment, demand, protest or further notice (all of which are expressly waived by Lessee). In the event Lessor repossesses any of the
Equipment. Lessor may sell, lease or otherwise dispose of said Equipment in such manner, at such times, and upon such terms as Lessor may reasonably determine. If Lessor does repossess and sell the Equipment, the proceeds thereof shall be applied
to: (i) all costs and expenses (including attorney’s fees) of such disposition; (ii) the unpaid accrued rentals, taxes, fees, delinquency charges, interest and all or any other sums due and owing; (iii) the unpaid accelerated
rentals; and (iv) the Fair Market Value of the Equipment. Any excess proceeds shall be remitted to Lessee. If Lessor re-leases the Equipment, the re-lease rentals
received for the period through the end of the 
  

					
	CELTIC LEASING CORP. (CMLR 3/03)	 	Initials: KA	 	

 original Base Term of the Lease shall be first applied as described in (i), (ii), (iii), and (iv), above,
with any excess to be remitted to the Lessee. The exercise of any of the foregoing remedies by Lessor shall not constitute a termination of the Lease or of any Schedule unless Lessor so notifies Lessee in writing. All remedies of Lessor shall be
deemed cumulative and may be exercised concurrently or separately. The waiver by Lessor of any breach of any obligation of Lessee shall not be deemed a waiver of a breach of any other obligation or of any future breach of the same obligation. The
subsequent acceptance of rental payments hereunder by Lessor shall not be deemed a waiver of any prior or existing breach by Lessee regardless of Lessor’s knowledge of such breach. If any Schedule is deemed at any lime to be a lease intended as
security. Lessee grants Lessor a security interest in the Equipment to secure its obligations under this Lease and all other indebtedness at any time owing by Lessee to Lessor. Lessee agrees that upon the occurrence of an Event of Default, in
addition to all of the other rights and remedies available to Lessor hereunder. Lessor shall have all of the rights and remedies of a secured party under the Uniform Commercial Code. 

19. PERFORMANCE OF LESSEE’S OBLIGATIONS BY LESSOR: If Lessee fails to perform any of its obligations hereunder. Lessor
shall have the right, but shall not be obligated, to perform the same for the account of Lessee without thereby waiving Lessee’s default. Any amount paid and any expense, penalty or other liability incurred by Lessor in such performance shall
become due and payable by Lessee to Lessor upon demand. 
 20. PURCHASE AGREEMENTS: In the event any of the Equipment is subject to any
acquisition or purchase agreement (“Acquisition Agreement”) between Lessee and the Manufacturer, then Lessee, as part of this Lease when approved by Lessor, transfers and assigns to Lessor any and all of Lessee’s rights, title and
interest (excepting that which is inherent to or granted by this Lease), but none of its obligations (except Lessee’s obligation to pay for the Equipment, which Lessor shall do after Lessee’s acceptance of the Equipment, provided all
documentation required by Lessor has been completed and that Lessor’s approval remains valid), in and to the Acquisition Agreement(s) and the subject Equipment IN THE EVENT LESSEE ISSUES A PURCHASE ORDER TO LESSOR WITH RESPECT TO THIS LEASE,
ANY SCHEDULE, OR ANY OF THE EQUIPMENT. IT IS AGREED THAT ANY SUCH PURCHASE ORDER IS FOR LESSEE’S INTERNAL PURPOSES ONLY AND THAT NONE OF ITS TERMS AND CONDITIONS SHALL MODIFY THIS LEASE OR ANY RELATED DOCUMENTATION. OR AFFECT EITHER
PARTIES’ RESPONSIBILITIES AS SET FORTH IN THIS LEASE. 
 21. NOTICES: All notices hereunder shall be in writing and shall be given
by personal delivery or sent by certified mail, return receipt requested, or reputable overnight courier service, postage expense prepaid, to the address of the other party as set forth herein or to any later address last known to the sender. All
notices to Lessor shall be addressed to the attention of Vice President, Contracts, and must be executed by an authorized officer of Lessee to be effective. Notice shall be effective upon signed receipt or other evidence of delivery. 

22. APPLICABLE LAW/ARBITRATION: The parties agree that any action brought to enforce any of the terms, or to recover for any breach,
whether based in tort, contract or otherwise, relating to or arising out of this Lease (collectively, “Lease Disputes”) will be submitted to the Orange County, California, office of JAMS/Endispute LLC (“JAMS”), for a trial of all
issues of law and fact conducted by a retired judge or justice from the panel of JAMS, appointed pursuant to a general reference under California Code of Civil Procedure, Section 638(1) (or any amendment, addition or successor section thereto)
unless Lessor or its Assignee selects an alternative forum. If the parties are unable to agree on a member of the JAMS panel, then one shall be appointed by the presiding Judge of the California Superior Court for the County of Orange. In the event
that JAMS in the County of Orange ceases to exist, then the parties agree that all Lease Disputes will be filed and conducted in the appropriate court having jurisdiction in the County of Orange, unless Lessor or its Assignee selects an alternative
forum. Lessee agrees to submit to the personal jurisdiction of the appropriate California Court for all Lease Disputes. Lessee waives its rights to a jury trial in any action arising out of or relating to this Lease. The prevailing party in any
Lease Disputes is entitled to recover from the other party reasonable attorney’s fees and costs, including all JAMS related costs and costs of collection (including judgment enforcement and collection costs). This Lease has been entered into
and shall be performed in California and, therefore, this Lease shall be construed in accordance with and shall be governed by. the internal substantive laws of the State of California (exclusive of principles of conflict of laws). TIME IS OF THE
ESSENCE. 
 23. GENERAL: Neither this Lease nor any Schedule shall hind Lessor in any manner, and no obligation of Lessor shall arise, until the
respective instrument is duly executed by an authorized officer of Lessor. If more than one Lessee is named in this Lease or there is a Guarantor of this Lease, the liability of each shall be joint and several. This Lease and each Schedule shall
inure to the benefit of and be binding upon Lessor, Lessee and their respective successors except as expressly provided for herein. All representations, warranties, indemnities and covenants contained herein, or in any document now or at any other
time delivered in connection herewith, which by their nature would continue beyond the termination or expiration of this Lease, shall continue in full force and effect and shall survive the termination or expiration of this Lease. 

24. ENTIRE AGREEMENT: THIS LEASE, TOGETHER WITH All DULY EXECUTED SCHEDULES, CONSTITUTES THE ENTIRE AGREEMENT BETWEEN LESSEE AND LESSOR WITH RESPECT TO
THE EQUIPMENT AND SHALL SUPERSEDE ANY AND ALL PRIOR PROPOSALS, NEGOTIATIONS AND/OR OTHER COMMUNICATIONS. ORAL OR WRITTEN. NO MODIFICATION TO THIS AGREEMENT SHALL BE EFFECTIVE UNLESS MADE IN WRITING AND DULY EXECUTED BY LESSEE AND AN AUTHORIZED
OFFICER OF LESSOR. NO ORAL OR WRITTEN GUARANTY, PROMISE. CONDITION. REPRESENTATION OR WARRANTY SHALL BE BINDING UNLESS MADE A PART OF THIS LEASE BY DULY EXECUTED ADDENDUM. UNLESS SPECIFIED OTHERWISE. IN THE EVENT ANY SUCH DULY EXECUTED MODIFICATION
IS ATTACHED TO AND MADE A PART OF ANY SPECIFIC SCHEDULE. THE TERMS AND CONDITIONS OF SUCH MODIFICATION SHALL APPLY ONLY TO THAT SPECIFIC SCHEDULE. AND SHALL NOT APPLY TO ANY OTHER SCHEDULE. 

PLEASE INITIAL BELOW TO CERTIFY YOUR ACKNOWLEDGMENT AND AGREEMENT THAT NO MODIFICATION TO THIS LEASE SHALL BE EFFECTIVE UNLESS IN WRITING
AND SIGNED BY LESSEE AND AN AUTHORIZED OFFICER OF LESSOR. 
  

									
	 Lessee Initials: KA
	 		 	 Lessor Initials: ___________

					
	Lessee:	 	Exagen Diagnostics, Inc.	 		 	Lessor:	 	CELTIC LEASING CORP.
	 Signature:
	 	/s/ Kamal Adawi	 		 	Signature:	 	/s/ Sarah A. Powers
	Name:	 	Kamal Adawi	 		 	Name:	 	Sarah A. Powers
	Title:	 	CFO	 		 	Title:	 	Vice President
	Date Offered:	 	 	 		 	Date Accepted:	 	

 CELTIC LEASING CORP. (CMLR 3/03) 

 CORPORATE CERTIFICATE 

THE UNDERSIGNED DOES HEREBY CERTIFY that: (a) I am an officer of Exagen Diagnostics, Inc., a corporation duly
organized and validly existing under the laws of the state of Delaware; and (b) that the persons whose names and signatures appear below are, and have been at all times, duly qualified and authorized to execute, on behalf
of this Corporation, any and all documents and instruments in connection with the lease, purchase, sale or other disposition of personal property from or to CELTIC LEASING CORP. including, but not limited to, Master Leases, Lease Schedules, Purchase
and Sale Agreements, and other documents relating thereto. 
  

					
	 NAME
	  	 TITLE
	  	 SIGNATURE

			
	Kamal Adawi	  	CFO	  	/s/ Kamal Adawi
			
	     
	  	  
	  	  

			
	     
	  	  
	  	  

 IN WITNESS WHEREOF, the undersigned officer has executed this Certificate on the date set forth below. 

 

							
		 		 	Signature:	 	/s/ Mark Hazeltine
		 		 		 	(OF CERTIFYING OFFICER)
	 (AFFIX CORP. SEAL HERE)
	 		 	Name:	 	Mark Hazeltine
		 		 		 	(PRINT OR TYPE)
		 		 	Title:	 	VP of Finance
		 		 		 	(OFFICER TITLE-PREFERABLY SECRETARY OR ASST. SEC.)
		 		 	Date:	 	FEBRUARY 1, 2018

 L:\CC000 

					
	 

	  	LEASE SCHEDULE No. 3861A01	  	ANNEXED TO AND MADE A PART OF MASTER
	  	CELTIC LEASING CORP. — Lessor	  	LEASE NO. CML- 3861A DATED:                     
		  	4 PARK PLAZA. SUITE 300. IRVINE. CALIFORNIA 92614 • (949) 263-3880 • FAX: (949) 263-1331

 Lessee: Exagen Diagnostics, Inc. 

Corporate Address : 1261 Liberty Way, Vista, CA 92081 
  

					
	Contact : Kamal Adawi	  	Title: CFO	  	Phone No. 

 Equipment 
 Location: Same as
above 
  

					
	 Contact: Kamal Adawi
	  	Title: CFO	  	Phone No. 

 This Schedule is issued pursuant to the Master Lease referenced above between Lessee and Lessor. All of the terms and
conditions of the Master Lease are incorporated herein and made a part hereof as if such terms and conditions were set forth in this Schedule. By their execution and delivery of this Schedule, the parties hereby reaffirm all of the terms and
conditions of the Master Lease. 
 Equipment Leased: 
  

							
	 ITEM
	  	 QTY
	  	 SERIAL NO.
	  	 DESCRIPTION

		  		  		  	VENDOR(S): to be determined
				
	 1.-?
	  	various	  		  	Items of Equipment expected to include: miscellaneous Tecan EVO 100, and/or other related and/or accessory property. Items 1, and on shall be enumerated and described in further detail, including location and vendor name, at a
later date on the related applicable Acceptance Certificate(S).

 NOTE: Equipment cost to Lessor not to exceed: $107,000 00 

 

													
	 MONTHLY RENT
	  	BASE TERM
IN MONTHS	 	  	 DEPOSIT APPLIED TO
LAST BILLING CYCLE
	  	 BILLING CYCLE
	  	 FINAL

COMMENCEMENT
DATE

	 $2,311.00

(PLUS APPLICABLE TAXES)
	  	 	48	 	  	 ONE MONTH’S RENT
	  	 ☐MONTHLY
 ☐BIANNUALLY
	 	 ☒QUARTERLY
 ☐ANNUALLY
	  	

 By execution hereof, the parties hereby reaffirm their acknowledgment and agreement that no modification to
this Lease shall be effective unless in writing and signed by Lessee and an authorized officer of Lessor. 
  

									
	OFFER	 		 	ACCEPTANCE
					
	Lessee:	 	Exagen Diagnostics, Inc.	 		 	Lessor:	 	CELTIC LEASING CORP.
	Signature:	 	/s/ Kamal Adawi	 		 	Signature:	 	/s/ Sarah A. Powers
	Name:	 	Kamal Adawi	 		 	Name:	 	Sarah A. Powers
	Title:	 	CFO	 		 	Title:	 	Vice President
	Date:	 	 	 		 	Date:	 	 

 LS 
 1991 CELTIC
LEASING CORP (CMLS 2/93) 

									
	

	 		 	 4 Park Plaza, Suite 300
 Irvine, CA
92614
	 	 TEL.: 949.263.3880
 FAX: 949.263.1331
	 	 info@celticleasing.com

www.celticleasing.com

 January 19, 2018 

Exagen Diagnostics, Inc., 
 1261 Liberty Way, 

Vista, CA 92081 
  

	RE:	 Lease Schedule No. 3861A01 (the “Schedule”), to Master Lease No. CML-386IA (the
“Lease”), by and between Celtic Leasing Corp., as Lessor, and Exagen Diagnostics, Inc. as Lessee, and all duly executed supplemental documentation relating to said Lease and Schedule (collectively, the Lease, the Schedule, and all
related supplemental documentation, is herein referred to as the “Transaction”). 

 Ladies/Gentlemen: 

Notwithstanding anything to the contrary contained in the above referenced Transaction, and to the limited extent hereof, this Letter Agreement amends and
supersedes said Transaction and is hereby incorporated by reference therein. 
 Lessee has requested and Lessor has agreed that, in the event Lessee returns
the Equipment subject to this Schedule in accordance with the terms of the Master Lease. Lessee shall pay to Lessor a restocking fee equal to 5% percent of the original Equipment cost. 

In all other respects, the terms of the Transaction as currently set forth shall remain in full force and effect. Please acknowledge your acceptance of this
Letter Agreement by your authorized signature below and return the original to Celtic Leasing Corp. 
 Sincerely, 

CELTIC LEASING CORP. 
  

							
	/s/ Sarah A. Powers	 		 	 ACKNOWLEDGED AND AGREED:
  

Exagen Diagnostics, Inc.

	 Sarah A. Powers

Vice President
	 		 	 Signature:
	 	/s/ Kamal Adawi
				
		 		 	Name:	 	Kamal Adawi
				
		 		 	Title:	 	CFO
				
	SAP/kg	 		 	Date:	 	 

 THE PERSONAL SIDE OF BUSINESS 

 MISDIRECTED INVOICE/ASSIGNMENT OF INVOICE/BILL OF SALE 

relating to 
 all Lease Schedules
now or hereafter attached to and made a part of Master Lease No. CML-3861A, 
 by and between 

CELTIC LEASING CORP., as Lessor, 

and 
 Exagen Diagnostics,
Inc., as Lessee (the “Lease”) 
 This is to acknowledge that for all items of equipment now or hereafter subject to the above-referenced
Lease Schedules (the “Equipment”), it has been and is since prior to delivery of said Equipment, the intent of Lessee to lease the Equipment from Lessor. However, certain vendor(s) may inadvertently misdirect invoicing to Lessee for the
Equipment, instead of to Lessor. Any such misdirected invoice(s) will be paid by Lessor (unless clearly documented otherwise). Lessee hereby acknowledges that it is not its intention to acquire any rights, title or interest in any of the Equipment
(except for those rights and interests granted under the Lease), and, therefore, for valuable consideration, receipt of which is hereby acknowledged, Lessee hereby assigns, sets over, and transfers to Lessor any and all rights, title and interest it
may inadvertently acquire to the Equipment as a result of any such misdirected invoice(s). Upon payment of these misdirected invoice(s) by Lessor (and/or its Assignee), Lessee acknowledges that Lessor shall acquire free and clear title to the
subject Equipment. 
 READ, ACKNOWLEDGED AND AGREED TO: 
  

									
	Lessee:	 	Exagen Diagnostics, Inc.	 		 	Lessor:	 	CELTIC LEASING CORP.
	Signature:	 	/s/ Kamal Adawi	 		 	Signature:	 	/s/ Sarah A. Powers
	Name:	 	Kamal Adawi	 		 	Name:	 	Sarah A. Powers
	Title:	 	CFO	 		 	Title:	 	Vice President
	Date:	 	 	 		 	Date:	 	 

 L:\MIBROAD00 

 NOTARIZATION OF SIGNATURES 

 

					
	RE	 	:	  	Celtic Master Lease No. CML-3861A
			
	LESSEE	 	:	  	Exagen Diagnostics, Inc.
			
	SIGNER(S)	 	:	  	Kamal Adawi

 In regards to the above referenced transaction, Celtic Leasing Corp. requires that the below requested Lessee signature(s) be
authenticated by a notary public. Please also attach photocopies of each signer’s driver’s license. Be sure to provide current address and phone number of each Signer. 

 

							
	NAME OF SIGNER :	 	Kamal Adawi	  	SIGNATURE:	 	/s/ Kamal Adawi
	HOME ADDRESS :	 	1431 PACIFIC HWY UNIT 812	  	PHONE:	 	
		 	San Diego, CA 92101	  		 	

  

			
	STATE OF California	  	 

	COUNTY OF San Diego SS.
	On this 01 day of February, 2018, before me, personally appeared Kamal Adawi personally known to me (or proved to me on the basis of satisfactory evidence) to be the person whose name is subscribed to the within instrument
and acknowledged that he executed the same in his authorized capacity, and that by his signature on the instrument the person or the entity upon behalf of which the person(s) acted, executed the instrument
		
	WITNESS my hand and official seal.	  	(This area for official notarial seal)
		
	

	  	
	Notary Public in and for said County and Slate	  	

 NOS 

 CELTIC LEASING CORP.—Lessor 

4 Park Plaza. Suite 300 Irvine, California 92614 (949)263-3880 FAX: (949)
263-1331 
 INSURANCE AUTHORIZATION 

January 18, 2018 
 Exagen Diagnostics,
Inc.—Lessee 
 1261 Liberty Way 
 Vista. CA 92081 

RE: Leased Property now or in the future subject to Celtic Master Lease No. CML-3861A (the “Agreement”). 

Gentlemen: 
 Please type or print clearly the following
information with respect to your insurance coverage and sign below to authorize us to obtain Certificates of Insurance covering the equipment subject to the above referenced Agreement naming Celtic Leasing Corp.—and our assignee, if any—as
Co-Loss Payee(s) on the Physical Damage Insurance and Additional Insured(s) on the Liability Coverage: 
  

			
	PROPERTY/CASUALTY:	  	LIABILITY:
		
	Klein & Costa/Lockton Insurance	  	Federal Insurance Company/Lockton Insurance
	Insurance Company/Agent	  	Insurance Company/Agent
		
	4275 Executive Square Ste 600	  	4275 Executive Square Ste 600
	Street Address	  	Street Address
		
	La Jolla, CA 92023	  	La Jolla, CA 92023
	City, State, Zip	  	City. State, Zip
		
	Julie Werner	  	Julie Werner
	 Contact
	  	 Contact

	Phone Number	  	Phone Number
		
	                                      
                      	  	                                      
                      
	Fax Number	  	Fax Number
	Email Address	  	Email Address

 Please call the undersigned at 949-263-3880,
x1051, if you have any questions. Thank you for your assistance. 
  

					
	Sincerely,	 	 	  	 
			
	CELTIC LEASING CORP.	 		  	
	/s/ Britney Brumley	 	 INSURANCE REQUEST CONFIRMED AND AUTHORIZED:

 
 Exagen Diagnostics, Inc.

	Britney Brumley	 		  	
	Assistant Documentation Administrator	 	Signature:	  	 /s/ Kamal Adawi

		 	Name:	  	Kamal Adawi
		 	Title:	  	CFO
	/bb	 	Date:	  	2-1-2018
			
	L:\IAANYDSEX-10.32

 Exhibit 10.32 

LOAN AND SECURITY AGREEMENT 

THIS LOAN AND SECURITY AGREEMENT (as the same may be amended, restated, modified, or supplemented from time to time, this
“Agreement”) dated as of September 7, 2017 (the “Effective Date”) among INNOVATUS LIFE SCIENCES LENDING FUND I, LP, a Delaware limited partnership (together with its successors and assigns,
“Innovatus”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, “Collateral Agent”), and the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto
from time to time, and EXAGEN DIAGNOSTICS, INC., a Delaware corporation (“Borrower”), provides the terms on which the Lenders shall lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows: 

 

	1.	 DEFINITIONS, ACCOUNTING AND OTHER TERMS 

1.1    Capitalized terms used herein shall have the meanings set forth in Section 13 to
the extent defined therein. All other capitalized terms used but not defined herein shall have the meaning given to such terms in the Code. Any accounting term used but not defined herein shall be construed in accordance with GAAP and all
calculations shall be made in accordance with GAAP. The term “financial statements” shall include the accompanying notes and schedules. Any section, subsection, schedule or exhibit references are to this Agreement unless otherwise
specified. 
  

	2.	 LOANS AND TERMS OF PAYMENT 

2.1    Promise to Pay. Borrower hereby unconditionally promises to pay each Lender the outstanding principal
amount of the Term Loan advanced to Borrower by such Lender and accrued and unpaid interest thereon and any other amounts due hereunder as and when due in accordance with this Agreement. 

2.2    Term Loans. 

(a)    Availability. (i) Subject to the terms and conditions of this Agreement, the Lenders agree, severally
and not jointly, to make a term loan to Borrower on the Effective Date in an aggregate principal amount of Twenty Million Dollars ($20,000,000.00) according to each Lender’s Term A Loan Commitment as set forth on Schedule 1.1 hereto (the
“Term A Loan”). After repayment, the Term A Loan may not be re-borrowed. 

(ii)    Subject to the terms and conditions of this Agreement, the Lenders agree, severally and not jointly, during the
Second Draw Period, to make an additional term loan to Borrower in an aggregate amount of Five Million Dollars ($5,000,000.00) according to each Lender’s Term B Loan Commitment as set forth on Schedule 1.1 hereto (such term loans are
hereinafter referred to singly as a “Term B Loan”, and collectively as the “Term B Loans”; each Term A Loan or Term B Loan is hereinafter referred to singly as a “Term Loan” and the Term A Loans and
the Term B Loans are hereinafter referred to collectively as the “Term Loans”). After repayment, no Term B Loan may be re-borrowed. 

(b)    Repayment. Borrower shall make monthly payments of interest only commencing on the second (2nd) Payment Date
following the Funding Date of the Term Loan, and continuing on the Payment Date of each successive month thereafter through and including the Payment Date immediately preceding the Amortization Date. Borrower agrees to pay, on the Funding Date of
the Term Loan, any initial partial monthly interest payment otherwise due for the period between the Funding Date of such Term Loan and the first Payment Date after such Funding Date. Commencing on the Amortization Date, and continuing on the
Payment Date of each month thereafter, Borrower shall make consecutive equal monthly payments of principal, plus interest, in arrears, to each Lender, as calculated by Collateral Agent (which calculations shall be deemed correct absent manifest
error) based upon: (1) the amount of such Lender’s Term Loan, (2) the effective rate of interest, as determined in Section 2.3(a), and (3) a repayment schedule equal to (i) in the case of the Early Amortization Date
being applicable, eighteen (18) months or (ii) in the case of any other Amortization Date being applicable, twenty-four (24) months. All unpaid principal and accrued and unpaid interest with respect to the Term Loan is due and payable
in full on the Maturity Date. The Term Loan may only be prepaid in accordance with Sections 2.2(c) and 2.2(d). 

 (c)    Mandatory Prepayments. If an event described in
Section 7.2(c)(ii) occurs or the Term Loan is accelerated following the occurrence of an Event of Default, Borrower shall immediately pay to Lenders, payable to each Lender in accordance with its respective Pro Rata Share, an amount equal to
the sum of: (i) all outstanding principal of the Term Loan plus accrued and unpaid interest thereon through the prepayment date, (ii) the Final Fee, (iii) the Prepayment Fee, plus (iv) all other Obligations that are due and payable,
including, without limitation, Lenders’ Expenses and interest at the Default Rate with respect to any past due amounts. Notwithstanding (but without duplication with) the foregoing, on the Maturity Date, if the Final Fee had not previously been
paid in full in connection with the prepayment of the Term Loan in full, Borrower shall pay to each Lender in accordance with its respective Pro Rata Share, the Final Fee in respect of the Term Loan. 

(d)    Permitted Prepayment of Term Loan. From and after the first anniversary of the Effective Date only, Borrower
shall have the option to prepay all or part of the Term Loan advanced by the Lenders under this Agreement, provided Borrower (i) provides written notice to Collateral Agent of its election to prepay the Term Loan at least five (5) days
prior to such prepayment, (ii) in the event of a partial prepayment, prepays such part of the Term Loan in a denomination that is a whole number multiple of Five Million Dollars ($5,000,000.00), and (iii) pays to the Lenders on the date of such
prepayment, payable to each Lender in accordance with its respective Pro Rata Share, an amount equal to the sum of (A) the portion of outstanding principal of the Term Loan being prepaid plus all accrued and unpaid interest thereon through the
prepayment date, (B) the applicable Final Payment with respect to the portion of the Term Loan being prepaid, (C) all other Obligations that are then due and payable, including Lenders’ Expenses and interest at the Default Rate with
respect to any past due amounts pursuant to the terms of this Agreement, and (D) the applicable Prepayment Fee with respect to the portion of the Term Loan being prepaid. For the sake of clarity, any partial prepayment shall be applied pro-rata to all outstanding amounts under the Term Loan, and shall be applied on a pro-rata basis to all remaining payments outstanding in inverse order of maturity.
Notwithstanding the foregoing, any prepayment made by Borrower after the first anniversary of the Effective Date but prior to the second anniversary of the Effective Date shall be in full and permitted solely in connection with a Permitted
Prepayment Reason. 
 2.3    Payment of Interest on the Term Loan. 

(a)    Interest Rate. Subject to Section 2.3(b), the principal amount outstanding under the Term Loan shall
accrue interest at a fixed per annum rate equal to eleven percent (11.00%), which interest shall be payable monthly in arrears in accordance with Sections 2.2(b) and 2.3(e); provided that two and one-half
percent (2.50%) of such eleven percent (11.00%) interest rate shall be payable in-kind by adding an amount equal to such two and one- half percent (2.50%) interest to
the then outstanding principal balance on a monthly basis so as to increase the outstanding principal balance of such Term Loan on each Payment Date and which amount shall be payable when the principal amount of the Term Loan is payable in
accordance with Sections 2.2(b) and 2.3(e) and on which principal amount interest shall be owed pursuant to Section 2.3(a). 
 Interest
shall accrue on the Term Loan commencing on, and including, the Funding Date of the Term Loan, and shall accrue on the principal amount outstanding under the Term Loan through and including the day on which the Term Loan is paid in full. 

(b)    Default Rate. Immediately upon the occurrence and during the continuance of an Event of Default, Obligations
shall accrue interest at a fixed per annum rate equal to the rate that is otherwise applicable thereto plus four percentage points (4.00%) (the “Default Rate”). Payment or acceptance of the increased interest rate provided in this
Section 2.3(b) is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of Collateral Agent. 

(c)    365-Day Year. Interest shall be computed on the basis of a three
hundred sixty-five (365) day year and the actual number of days elapsed. 
 (d)    Debit of Accounts.
Collateral Agent and each Lender may debit (or ACH) any deposit accounts designated by Borrower, maintained by Borrower for principal and interest payments or any other amounts Borrower owes the Lenders under the Loan Documents when due. Any such
debits (or ACH activity) shall not constitute a set off. 

  
 2 

 (e)    Payments. Except as otherwise expressly provided herein,
all payments by Borrower under the Loan Documents shall be made to the respective Lender to which such payments are owed, at such Lender’s office in immediately available funds on the date specified herein. Unless otherwise provided, interest
is payable monthly on the Payment Date of each month. Payments of principal and/or interest received after 2:00 p.m. New York City time are considered received at the opening of business on the next Business Day. When a payment is due on a day that
is not a Business Day, the payment is due the next Business Day and additional fees or interest, as applicable, shall continue to accrue until paid. All payments to be made by Borrower hereunder or under any other Loan Document, including payments
of principal and interest, and all fees, expenses, indemnities and reimbursements, shall be made without set-off, recoupment or counterclaim, in lawful money of the United States and in immediately available
funds. 
 2.4    Fees. Borrower shall pay to Collateral Agent: 

(a)    Facility Fee. The Facility Fee, which shall be due on the Effective Date, payable solely for the account of
Collateral Agent; 
 (b)    Final Fee. The Final Fee, when due hereunder, to be shared among the Lenders in
accordance with their respective Pro Rata Shares; 
 (c)    Prepayment Fee. The Prepayment Fee, when due
hereunder, to be shared among the Lenders in accordance with their respective Pro Rata Shares; and 

(d)    Lenders’ Expenses. All Lenders’ Expenses (including reasonable attorneys’ fees and expenses
for due diligence, investigation, documentation and negotiation of this Agreement) incurred through and after the Effective Date, when due. 

2.5    Taxes. 

(a)    Payments Free of Taxes. Any and all payments by or on account of any obligation of Borrower under any Loan
Document shall be made without deduction or withholding for any Taxes, except as required by applicable law. If any applicable law (as determined in the good faith discretion of an applicable Withholding Agent) requires the deduction or withholding
of any Tax from any such payment by a Withholding Agent, then the applicable Withholding Agent shall be entitled to make such deduction or withholding and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority
in accordance with applicable law and, if such Tax is an Indemnified Tax, then the sum payable by Borrower shall be increased as necessary so that after such deduction or withholding has been made (including such deductions and withholdings
applicable to additional sums payable under this Section) the applicable Recipient receives an amount equal to the sum it would have received had no such deduction or withholding been made. 

(b)    Payment of Other Taxes by Borrower. Borrower shall timely pay to the relevant Governmental Authority in
accordance with applicable law, or at the option of the Lender timely reimburse it for the payment of, any Other Taxes. 

(c)    Indemnification by the Borrower. Borrower shall indemnify each Recipient, within 10 days after demand
therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section) payable or paid by such Recipient or required to be withheld or deducted from a payment
to such Recipient and any reasonable expenses arising therefrom or with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of
such payment or liability delivered to the Borrower by a Lender (with a copy to the Collateral Agent), or by the Collateral Agent on its own behalf or on behalf of a Lender, shall be conclusive absent manifest error. 

(d)    Evidence of Payments. As soon as practicable after any payment of Taxes by the Borrower to a Governmental
Authority pursuant to this Section 2.5, Borrower shall deliver to the Collateral Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy

  
 3 

 
of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Collateral Agent. 

(e)    Status of Lenders. 

(i)    Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made
under any Loan Document shall deliver to Borrower, at the time or times reasonably requested by Borrower, such properly completed and executed documentation reasonably requested by Borrower as will permit such payments to be made without withholding
or at a reduced rate of withholding. In addition, any Lender, if reasonably requested by Borrower, shall deliver such other documentation prescribed by applicable law or reasonably requested by Borrower as will enable Borrower to determine whether
or not such Lender is subject to backup withholding or information reporting requirements. Notwithstanding anything to the contrary in the preceding two sentences, the completion, execution and submission of such documentation shall not be required
if in the Lender’s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender; 

(ii)    Without limiting the generality of the foregoing, in the event that Borrower is a U.S. Borrower; 

1)    any Lender that is a U.S. Person shall deliver to the Borrower on or prior to the date on which such Lender becomes
a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower), executed copies of IRS Form W-9 certifying that such Lender is exempt from U.S. federal backup
withholding tax; 
 2)    any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to Borrower
(in such number of copies as shall be requested by the Recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Borrower), whichever of
the following is applicable; 
 i)    in the case of a Foreign Lender claiming the benefits of an income tax treaty to
which the United States is a party (x) with respect to payments of interest under any Loan Document, executed copies of IRS Form W-8BEN or
W-8BEN-E establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “interest” article of such tax treaty and (y) with
respect to any other applicable payments under any Loan Document, IRS Form W-8BEN or W-8BEN-E establishing an exemption from, or
reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other income” article of such tax treaty; 

ii)    executed copies of IRS Form W-8ECI; 

iii)    in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under
Section 881(c) of the IRC, (x) a certificate substantially in the form of Annex- W to the effect that such Foreign Lender is not a “bank” within the meaning of Section 881(c)(3)(A) of the IRC, a “10 percent
shareholder” of the Borrower within the meaning of Section 881(c)(3)(B) of the IRC, or a “controlled foreign corporation” described in Section 881(c)(3)(C) of the IRC (a “U.S. Tax Compliance Certificate”) and
(y) executed copies of IRS Form W-8BEN or W-8BEN-E; or 

iv)    to the extent a Foreign Lender is not the beneficial owner, executed copies of IRS Form W-8IMY, accompanied by IRS Form W-8ECI, IRS Form W-8BEN,
W-8BEN-E, a U.S. Tax Compliance Certificate substantially in the form of Annex-X or
Annex-Y, IRS Form W-9, and/or other certification documents from each beneficial owner, as applicable; provided that if the Foreign Lender is a partnership and one or
more direct or indirect partners of such Foreign Lender are claiming the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate substantially in the form of Annex- Z on behalf of each such direct and indirect
partner; 

  
 4 

 3)    any Foreign Lender shall, to the extent it is legally entitled to
do so, deliver to the Borrower (in such number of copies as shall be requested by the Recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request
of the Borrower), executed copies of any other form prescribed by applicable law as a basis for claiming exemption from or a reduction in U.S. federal withholding Tax, duly completed, together with such supplementary documentation as may be
prescribed by applicable law to permit the Borrower to determine the withholding or deduction required to be made; and 

4)    if a payment made to a Lender under any Loan Document would be subject to U.S. federal withholding Tax imposed by
FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the IRC, as applicable), such Lender shall deliver to the Borrower at the time or times
prescribed by law and at such time or times reasonably requested by the Borrower such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the IRC) and such additional documentation reasonably
requested by the Borrower as may be necessary for the Borrower to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and
withhold from such payment. Solely for purposes of this clause (4), “FATCA” shall include any amendments made to FATCA after the date of this Agreement. 

Each Lender agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall update such
form or certification or promptly notify the Borrower in writing of its legal inability to do so. 

(f)    Survival. Each party’s obligations under this Section 2.5 shall survive the resignation or
replacement of the Collateral Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all obligations under any Loan Document. 

2.6    Secured Promissory Notes. The Term Loan shall be evidenced by a Secured Promissory Note or Notes in
the form attached as Exhibit D hereto (each a “Secured Promissory Note”), and shall be repayable as set forth in this Agreement. Borrower irrevocably authorizes each Lender to make or cause to be made, on or about the Funding
Date of any Term Loan or at the time of receipt of any payment of principal on such Lender’s Secured Promissory Note, an appropriate notation on such Lender’s Secured Promissory Note Record reflecting the making of such Term Loan or (as
the case may be) the receipt of such payment. Absent manifest error, the outstanding amount of each Term Loan set forth on such Lender’s Secured Promissory Note Record shall be prima facie evidence of the principal amount thereof owing and
unpaid to such Lender, but the failure to record, or any error in so recording, any such amount on such Lender’s Secured Promissory Note Record shall not limit or otherwise affect the obligations of Borrower under any Secured Promissory Note or
any other Loan Document to make payments of principal of or interest on any Secured Promissory Note when due. Upon receipt of an affidavit of an officer of a Lender, in form and substance reasonably satisfactory to Borrower as to the loss, theft,
destruction, or mutilation of its Secured Promissory Note, Borrower shall issue, in lieu thereof, a replacement Secured Promissory Note in the same principal amount thereof and of like tenor. 

 

	3.	 CONDITIONS OF LOANS 

3.1    Conditions Precedent to Initial Term Loan. Each Lender’s obligation to make the Term Loan is
subject to the condition precedent that Collateral Agent and each Lender shall consent to or shall have received, in form and substance satisfactory to Collateral Agent and each Lender, such documents, and completion of such other matters, as
Collateral Agent and each Lender may reasonably deem necessary or appropriate, including, without limitation: 

(a)    original Loan Documents, each duly executed by Borrower and each Subsidiary, as applicable; 

(b)    a completed Perfection Certificate for Borrower and each of its Subsidiaries; 

  
 5 

 (c)    duly executed original Control Agreements with respect to any
Collateral Accounts maintained by Borrower or any of its Subsidiaries as required under Section 6.6; 
 (d)    the
Operating Documents and good standing certificates of Borrower and its Subsidiaries certified by the Secretary of State (or equivalent agency) of Borrower’s and such Subsidiaries’ jurisdiction of organization or formation and each
jurisdiction in which Borrower and each Subsidiary is qualified to conduct business, each as of a date no earlier than thirty (30) days prior to the Effective Date; 

(e)    a copy of resolutions of the governing body for Borrower evidencing approval of the Term Loan and other
transactions evidenced by the Loan Documents; 
 (f)    duly executed original officer’s certificates for Borrower
and each Subsidiary that is a party to the Loan Documents certifying as to (i) the incumbency of each Responsible Officer executing each Loan Document and (ii) the documents delivered pursuant to Section 3.1(d) and 3.1(e), in a form
acceptable to Collateral Agent and the Lenders; 
 (g)    certified copies, dated as of date no earlier than thirty
(30) days prior to the Effective Date, of financing statement searches, as Collateral Agent shall request, accompanied by written evidence (including any UCC termination statements) that the Liens indicated in any such financing statements
either constitute Permitted Liens or have been or, in connection with the initial Term Loan, will be terminated or released; 

(h)     a duly executed legal opinion of counsel to Borrower dated as of the Effective Date; 

(i)    evidence satisfactory to Collateral Agent and the Lenders that the insurance policies required by Section 6.5
hereof are in full force and effect, together with appropriate evidence showing loss payable and/or additional insured clauses or endorsements in favor of Collateral Agent, for the ratable benefit of the Lenders; 

(j)     a copy of any applicable Investors Rights Agreement and any amendments thereto; 

(k)     payment of the Facility Fee and Lenders’ Expenses then due as specified in Section 2.4 hereof; 

(l)    a landlord’s consent executed in favor of Collateral Agent in respect of all of Borrower’s and each
Subsidiaries’ leased locations; 
 (m)    a bailee waiver executed in favor of Collateral Agent in respect of each
third party bailee where Borrower or any Subsidiary maintains Collateral having a book value in excess of Two Hundred Fifty Thousand Dollars ($250,000.00); 

(n)     a payoff letter from CRP in respect of the Existing Indebtedness; and 

(o)     evidence that (i) the Liens securing the Existing Indebtedness will be terminated and (ii) the documents
and/or filings evidencing the perfection of such Liens, including without limitation any financing statements and/or control agreements, have or will, concurrently with the initial Credit Extension, be terminated. 

3.2    Conditions Precedent to all Term Loans. The obligation of each Lender to extend each Term Loan,
including the initial Term Loan, is subject to the following conditions precedent: 
 (a)    receipt by Collateral Agent
of (i) an executed Loan Payment Request Form in the form of Exhibit B-1 attached hereto and (ii) an executed Disbursement Letter in the form of Exhibit
B-2 attached hereto; 
 (b)    the representations and warranties in
Section 5 hereof shall be true, accurate and complete in all material respects on the date of each Loan Payment Request Form and the date of each Disbursement Letter and the Funding Date of each Term Loan; provided, however, that such
materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text 

  
 6 

 
thereof; and provided, further that those representations and warranties expressly referring to a specific date shall be true, accurate and complete in all material respects as of such date, and
no Event of Default shall have occurred and be continuing or result from the funding of such Term Loan; 
 (c)    in
such Lender’s reasonable discretion, there has not been any Material Adverse Change; 
 (d)    no Event of Default
or an event that with the passage of time could result in an Event of Default, shall exist; 
 (e)    to the extent not
delivered at the Effective Date, duly executed original Secured Promissory Notes and Warrants, in number, form and content acceptable to each Lender, and in favor of each Lender according to its Commitment Percentage, with respect to each Credit
Extension made by such Lender after the Effective Date; and 
 (f)    payment of the fees and Lenders’ Expenses
then due as specified in Section 2.5 hereof. 
 3.3    Intentionally Omitted. 

3.4    Covenant to Deliver. Borrower agrees to deliver to Collateral Agent and the Lenders each item
required to be delivered to Collateral Agent under this Agreement as a condition precedent to any Term Loan. Borrower expressly agrees that the Term Loan made prior to the receipt by Collateral Agent or any Lender of any such item shall not
constitute a waiver by Collateral Agent or any Lender of Borrower’s obligation to deliver such item, and any such Term Loan in the absence of a required item shall be made in each Lender’s sole discretion. 

3.5    Procedures for Borrowing. Subject to the prior satisfaction of all other applicable conditions to the
making of the Term Loan set forth in this Agreement, to obtain the Term Loan (other than the Term Loan funded on the Effective Date), Borrower shall notify the Lenders (which notice shall be irrevocable) by electronic mail, facsimile, or telephone
by 2:00 p.m. New York City time twelve (12) Business Days prior to the date the Term Loan is to be made. Together with any such electronic, facsimile or telephonic notification, Borrower shall deliver to Collateral Agent by electronic mail or
facsimile a completed Disbursement Letter and Loan Payment Request Form executed by a Responsible Officer or his or her designee. The Collateral Agent may rely on any telephone notice given by a person whom Collateral Agent reasonably believes is a
Responsible Officer or designee. 
  

	4.	 CREATION OF SECURITY INTEREST 

4.1    Grant of Security Interest. Borrower hereby grants Collateral Agent, for the ratable benefit of the
Lenders, to secure the payment and performance in full of all of the Obligations, a continuing security interest in, and pledges to Collateral Agent, for the ratable benefit of the Lenders, the Collateral, wherever located, whether now owned or
hereafter acquired or arising, and all proceeds and products thereof. If Borrower shall acquire a commercial tort claim (as defined in the Code) in an amount equal to or greater than One Hundred Thousand Dollars ($100,000.00), Borrower shall grant
to Collateral Agent, for the ratable benefit of the Lenders, a security interest therein and in the proceeds thereof, all upon the terms of this Agreement, with such writing to be in form and substance reasonably satisfactory to Collateral Agent.

 If this Agreement is terminated, Collateral Agent’s Lien in the Collateral shall continue until the Obligations (other than inchoate
indemnity obligations) are repaid in full in cash. Upon payment in full in cash of the Obligations (other than inchoate indemnity obligations) and at such time as the Lenders’ obligation to extend the Term Loan has terminated, Collateral Agent
shall, at the sole cost and expense of Borrower, release its Liens in the Collateral and all rights therein shall revert to Borrower. 

4.2    Authorization to File Financing Statements. Borrower hereby authorizes Collateral Agent to file
financing statements or take any other action required to perfect Collateral Agent’s security interests in the Collateral, without notice to Borrower, with all appropriate jurisdictions to perfect or protect Collateral Agent’s interest or
rights under the Loan Documents. 

  
 7 

	5.	 REPRESENTATIONS AND WARRANTIES 

Borrower represents and warrants to Collateral Agent and the Lenders as follows: 

5.1    Due Organization, Authorization: Power and Authority. Borrower and each of its Subsidiaries is duly
existing and in good standing as a Registered Organization in its jurisdictions of organization or formation and Borrower and each of its Subsidiaries is qualified and licensed to do business and is in good standing in any jurisdiction in which the
conduct of its businesses or its ownership of property requires that it be qualified except where the failure to do so could not reasonably be expected to have a Material Adverse Change. In connection with this Agreement, Borrower and each of its
Subsidiaries has delivered to Collateral Agent a completed perfection certificate and any updates or supplements thereto on or before the Effective Date (each a “Perfection Certificate” and collectively, the “Perfection
Certificates”). Borrower represents and warrants that all the information set forth on the Perfection Certificates pertaining to Borrower and each of its Subsidiaries is accurate and complete in all material respects as of the date
delivered or supplemented (to the extent permitted hereunder). 
 The execution, delivery and performance by Borrower and each of its
Subsidiaries of the Loan Documents to which it is a party have been duly authorized, and do not (i) conflict with any of Borrower’s or such Subsidiaries’ organizational documents, including its respective Operating Documents,
(ii) contravene, conflict with, constitute a default under or violate any material Requirement of Law applicable thereto, (iii) contravene, conflict or violate any material applicable order, writ, judgment, injunction, decree,
determination or award of any Governmental Authority by which Borrower or such Subsidiary, or any of their property or assets may be bound or affected, (iv) require any action by, filing, registration, or qualification with, or Governmental
Approval from, any Governmental Authority (except such Governmental Approvals which have already been obtained and are in full force and effect or any action or filing that is immaterial to Borrower’s business) or are being obtained pursuant to
Section 6.1(b), or (v) constitute an event of default under any material agreement by which Borrower or any of such Subsidiaries, or their respective properties, is bound. Neither Borrower nor any of its Subsidiaries is in default under any
agreement to which it is a party or by which it or any of its assets is bound in which such default could reasonably be expected to have a Material Adverse Change. 

5.2    Collateral. 

(a)    Borrower and each its Subsidiaries have good title to, have rights in, and the power to transfer each item of the
Collateral upon which it purports to grant a Lien under the Loan Documents, free and clear of any and all Liens except Permitted Liens, and neither Borrower nor any of its Subsidiaries have any Deposit Accounts, Securities Accounts, Commodity
Accounts or other investment accounts other than the Collateral Accounts or the other investment accounts, if any, described in the Perfection Certificates delivered to Collateral Agent in connection herewith or as permitted otherwise under this
Agreement with respect of which Borrower or such Subsidiary has given Collateral Agent notice and taken such actions as are necessary to give Collateral Agent a perfected security interest therein as required under this Agreement. 

(b)    The security interest granted herein is and shall at all times continue to be a first priority perfected security
interest in the Collateral, subject only to Permitted Liens under clauses (c), (d), (e), (f) and (h) of the definition of “Permitted Liens”. 

(c)    On the Effective Date, and except as disclosed on the Perfection Certificate (i) the Collateral is not in the
possession of any third party bailee, and (ii) no such third party bailee possesses components of the Collateral in excess of Fifty Thousand Dollars ($50,000.00). 

(d)    All Inventory and Equipment is in all material respects of good and marketable quality, free from material defects.

 (e)    Borrower and each of its Subsidiaries is the sole owner of the Intellectual Property each respectively
purports to own necessary for its operations other than licenses permitted hereunder, free and clear of all Liens other than Permitted Liens. Except as noted on the Perfection Certificates or as otherwise disclosed in

  
 8 

 
writing to Collateral Agent, neither Borrower nor any of its Subsidiaries is a party to, nor is bound by, any material license or other Material Agreement. 

5.3    Litigation. Except as disclosed on the Perfection Certificate or for which notice has been provided
by Borrower as required under this Agreement, there are no actions, suits, investigations, or proceedings pending or, to the Knowledge of the Responsible Officers, threatened in writing by or against Borrower or any of its Subsidiaries involving
more than Two Hundred Fifty Thousand Dollars ($250,000.00) or a claim for infringement of any owned Intellectual Property. Except as disclosed on the Perfection Certificate or for which notice has been provided by Borrower as required under this
Agreement, there are no actions, suits, investigations or proceedings pending or, to the Knowledge of the Responsible Officers, threatened in writing by or against Borrower or any Subsidiaries involving challenges to the validity of any material
Intellectual Property of Borrower or any Subsidiary. 
 5.4    No Material Adverse Change; Financial
Statements. All consolidated financial statements for Borrower and its Subsidiaries, delivered to Collateral Agent fairly present, in conformity with GAAP, in all material respects the consolidated financial condition of Borrower and its
Subsidiaries, and the consolidated results of operations of Borrower and its Subsidiaries. Since the date of the most recent financial statements submitted to Collateral Agent and Innovatus, there has not been a Material Adverse Change. 

5.5    Solvency. Borrower and each of its Subsidiaries, when taken as a whole, is Solvent. 

5.6    Regulatory Compliance. Neither Borrower nor any of its Subsidiaries is an “investment
company” or a company “controlled” by an “investment company” under the Investment Company Act of 1940, as amended. Neither Borrower nor any of its Subsidiaries is engaged as one of its important activities in extending
credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors). Borrower and each of its Subsidiaries has complied in all material respects with the Federal Fair Labor Standards Act. Neither Borrower nor any of its
Subsidiaries is a “holding company” or an “affiliate” of a “holding company” or a “subsidiary company” of a “holding company” as each term is defined and used in the Public Utility Holding Company
Act of 2005. Neither Borrower nor any of its Subsidiaries has violated any laws, ordinances or rules, the violation of which could reasonably be expected to have a Material Adverse Change. Neither Borrower’s nor any of its Subsidiaries’
properties or assets has been used by Borrower or such Subsidiary or, to Borrower’s Knowledge, by previous Persons, in disposing, producing, storing, treating, or transporting any hazardous substance other than in material compliance with
applicable laws. Borrower and each of its Subsidiaries has obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their
respective businesses as currently conducted. 
 None of Borrower, any of its Subsidiaries, or any of Borrower’s or its
Subsidiaries’ controlled Affiliates or any of their respective agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement is (i) in violation of any Anti-Terrorism Law, (ii) engaging
in or conspiring to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law, or (iii) is a Blocked Person. None of Borrower,
any of its Subsidiaries, or to the Knowledge of Borrower, any of their Affiliates or agents, acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement, (x) conducts any business or engages in making
or receiving any contribution of funds, goods or services to or for the benefit of any Blocked Person, or (y) deals in, or otherwise engages in any transaction relating to, any property or interest in property blocked pursuant to Executive
Order No. 13224, any similar executive order or other Anti-Terrorism Law. 
 5.7    Investments.
Neither Borrower nor any of its Subsidiaries owns any stock, shares, partnership interests or other equity securities except for Permitted Investments. 

5.8    Tax Returns and Payments; Pension Contributions. Borrower and each of its Subsidiaries has timely
filed all required tax returns and reports, and Borrower and each of its Subsidiaries, has timely paid all foreign, federal, state, and local taxes, assessments, deposits and contributions owed by Borrower and such Subsidiaries in an amount greater
than One Hundred Thousand Dollars ($100,000.00), in all jurisdictions in which Borrower or any such Subsidiary is subject to taxes, including the United States, unless such taxes are being contested in accordance with the next sentence. Borrower and
each of its Subsidiaries may defer payment of any contested taxes, provided that Borrower or such Subsidiary in good faith contests its obligation to pay the taxes by 

  
 9 

 
appropriate proceedings promptly and diligently instituted and conducted. Neither Borrower nor any of its Subsidiaries is aware of any claims or adjustments proposed for any of Borrower’s or
such Subsidiaries’ prior tax years which could result in additional taxes becoming due and payable by Borrower or its Subsidiaries in an amount greater than One Hundred Thousand Dollars ($100,000.00). Borrower and each of its Subsidiaries have
paid all amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their material terms, and neither Borrower nor any of its Subsidiaries have, withdrawn from participation in, and have not
permitted partial or complete termination of, or permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any material liability of Borrower or its Subsidiaries, including any
liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority. 

5.9    Use of Proceeds. Subject to the next sentence, Borrower shall use the proceeds of the Term Loan
solely as working capital and to fund its general business requirements in accordance with the provisions of this Agreement, and not for personal, family, household or agricultural purposes. A portion of the proceeds of
the    Term A Loans shall be used by Borrower to repay the Existing Indebtedness in full on the Effective Date. 

5.10    Full Disclosure. No written representation, warranty or other statement of Borrower or any of its
Subsidiaries in any certificate or written statement given to Collateral Agent or any Lender, as of the date such representation, warranty, or other statement was made, taken together with all such written certificates and written statements given
to Collateral Agent or any Lender, contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements contained in the certificates or statements not materially misleading (it being recognized that
projections and forecasts provided by Borrower in good faith and based upon reasonable assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected
or forecasted results). 
  

	6.	 AFFIRMATIVE COVENANTS 

Borrower shall, and shall cause each of its Subsidiaries to, do all of the following: 

6.1    Government Compliance. 

(a)    Maintain its and all its Subsidiaries’ legal existence and good standing in their respective jurisdictions of
organization and maintain qualification in each jurisdiction in which the failure to so qualify could reasonably be expected to have a Material Adverse Change. Comply with all laws, ordinances and regulations to which Borrower or any of its
Subsidiaries is subject, the noncompliance with which could reasonably be expected to have a Material Adverse Change. 

(b)    Obtain and keep in full force and effect, all of the material Governmental Approvals necessary for the performance
by Borrower and its Subsidiaries of their respective businesses and obligations under the Loan Documents and the grant of a security interest to Collateral Agent for the ratable benefit of the Lenders, in all of the Collateral. 

6.2    Financial Statements, Reports, Certificates; Notices. 

(a)    Deliver to Collateral Agent and Innovatus: 

(i)    as soon as available, but no later than forty-five (45) days after the last day of each quarter, a company
prepared consolidated and consolidating balance sheet, income statement and cash flow statement covering the consolidated operations of Borrower and its Subsidiaries for such quarter certified by a Responsible Officer and in a form reasonably
acceptable to Collateral Agent; 
 (ii)    as soon as available, but no later than one hundred fifty (150) days
after the last day of Borrower’s fiscal year or within five (5) days of filing with the Securities and Exchange Commission, audited consolidated financial statements prepared under GAAP, consistently applied, together with an unqualified
opinion (including no “going concern” or like qualification or exception or any qualification or exception as to the scope of 

  
 10 

 
such audit) on the financial statements from an independent certified public accounting firm acceptable to Collateral Agent in its reasonable discretion; provided that if Borrower is issued an
audit with a “going concern” or similar limitation solely in connection with its liquidity, such audit shall not constitute an Event of Default under any Loan Document if the Borrower demonstrates that it is cash flow positive for the
trailing six (6) months from the date such audit was delivered to Innovatus within six (6) months from the date such audit was delivered (i.e. 330 days from the last day of the Borrower’s fiscal year), subject to calculations and
evidence reasonably acceptable to Innovatus; 
 (iii)    as soon as available after approval thereof by Borrower’s
board of directors, but no later than the earlier of ten (10) days after such approval and forty-five (45) days after the last day of Borrower’s fiscal year, and within twenty (20) days following any Equity Cure, Borrower’s
annual (A) financial projections and (B) budget, in each case, for the entire current fiscal year as approved by Borrower’s board of directors; provided that, any revisions to such projections and/or budget approved by Borrower’s
board of directors shall be delivered to Collateral Agent and the Lenders no later than seven (7) days after such approval); 

(iv)    within five (5) days of delivery, copies of all non-ministerial
statements, reports and notices made generally available to Borrower’s security holders or holders of Subordinated Debt; 

(v)    in the event that Borrower becomes subject to the reporting requirements under the Securities Exchange Act of
1934, as amended, within five (5) days of filing, all reports on Form 10-K, 10-Q and 8-K filed with the Securities and
Exchange Commission; 
 (vi)    along with the delivery of the financial statements under Section 6.2(a)(i), any
material amendments of or other material changes to the capitalization table of Borrower and to the Operating Documents of Borrower or any of its Subsidiaries, together with any copies reflecting such amendments or changes with respect thereto; 

(vii)    as soon as available, but no later than thirty (30) days after the last day of each month, copies of the month-end account statements for each Collateral Account maintained by Borrower or its Subsidiaries, which statements may be provided to Collateral Agent and Innovatus by Borrower or directly from the applicable
institution(s); 
 (viii)    prompt delivery of (and in any event within five (5) days after the same are sent or
received) copies of all material correspondence, reports, documents and other filings with any Governmental Authority that could reasonably be expected to have a material adverse effect on any of the Governmental Approvals material to
Borrower’s business or otherwise could reasonably be expected to have a Material Adverse Change; 
 (ix)    prompt
notice of any event that (A) could reasonably be expected to materially and adversely affect the Borrower’s Intellectual Property and (B) could reasonably be expected to result in a Material Adverse Change; 

(x)    written notice substantially contemporaneously with Borrower’s creation of a New Subsidiary in accordance
with the terms of Section 6.10; 
 (xi)    written notice at least twenty (20) days prior to Borrower’s
(A) adding any new offices or business locations, including warehouses (unless such new offices or business locations contain less than Five Hundred Thousand Dollars ($500,000.00) in assets or property of Borrower or any of its Subsidiaries),
(B) changing its jurisdiction of organization, (C) changing its organizational structure or type, (D) changing its legal name, or (E) changing any organizational number (if any) assigned by its jurisdiction of organization; 

(xii)    upon Borrower becoming aware of the existence of any Event of Default or event which, with the giving of notice
or passage of time, or both, would constitute an Event of Default, prompt (and in any event within three (3) Business Days) written notice of such occurrence, which such notice shall include a reasonably detailed description of such Event of
Default or event which, with the giving of notice or passage of time, or both, would constitute an Event of Default; 

  
 11 

 (xiii)    immediate notice if Borrower or such Subsidiary has Knowledge
that Borrower, or any Subsidiary or Controlled Affiliate of Borrower, is listed on the OFAC Lists or (a) is convicted on, (b) pleads nolo contendere to, (c) is indicted on, or (d) is arraigned and held over on charges
involving money laundering or predicate crimes to money laundering; 
 (xiv)    prompt notice of any commercial tort
claim in an amount equal to or greater than One Hundred Thousand Dollars ($100,000.00) and of the general details thereof; 

(xv)    if Borrower or any of its Subsidiaries is not now a Registered Organization but later becomes one, written notice
of such occurrence and information regarding such Person’s organizational identification number within seven (7) Business Days of receiving such organizational identification number; and 

(xvi)    other information as reasonably requested by Collateral Agent or any Lender. 

Notwithstanding the foregoing, documents required to be delivered pursuant to the terms hereof, to the extent any such documents are included in materials
otherwise filed with the Securities and Exchange Commission, such documents or materials may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date on which Borrower posts such documents, or provides a
link thereto, on Borrower’s website on the internet at Borrower’s website address. 
 (b)    Concurrently with
the delivery of the financial statements specified in Section 6.2(a)(i) above but no later than forty-five (45) days after the last day of each quarter, except as otherwise indicated, deliver to Collateral Agent and Innovatus: 

(i)    a duly completed Compliance Certificate signed by a Responsible Officer; 

(ii)    an updated Perfection Certificate to reflect any material amendments, modifications and updates to certain
information in the Perfection Certificate after the Effective Date, as and when such amendments, modifications or updates are necessitated by material events or conditions, but not less frequently than on each anniversary of the Effective Date; in
each case, subject to the terms of this Agreement; 
 (iii)    copies of any material Governmental Approvals obtained
by Borrower or any of its Subsidiaries; 
 (iv)    written notice of the commencement of, and any material development
in, the proceedings contemplated by Section 5.8 hereof; 
 (v)    written notice of any litigation or governmental
proceedings pending or threatened (in writing) against Borrower or any of its Subsidiaries, which could reasonably be expected to result in damages or costs to Borrower or any of its Subsidiaries of more than Two Hundred Fifty Thousand Dollars
($250,000.00); and 
 (vi)    written notice of all returns, recoveries, disputes and claims regarding Inventory that
involve more than Five Hundred Thousand Dollars ($500,000.00) individually or in the aggregate in any calendar year. 

(c)    Keep proper, complete and true books of record and account in accordance with GAAP in all material respects.
Borrower shall, and shall cause each of its Subsidiaries to, allow, at the sole cost of Borrower, Collateral Agent or any Lender, during regular business hours upon reasonable prior notice (provided that no notice shall be required when an Event of
Default has occurred and is continuing), to visit and inspect any of its properties, to examine and make abstracts or copies from any of its books and records, and to conduct a collateral audit and analysis of its operations and the Collateral. Such
audits shall be conducted no more often than once every year unless (and may be more frequently if) an Event of Default has occurred and is continuing. Notwithstanding the foregoing, upon request of Collateral Agent and/or Innovatus, Borrower agrees
to permit Collateral Agent and Innovatus to communicate with Borrower’s accounting firm with respect to the consolidated financial statements 

  
 12 

 
delivered pursuant to this Section 6.2 in the presence of Borrower and to the extent the accounting firm agrees to such communications. 

6.3    Inventory; Returns. Keep all Inventory in good and marketable condition, free from material defects.
Returns and allowances between Borrower, or any of its Subsidiaries, and their respective Account Debtors shall follow Borrower’s, or such Subsidiary’s, customary practices as they exist at the Effective Date. 

6.4    Taxes; Pensions. Timely file and require each of its Subsidiaries to timely file, all required tax
returns and reports and timely pay, and require each of its Subsidiaries to timely pay, all foreign, federal, state, and local taxes, assessments, deposits and contributions owed by Borrower or its Subsidiaries, except as otherwise permitted
pursuant to the terms of Section 5.8 hereof, and shall deliver to Collateral Agent and Innovatus, on demand, appropriate certificates attesting to such payments, and pay all amounts necessary to fund all present pension, profit sharing and
deferred compensation plans in accordance with the terms of such plans. 
 6.5    Insurance. Keep
Borrower’s and its Subsidiaries’ business and the Collateral insured for risks and in amounts standard for companies in Borrower’s and its Subsidiaries’ industry and location and as Collateral Agent may reasonably request,
including, but not limited to, D&O insurance reasonably satisfactory to Collateral Agent. Insurance policies shall be in a form, with companies, and in amounts that are reasonably satisfactory to Collateral Agent and Lenders. All property
policies shall have a lender’s loss payable endorsement showing Collateral Agent as lender loss payee, and all liability policies shall show, or have endorsements showing, Collateral Agent, as additional insured. The Collateral Agent shall be
named as lender loss payee and/or additional insured with respect to any such insurance providing coverage in respect of any Collateral, and each provider of any such insurance shall agree, by endorsement upon the policy or policies issued by it or
by independent instruments furnished to the Collateral Agent (or Borrower, in the event such provider cannot or will not do so), that it will give the Collateral Agent thirty (30) days’ prior written notice before any such policy or
policies shall be materially altered or canceled (other than cancellation for non-payment of premiums, for which ten (10) days’ prior written notice shall be required). At Collateral Agent’s
request, Borrower shall deliver certified copies of policies and evidence of all premium payments. Proceeds payable under any policy shall, at Collateral Agent’s option, be payable to Collateral Agent, for the ratable benefit of the Lenders, on
account of the Obligations. Notwithstanding the foregoing, (a) so long as no Event of Default has occurred and is continuing, Borrower shall have the option of applying the proceeds of any casualty policy within 90 days of receipt thereof up to
Two Hundred Fifty Thousand Dollars ($250,000.00) with respect to any loss, but not exceeding Five Hundred Thousand Dollars ($500,000.00), in the aggregate for all losses under all casualty policies in any one year, toward the replacement or repair
of destroyed or damaged property; provided that any such replaced or repaired property (i) shall be of equal or like value as the replaced or repaired Collateral and (ii) shall be deemed Collateral in which Collateral Agent has been
granted a first priority security interest, and (b) after the occurrence and during the continuance of an Event of Default, all proceeds payable under such casualty policy shall, at the option of Collateral Agent, be payable to Collateral
Agent, for the ratable benefit of the Lenders, on account of the Obligations. If Borrower or any of its Subsidiaries fails to obtain insurance as required under this Section 6.5 or to pay any amount or furnish any required proof of payment to
third persons, Collateral Agent and/or any Lender may make (but has no obligation to do so), at Borrower’s expense, all or part of such payment or obtain such insurance policies required in this Section 6.5, and take any action under the
policies Collateral Agent or such Lender deems prudent. 
 6.6    Operating Accounts. 

(a)    Borrower shall provide Collateral Agent five (5) Business Days’ prior written notice before Borrower or
any of its Subsidiaries establishes any Collateral Account. In addition, for each Collateral Account that Borrower or any of its Subsidiaries at any time maintains, Borrower or such Subsidiary shall cause the applicable bank or financial institution
at or with which such Collateral Account is maintained to execute and deliver a Control Agreement or other appropriate instrument with respect to such Collateral Account to perfect Collateral Agent’s Lien in such Collateral Account in
accordance with the terms hereunder prior to the establishment of such Collateral Account, which Control Agreement may not be terminated without prior written consent of Collateral Agent. The provisions of the previous sentence shall not apply to
deposit accounts exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of Borrower’s, or any of its Subsidiaries’, employees and identified to Collateral Agent by Borrower as such in
the Perfection Certificate. 

  
 13 

 (b)    Neither Borrower nor any of its Subsidiaries shall maintain any
Collateral Accounts except Collateral Accounts maintained in accordance with Section 6.6. 
 6.7    Protection
of Intellectual Property Rights. Borrower and each of its Subsidiaries shall: (a) protect, defend and maintain the validity and enforceability of its Intellectual Property that is material to its business; (b) promptly advise Collateral
Agent in writing of a challenge to the validity, or material infringement by a third party of its Intellectual Property; and (c) not allow any Intellectual Property material to its business to be abandoned, forfeited or dedicated to the public
without Collateral Agent’s prior written consent. If Borrower or any of its Subsidiaries (i) obtains any patent, registered trademark or servicemark, registered copyright, registered mask work, or any pending application for any of the
foregoing, whether as owner, licensee or otherwise, or (ii) applies for any patent or the registration of any trademark or servicemark, then Borrower or such Subsidiary shall promptly provide written notice thereof to Collateral Agent and shall
execute such intellectual property security agreements and other documents and take such other actions as Collateral Agent shall reasonably request in its good faith business judgment to perfect and maintain a first priority perfected security
interest in favor of Collateral Agent, for the ratable benefit of the Lenders, in such property. If Borrower or any of its Subsidiaries decides to register any copyrights or mask works in the United States Copyright Office, Borrower or such
Subsidiary shall: (x) execute an intellectual property security agreement and such other documents and take such other actions as Collateral Agent may reasonably request in its good faith business judgment to perfect and maintain a first
priority perfected security interest in favor of Collateral Agent, for the ratable benefit of the Lenders, in the copyrights or mask works intended to be registered with the United States Copyright Office; and (y) record such intellectual
property security agreement with the United States Copyright Office. Borrower or such Subsidiary shall promptly provide to Collateral Agent and each Lender with evidence of the recording of such intellectual property security agreement. 

6.8    Litigation Cooperation. Commencing on the Effective Date and continuing through the termination of
this Agreement, make available to Collateral Agent and the Lenders, without expense to Collateral Agent or the Lenders, Borrower and each of Borrower’s officers, employees and agents and Borrower’s Books, to the extent that Collateral
Agent or any Lender may reasonably deem them necessary to prosecute or defend any third-party suit or proceeding instituted by or against Collateral Agent or any Lender with respect to any Collateral or relating to Borrower. 

6.9    Landlord Waivers; Bailee Waivers. In the event that Borrower or any of its Subsidiaries, after the
Effective Date, intends to add any new offices or business locations, including warehouses, or otherwise store any portion of the Collateral with, or deliver any portion of the Collateral to, a bailee, in each case pursuant to Section 7.2, then
Borrower or such Subsidiary will first receive the written consent of Collateral Agent and, in the event that the Collateral at any new location is valued in excess of Five Hundred Thousand Dollars ($500,000.00) in the aggregate, at Collateral
Agent’s election, such bailee or landlord, as applicable, shall execute and deliver a bailee waiver or landlord waiver, as applicable, in form and substance reasonably satisfactory to Collateral Agent prior to the addition of any new offices or
business locations, or any such storage with or delivery to any such bailee, as the case may be. 

6.10    Creation/Acquisition of Subsidiaries. In the event any Borrower or any Subsidiary of any Borrower
creates or acquires any Subsidiary after the Effective Date, Borrower or such Subsidiary shall promptly notify Collateral Agent of such creation or acquisition, and Borrower or such Subsidiary shall take all actions reasonably requested by
Collateral Agent to achieve any of the following with respect to such “New Subsidiary” (defined as a Subsidiary formed after the date hereof during the term of this Agreement): (i) to cause such New Subsidiary to become either a co-Borrower hereunder or a secured guarantor with respect to the Obligations, in each case if such New Subsidiary is organized under the laws of the United States; and (ii) to grant and pledge to Collateral
Agent a perfected security interest in the Shares of such New Subsidiary. 
 6.11    Minimum Liquidity.
Borrower shall at all times maintain minimum unrestricted cash and Cash Equivalents, in an account subject to a control agreement in favor of Collateral Agent, in an amount equal to (x) if the Interest-Only Milestones are met,
(i) Three Million Dollars ($3,000,000.00) from the Effective Date through June 30, 2018, and (ii) Two Million Dollars ($2,000,000) at all times thereafter; and (y) in the event the Interest- Only Milestones are not met,
Borrower’s trailing four (4) months’ cash used to fund operating activities. 

  
 14 

 6.12    Royalty Pharma Payments. Borrower shall make or
cause to be made each regularly scheduled royalty payment owing from Borrower to Royalty Pharma and provide confirmation of such payment to Collateral Agent with each Compliance Certificate delivered in accordance with this Agreement. 

6.13    License Transaction; Allegheny-Singer. Borrower shall use commercially reasonable efforts to enter
into on commercially reasonable terms, and delivery written evidence thereof to Collateral Agent, by no later than March 7, 2018, of an exclusive license (or similar arrangement), between Borrower and Allegheny-Singer Research Institute, with
respect to U.S. Pat. No. 9,495,517 and U.S. Patent Application No. 15/264,516. 
 6.14    Further
Assurances. Execute any further instruments and take further action as Collateral Agent reasonably requests to perfect or continue Collateral Agent’s Lien in the Collateral or to effect the purposes of this Agreement. 

 

	7.	 NEGATIVE COVENANTS 

Borrower shall not, and shall not permit any of its Subsidiaries to, do any of the following without the prior written consent of the Required
Lenders: 
 7.1    Dispositions. Convey, sell, lease, transfer, assign, dispose of (collectively,
“Transfer”), or permit any of its Subsidiaries to Transfer, all or any part of its business or property (including Intellectual Property), except for Transfers (a) of Inventory in the ordinary course of business; (b) of worn-out or obsolete Equipment; (c) in connection with Permitted Liens, Permitted Investments and Permitted Indebtedness; (d) of Cash or Cash Equivalents pursuant to transactions not prohibited hereunder
in the ordinary course of business and approved by Borrower’s board of directors, provided that any such Transfer greater than One Million Dollars ($1,000,000) shall be consistent with the then-applicable Annual Projections; and (e) other
Transfers not to exceed Five Hundred Thousand Dollars ($500,000.00) in each fiscal year. 
 7.2    Changes in
Business, Management, Ownership, or Business Locations. (a) Engage in or permit any of its Subsidiaries to engage in any business other than the businesses engaged in by Borrower as of the Effective Date or reasonably related thereto;
(b) liquidate or dissolve; or (c) (i) any Key Person shall cease to be actively engaged in the management of Borrower unless written notice thereof is provided to Collateral Agent and Innovatus within ten (10) days after such
occurrence, or (ii) enter into any transaction or series of related transactions in which (A) the stockholders of Borrower who were not stockholders immediately prior to the first such transaction own more than forty-nine percent (49.00%)
of the voting stock of Borrower immediately after giving effect to such transaction or related series of such transactions (other than by the sale of Borrower’s equity securities in a public offering, a private placement of public equity or to
venture capital investors so long as Borrower identifies to Collateral Agent the venture capital or private equity investors prior to the closing of such transaction or series of related transactions); and (B) Borrower ceases to own one hundred
percent (100.00%) of the ownership interests of a Subsidiary of Borrower. Borrower shall not, without at least twenty (20) days’ prior written notice to Collateral Agent: (A) add any new offices or business locations, including
warehouses (unless such new offices or business locations contain less than Five Hundred Thousand Dollars ($500,000.00) (measured by book value) in assets or property; provided that a customer or vendor location where Collateral is held or is in
transit shall not be considered a business location of Borrower for purposes of this section; provided, further that any customer and vendor locations shall be subject to Section 5.2(b) above, of Borrower or any of its Subsidiaries); (B) change
its jurisdiction of organization, (C) change its organizational structure or type, (D) change its legal name, or (E) change any organizational number (if any) assigned by its jurisdiction of organization. 

7.3    Mergers or Acquisitions. Merge or consolidate, or permit any of its Subsidiaries to merge or
consolidate, with any other Person, or acquire, or permit any of its Subsidiaries to acquire, all or substantially all of the capital stock, shares or property of another Person, except where (a) total consideration including cash and the value
of any non-cash consideration for all such transactions does not in the aggregate exceed Five Million Dollars ($5,000,000.00) in any fiscal year of Borrower; provided that (x) all cash consideration shall
be proceeds of contemporaneous sales or issuances of Borrowers Subordinated Debt or equity securities; and (y) any incremental cash burn attributable to the transaction(s) must be funded from the proceeds of the sale and issuance of
Borrower’s equity securities; (b) no Event of Default has occurred and is continuing or would exist after giving effect to the transactions; (c) Borrower is the surviving legal entity; and (d) no less than thirty (30) days
prior to the 

  
 15 

 
consummation of any such transaction, Borrower and Collateral Agent shall agree on a pro forma financial model for the Borrower on a post-transaction basis (such model to demonstrate, among other
things, that, except as set forth in (a)(y) above, each transaction is cash-flow accretive to Borrower for the balance of the term of this Agreement). A Subsidiary may merge or consolidate into another Subsidiary (provided such surviving Subsidiary
is a “co-Borrower” hereunder or has provided a secured Guaranty of Borrower’s Obligations hereunder) or with (or into) Borrower provided Borrower is the surviving legal entity, and as long as no
Event of Default is occurring prior thereto or arises as a result therefrom. 
 7.4    Indebtedness.
Create, incur, assume, or be liable for any Indebtedness, or permit any Subsidiary to do so, other than Permitted Indebtedness. 

7.5    Encumbrance. Create, incur, allow, or suffer any Lien on any of its property, or assign or convey any
right to receive income, including the sale of any Accounts, or permit any of its Subsidiaries to do so, except for Permitted Liens, or permit any Collateral not to be subject to the first priority security interest granted herein (except for
Permitted Liens), or enter into any agreement, document, instrument or other arrangement (except with or in favor of Collateral Agent, for the ratable benefit of the Lenders) with any Person which directly or indirectly prohibits or has the effect
of prohibiting Borrower, or any of its Subsidiaries, from assigning, mortgaging, pledging, granting a security interest in or upon, or encumbering any of Borrower’s or such Subsidiary’s Intellectual Property, except as is otherwise
permitted in Section 7.1 hereof and the definition of “Permitted Liens”. 
 7.6    Maintenance
of Collateral Accounts. Maintain any Collateral Account except pursuant to the terms of Section 6.6 hereof. 

7.7    Restricted Payments. Pay any dividends (other than dividends payable solely in capital stock) or make
any distribution or payment in respect of or redeem, retire or purchase any capital stock (other than (i) repurchases pursuant to the terms of employee stock purchase plans, employee restricted stock agreements, stockholder rights plans,
director or consultant stock option plans, or similar plans, provided such repurchases do not exceed Two Hundred Fifty Thousand Dollars ($250,000.00) in the aggregate per fiscal year or (ii) any repurchases solely from the proceeds of a
simultaneous equity issuance not prohibited hereunder). 
 7.8    Investments. Directly or indirectly
make, or permit any Subsidiary to make, any Investment other than Permitted Investments. 

7.9    Transactions with Affiliates. Directly or indirectly enter into or permit to exist any material
transaction with any Affiliate of Borrower or any of its Subsidiaries, except for (a) transactions that are in the ordinary course of Borrower’s or such Subsidiary’s business, upon fair and reasonable terms that are no less favorable
to Borrower or such Subsidiary than would be obtained in an arm’s length transaction with a non-affiliated Person, (b) equity investments or Subordinated Debt by Borrower’s investors in Borrower
or its Subsidiaries, and (c) compensation arrangements entered into in the ordinary course of business. 

7.10    Subordinated Debt. (a) Make or permit any payment on any Subordinated Debt, except under the
terms of the subordination, intercreditor, or other similar agreement to which such Subordinated Debt is subject, or (b) amend any provision in any document relating to the Subordinated Debt which would increase the amount thereof or adversely
affect the subordination thereof to Obligations owed to the Lenders. 
 7.11    Compliance. Become an
“investment company” or a company controlled by an “investment company”, under the Investment Company Act of 1940, as amended, or undertake as one of its important activities extending credit to purchase or carry margin stock (as
defined in Regulation U of the Board of Governors of the Federal Reserve System), or use the proceeds of any Term Loan for that purpose; fail to meet the minimum funding requirements of ERISA, permit a Reportable Event or Prohibited Transaction, as
defined in ERISA, to occur; fail to comply with the Federal Fair Labor Standards Act or violate any other law or regulation, if the failure to comply or violation could reasonably be expected to have a Material Adverse Change, or permit any of its
Subsidiaries to do so; withdraw or permit any Subsidiary to withdraw from participation in, permit partial or complete termination of, or permit the occurrence of any other event with respect to, any present pension, profit sharing and deferred
compensation plan which could reasonably be expected to result in any liability of Borrower or any of its 

  
 16 

 
Subsidiaries, including any liability to the Pension Benefit Guaranty Corporation or its successors or any other Governmental Authority. 

7.12    Compliance with Anti-Terrorism Laws. Neither Borrower nor any of its Subsidiaries shall, nor shall
Borrower or any of its Subsidiaries permit any controlled Affiliate to, directly or indirectly, knowingly enter into any documents, instruments, agreements or contracts with any Person listed on the OFAC Lists. Neither Borrower nor any of its
Subsidiaries shall, nor shall Borrower or any of its Subsidiaries, permit any Affiliate to, directly or indirectly, (i) conduct any business or engage in any transaction or dealing with any Blocked Person, including, without limitation, the
making or receiving of any contribution of funds, goods or services to or for the benefit of any Blocked Person, (ii) deal in, or otherwise engage in any transaction relating to, any property or interests in property blocked pursuant to
Executive Order No. 13224 or any similar executive order or other Anti-Terrorism Law, or (iii) engage in or conspire to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any
of the prohibitions set forth in Executive Order No. 13224 or other Anti-Terrorism Law. 
  

	8.	 EVENTS OF DEFAULT 

Any one of the following shall constitute an event of default (an “Event of Default”) under this Agreement: 

8.1    Payment Default. Borrower fails to (a) make any payment of principal or interest on any Term
Loan on its due date, or (b) pay any other Obligations within three (3) Business Days after such Obligations are due and payable (which three (3) Business Day grace period shall not apply to payments due on the Maturity Date or the
date of acceleration pursuant to Section 9.1 (a) hereof); 
 8.2    Covenant Default. 

(a)    Borrower or any of its Subsidiaries fails or neglects to perform any obligation in Sections 6.2 (Financial
Statements, Reports, Certificates), 6.4 (Taxes), 6.5 (Insurance), 6.6 (Operating Accounts), 6.7 (Protection of Intellectual Property Rights), 6.11 (Minimum Liquidity) or Borrower violates any provision in Section 7; or 

(b)    Borrower, or any of its Subsidiaries, fails or neglects to perform, keep, or observe any other term, provision,
condition, covenant or agreement contained in this Agreement or any Loan Documents, and as to any default (other than those specified in this Section 8) under such other term, provision, condition, covenant or agreement that can be cured, has
failed to cure the default within fifteen (15) days after the occurrence thereof; provided, however, that if the default cannot by its nature be cured within the fifteen (15) day period or cannot after diligent attempts by Borrower be
cured within such fifteen (15) day period, and such default is likely to be cured within a reasonable time, then Borrower shall have an additional period (which shall not in any case exceed thirty (30) days) to attempt to cure such default, and
within such reasonable time period the failure to cure the default shall not be deemed an Event of Default (but no Term Loan shall be made during such cure period); 

8.3    Material Adverse Change. A Material Adverse Change has occurred; 

8.4    Attachment; Levy; Restraint on Business. 

(a)    (i) The service of process seeking to attach, by trustee or similar process, any funds of Borrower or any of its
Subsidiaries or of any entity under control of Borrower or its Subsidiaries on deposit with any institution at which Borrower or any of its Subsidiaries maintains a Collateral Account, or (ii) a notice of lien, levy, or assessment is filed
against Borrower or any of its Subsidiaries or their respective assets by any government agency, and the same under subclauses (i) and (ii) hereof are not, within twenty (20) days after the occurrence thereof, discharged or stayed (whether
through the posting of a bond or otherwise); and 

  
 17 

 (b)    (i) any material portion of Borrower’s or any of its
Subsidiaries’ assets is attached, seized, levied on, or comes into possession of a trustee or receiver, or (ii) any court order enjoins, restrains, or prevents Borrower or any of its Subsidiaries from conducting any material part of its
business; 
 8.5    Insolvency. (a) Borrower or any of its Subsidiaries is or becomes Insolvent;
(b) Borrower or any of its Subsidiaries begins an Insolvency Proceeding; or (c) an Insolvency Proceeding is begun against Borrower or any of its Subsidiaries and not dismissed or stayed within forty-five (45) days (but no Term Loan
shall be extended while Borrower or any Subsidiary is Insolvent and/or until any Insolvency Proceeding is dismissed); 

8.6    Other Agreements. There is a default in any agreement to which Borrower or any of its Subsidiaries is
a party with a third party or parties resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount in excess of Five Hundred Fifty Thousand Dollars ($500,000.00) or that
could reasonably be expected to have a Material Adverse Change; 
 8.7    Judgments. (a) One or more
judgments, orders, or decrees for the payment of money in an amount, individually or in the aggregate, of at least Five Hundred Thousand Dollars ($500,000.00) (not covered by independent third-party insurance) shall be rendered against Borrower or
any of its Subsidiaries and shall remain unsatisfied, unvacated, or unstayed for a period of twenty (20) days after the entry thereof or (b) any judgments, orders or decrees rendered against Borrower that could reasonably be expected to
result in a Material Adverse Change; 
 8.8    Misrepresentations. Borrower or any of its Subsidiaries or
any Person acting for Borrower or any of its Subsidiaries makes any representation, warranty, or other statement, taken as a whole, now or later in this Agreement, any Loan Document or in any writing delivered to Collateral Agent and/or Lenders or
to induce Collateral Agent and/or the Lenders to enter this Agreement or any Loan Document, and such representation, warranty, or other statement, when taken as a whole, is incorrect in any material respect when made; 

8.9    Subordinated Debt. A default or breach occurs under any agreement between Borrower or any of its
Subsidiaries and any creditor of Borrower or any of its Subsidiaries that signed a subordination, intercreditor, or other similar agreement with Collateral Agent or the Lenders, or any creditor that has signed such an agreement with Collateral Agent
or the Lenders breaches any terms of such agreement; 
 8.10    Guaranty. (a) Any Guaranty terminates or
ceases for any reason to be in full force and effect; (b) any Guarantor does not perform any obligation or covenant under any Guaranty; (c) any circumstance described in Section 8 occurs with respect to any Guarantor; or (d) a
Material Adverse Change with respect to any Guarantor; 
 8.11    Governmental Approvals; FDA Action.
(a) Any Governmental Approval shall have been revoked, rescinded, suspended, modified in an adverse manner, or not renewed in the ordinary course for a full term and such revocation, rescission, suspension, modification or non-renewal has resulted in or could reasonably be expected to result in a Material Adverse Change; or (b) (i) the FDA, DOJ, or other Governmental Authority initiates a Regulatory Action or any other
enforcement action against Borrower or any of its Subsidiaries or any supplier of Borrower or any of its Subsidiaries that causes Borrower or any of its Subsidiaries to recall, withdraw, remove or discontinue manufacturing, distributing, and/or
marketing any of its products, even if such action is based on previously disclosed conduct, and in each case such action is reasonably expected to cause a Material Adverse Effect; (ii) the FDA issues a warning letter or Regulatory Action to
Borrower or any of its Subsidiaries with respect to any of its activities or products which could reasonably be expected to result in a Material Adverse Change; (iii) Borrower or any of its Subsidiaries conducts a mandatory or voluntary recall
which could reasonably be expected to result in a Material Adverse Effect; (iv) Borrower or any of its Subsidiaries enters into a settlement agreement with the FDA, DOJ, or other Governmental Authority that could reasonably be expected to
result in a Material Adverse Change even if such settlement agreement is based on previously disclosed conduct; or (v) Borrower or any of its Subsidiaries fails to remediate, in a manner satisfactory to the FDA, observations identified in an
FDA Form 483 notice of inspection observation to the FDA’s reasonable satisfaction within six (6) months of receipt; or (vi) the FDA revokes any authorization or permission granted under any Registration, or Borrower or any of its
Subsidiaries withdraws any Registration, that could reasonably be expected to result in a Material Adverse Change. 

  
 18 

 8.12    Lien Priority; Intellectual Property. Any Lien
created hereunder or by any other Loan Document shall at any time fail to constitute a valid and perfected Lien on any of the Collateral purported to be secured thereby, subject to no prior or equal Lien, other than Permitted Liens arising as a
matter of applicable law. Any Intellectual Property material to Borrower’s business shall cease to be validly owned or licensed by Borrower free and clear of any Liens other than Permitted Liens. 

 

	9.	 RIGHTS AND REMEDIES 

9.1    Rights and Remedies. 

(a)    Upon the occurrence and during the continuance of an Event of Default, Collateral Agent may, and at the written
direction of the Required Lenders shall, without notice or demand, do any or all of the following: (i) deliver notice of the Event of Default to Borrower, (ii) by notice to Borrower declare all Obligations immediately due and payable (but
if an Event of Default described in Section 8.5 occurs all Obligations shall be immediately due and payable without any action by Collateral Agent or the Lenders) or (iii) by notice to Borrower suspend or terminate the obligations, if any,
of the Lenders to advance money or extend credit for Borrower’s benefit under this Agreement or under any other agreement between Borrower and Collateral Agent and/or the Lenders (but if an Event of Default described in Section 8.5 occurs
all obligations, if any, of the Lenders to advance money or extend credit for Borrower’s benefit under this Agreement or under any other agreement between Borrower and Collateral Agent and/or the Lenders shall be immediately terminated without
any action by Collateral Agent or the Lenders). 
 (b)    Without limiting the rights of Collateral Agent and the
Lenders set forth in Section 9.1(a) above, upon the occurrence and during the continuance of an Event of Default, Collateral Agent shall have the right, and shall at the written direction of the Required Lenders, without notice or demand, to do
any or all of the following: 
 (i)    foreclose upon and/or sell or otherwise liquidate, the Collateral; 

(ii)    apply to the Obligations any (a) balances and deposits of Borrower that Collateral Agent or any Lender holds
or controls, or (b) any amount held or controlled by Collateral Agent or any Lender owing to or for the credit or the account of Borrower; and/or 

(iii)    commence and prosecute an Insolvency Proceeding or consent to Borrower commencing any Insolvency Proceeding.

 (c)    Without limiting the rights of Collateral Agent and the Lenders set forth in Sections 9.1(a) and
(b) above, upon the occurrence and during the continuance of an Event of Default, Collateral Agent shall have the right, without notice or demand, to do any or all of the following: 

(i)    settle or adjust disputes and claims directly with Account Debtors for amounts on terms and in any order that
Collateral Agent considers advisable, notify any Person owing Borrower money of Collateral Agent’s security interest in such funds, and verify the amount of such account; 

(ii)    make any payments and do any acts it considers necessary or reasonable to protect the Collateral and/or its
security interest in the Collateral. Borrower shall assemble the Collateral if Collateral Agent requests and make it available in a location as Collateral Agent reasonably designates. Collateral Agent may enter premises where the Collateral is
located, take and maintain possession of any part of the Collateral, and pay, purchase, contest, or compromise any Lien which appears to be prior or superior to its security interest and pay all expenses incurred. Borrower grants Collateral Agent a
license to enter and occupy any of its premises, without charge, to exercise any of Collateral Agent’s rights or remedies; 

(iii)    ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, and/or advertise for sale, the
Collateral. Collateral Agent is hereby granted a non-exclusive, royalty-free license or other right to use, without charge, Borrower’s and each of its Subsidiaries’ labels, Patents, Copyrights, mask
works, rights 

  
 19 

 
of use of any name, trade secrets, trade names, Trademarks, service marks, and advertising matter, or any similar property as it pertains to the Collateral, in completing production of,
advertising for sale, and selling any Collateral and, in connection with Collateral Agent’s exercise of its rights under this Section 9.1, Borrower’s and each of its Subsidiaries’ rights under all licenses and all franchise
agreements inure to Collateral Agent, for the benefit of the Lenders; 
 (iv)    place a “hold” on any
account maintained with Collateral Agent or the Lenders and/or deliver a notice of exclusive control, any entitlement order, or other directions or instructions pursuant to any Control Agreement or similar agreements providing control of any
Collateral; 
 (v)    demand and receive possession of Borrower’s Books; 

(vi)    appoint a receiver to seize, manage and realize any of the Collateral, and such receiver shall have any right and
authority as any competent court will grant or authorize in accordance with any applicable law, including any power or authority to manage the business of Borrower or any of its Subsidiaries; and 

(vii)    subject to clauses 9.1(a) and (b), exercise all rights and remedies available to Collateral Agent and each
Lender under the Loan Documents or at law or equity, including all remedies provided under the Code (including disposal of the Collateral pursuant to the terms thereof). 

Notwithstanding any provision of this Section 9.1 to the contrary, upon the occurrence of any Event of Default, Collateral Agent shall have the right to
exercise any and all remedies referenced in this Section 9.1 without the written consent of Required Lenders following the occurrence of an Exigent Circumstance. 

9.2    Power of Attorney. Borrower hereby irrevocably appoints Collateral Agent as its lawful attorney-in-fact, exercisable upon the occurrence and during the continuance of an Event of Default, to: (a) endorse Borrower’s or any of its Subsidiaries’ name
on any checks or other forms of payment or security; (b) sign Borrower’s or any of its Subsidiaries’ name on any invoice or bill of lading for any Account or drafts against Account Debtors; (c) settle and adjust disputes and
claims about the Accounts directly with Account Debtors, for amounts and on terms Collateral Agent determines reasonable; (d) make, settle, and adjust all claims under Borrower’s insurance policies; (e) pay, contest or settle any
Lien, charge, encumbrance, security interest, and adverse claim in or to the Collateral, or any judgment based thereon, or otherwise take any action to terminate or discharge the same; and (f) transfer the Collateral into the name of Collateral
Agent or a third party as the Code or any applicable law permits. Borrower hereby appoints Collateral Agent as its lawful attorney-in-fact to sign Borrower’s or any
of its Subsidiaries’ name on any documents necessary to perfect or continue the perfection of Collateral Agent’s security interest in the Collateral regardless of whether an Event of Default has occurred until all Obligations (other than
inchoate indemnity obligations) have been satisfied in full and Collateral Agent and the Lenders are under no further obligation to extend the Term Loan hereunder. Collateral Agent’s foregoing appointment as Borrower’s or any of its
Subsidiaries’ attorney in fact, and all of Collateral Agent’s rights and powers, coupled with an interest, are irrevocable until all Obligations (other than inchoate indemnity obligations) have been fully repaid and performed and
Collateral Agent’s and the Lenders’ obligation to provide the Term Loan terminates. 

9.3    Protective Payments. If Borrower or any of its Subsidiaries fail to obtain the insurance called for
by Section 6.5 or fails to pay any premium thereon or fails to pay any other amount which Borrower or any of its Subsidiaries is obligated to pay under this Agreement or any other Loan Document, Collateral Agent may obtain such insurance or
make such payment, and all amounts so paid by Collateral Agent are Lenders’ Expenses and immediately due and payable, bearing interest at the Default Rate, and secured by the Collateral. Collateral Agent will make reasonable efforts to provide
Borrower with notice of Collateral Agent obtaining such insurance or making such payment at the time it is obtained or paid or within a reasonable time thereafter. No such payments by Collateral Agent are deemed an agreement to make similar payments
in the future or Collateral Agent’s waiver of any Event of Default. 
 9.4    Application of Payments and
Proceeds. Notwithstanding anything to the contrary contained in this Agreement, upon the occurrence and during the continuance of an Event of Default, (a) Borrower irrevocably waives the right to direct the application of any and all
payments at any time or times thereafter received by 

  
 20 

 
Collateral Agent from or on behalf of Borrower or any of its Subsidiaries of all or any part of the Obligations, and, as between Borrower on the one hand and Collateral Agent and Lenders on the
other, Collateral Agent shall have the continuing and exclusive right to apply and to reapply any and all payments received against the Obligations in such manner as Collateral Agent may deem advisable notwithstanding any previous application by
Collateral Agent, and (b) the proceeds of any sale of, or other realization upon all or any part of the Collateral shall be applied: first, to the Lenders’ Expenses; second, to accrued and unpaid interest on the Obligations (including any
interest which, but for the provisions of the United States Bankruptcy Code, would have accrued on such amounts); third, to the principal amount of the Obligations outstanding; and fourth, to any other indebtedness or obligations of Borrower owing
to Collateral Agent or any Lender under the Loan Documents. Any balance remaining shall be delivered to Borrower or to whoever may be lawfully entitled to receive such balance or as a court of competent jurisdiction may direct. In carrying out the
foregoing, (x) amounts received shall be applied in the numerical order provided until exhausted prior to the application to the next succeeding category, and (y) each of the Persons entitled to receive a payment in any particular category
shall receive an amount equal to its pro rata share of amounts available to be applied pursuant thereto for such category. Any reference in this Agreement to an allocation between or sharing by the Lenders of any right, interest or obligation
“ratably,” “proportionally” or in similar terms shall refer to Pro Rata Share unless expressly provided otherwise. Collateral Agent, or if applicable, each Lender, shall promptly remit to the other Lenders such sums as may be
necessary to ensure the ratable repayment of each Lender’s portion of any Term Loan and the ratable distribution of interest, fees and reimbursements paid or made by Borrower. Notwithstanding the foregoing, a Lender receiving a scheduled
payment shall not be responsible for determining whether the other Lenders also received their scheduled payment on such date; provided, however, if it is later determined that a Lender received more than its ratable share of scheduled payments made
on any date or dates, then such Lender shall remit to Collateral Agent or other Lenders such sums as may be necessary to ensure the ratable payment of such scheduled payments, as instructed by Collateral Agent. If any payment or distribution of any
kind or character, whether in cash, properties or securities, shall be received by a Lender in excess of its ratable share, then the portion of such payment or distribution in excess of such Lender’s ratable share shall be received by such
Lender in trust for and shall be promptly paid over to the other Lender for application to the payments of amounts due on the other Lenders’ claims. To the extent any payment for the account of Borrower is required to be returned as a voidable
transfer or otherwise, the Lenders shall contribute to one another as is necessary to ensure that such return of payment is on a pro rata basis. If any Lender shall obtain possession of any Collateral, it shall hold such Collateral for itself and as
agent and bailee for Collateral Agent and other Lenders for purposes of perfecting Collateral Agent’s security interest therein. 

9.5    Liability for Collateral. So long as Collateral Agent and the Lenders comply with reasonable banking
practices regarding the safekeeping of the Collateral in the possession or under the control of Collateral Agent and the Lenders, Collateral Agent and the Lenders shall not be liable or responsible for: (a) the safekeeping of the Collateral;
(b) any loss or damage to the Collateral; (c) any diminution in the value of the Collateral; or (d) any act or default of any carrier, warehouseman, bailee, or other Person. Borrower bears all risk of loss, damage or destruction of
the Collateral. 
 9.6    No Waiver; Remedies Cumulative. Failure by Collateral Agent or any Lender, at
any time or times, to require strict performance by Borrower of any provision of this Agreement or any other Loan Document shall not waive, affect, or diminish any right of Collateral Agent or any Lender thereafter to demand strict performance and
compliance herewith or therewith. No waiver hereunder shall be effective unless signed by Collateral Agent and the Required Lenders and then is only effective for the specific instance and purpose for which it is given. The rights and remedies of
Collateral Agent and the Lenders under this Agreement and the other Loan Documents are cumulative. Collateral Agent and the Lenders have all rights and remedies provided under the Code, any applicable law, by law, or in equity. The exercise by
Collateral Agent or any Lender of one right or remedy is not an election, and Collateral Agent’s or any Lender’s waiver of any Event of Default is not a continuing waiver. Collateral Agent’s or any Lender’s delay in exercising
any remedy is not a waiver, election, or acquiescence. 
 9.7    Demand Waiver. Borrower waives, to the
fullest extent permitted by law, demand, notice of default or dishonor, notice of payment and nonpayment, notice of any default, nonpayment at maturity, release, compromise, settlement, extension, or renewal of accounts, documents, instruments,
chattel paper, and guarantees held by Collateral Agent or any Lender on which Borrower or any Subsidiary is liable. 

  
 21 

	10.	 NOTICES 

All notices, consents, requests, approvals, demands, or other communication (collectively, “Communication”)
by any party to this Agreement or any other Loan Document must be in writing and shall be deemed to have been validly served, given, or delivered: (a) upon the earlier of actual receipt and three (3) Business Days after deposit in the U.S.
mail, first class, registered or certified mail return receipt requested, with proper postage prepaid; (b) upon transmission, when sent by electronic mail (if an email address is specified herein) or facsimile transmission; (c) one (1)
Business Day after deposit with a reputable overnight courier with all charges prepaid; or (d) when delivered, if hand delivered by messenger, all of which shall be addressed to the party to be notified and sent to the address, facsimile
number, or email address indicated below. Any of Collateral Agent, Lender or Borrower may change its mailing electronic mail address or facsimile number by giving the other party written notice thereof in accordance with the terms of this
Section 10. 
  

							
	                                    	  	If to Borrower:	 	EXAGEN DIAGNOSTICS, INC.	  	
		  		 	1261 Liberty Way, Suite C	  	
		  		 	Vista, CA 92081	  	
		  		 	Attn: Chief Financial Officer	  	
		  		 	Email: 	  	
				
		  	 with a copy (which shall not
 constitute notice)
to:
	 	LATHAM & WATKINS LLP	  	
		  		 	505 Montgomery Street, Suite 2000	  	
		  		 	San Francisco, CA 94111-6538	  	
		  		 	Attn: Haim Zaltzman	  	
		  		 	Email: 	  	
				
		  	If to Collateral Agent:	 	INNOVATUS LIFE SCIENCES	  	
		  		 	LENDING FUND I, LP	  	
		  		 	777 Third Avenue, 25th Floor	  	
		  		 	New York, NY 10017	  	
		  		 	Attn: Claes Ekstrom	  	
		  		 	Email: 	  	
				
		  	 with a copy (which shall not
 constitute notice)
to:
	 	 COOLEY LLP (US)
 3175 Hanover Street
	  	
		  		 	Palo Alto, California 94304-1130	  	
		  		 	Attn: Troy Zander	  	
		  		 	Email: 	  	

  

	11.	 CHOICE OF LAW, VENUE AND JURY TRIAL WAIVER 

11.1    Waiver of Jury Trial. EACH OF BORROWER, COLLATERAL AGENT AND LENDERS UNCONDITIONALLY WAIVES ANY AND
ALL RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, ANY OF THE OTHER LOAN DOCUMENTS, ANY OF THE INDEBTEDNESS SECURED HEREBY, ANY DEALINGS AMONG BORROWER, COLLATERAL AGENT AND/OR LENDERS RELATING TO
THE SUBJECT MATTER OF THIS TRANSACTION OR ANY RELATED TRANSACTIONS, AND/OR THE RELATIONSHIP THAT IS BEING ESTABLISHED AMONG BORROWER, COLLATERAL AGENT AND/OR LENDERS. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL ENCOMPASSING OF ANY AND ALL
DISPUTES THAT MAY BE FILED IN ANY COURT. THIS WAIVER IS IRREVOCABLE. THIS WAIVER MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING. THE WAIVER ALSO SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT, ANY
OTHER LOAN DOCUMENTS, OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING TO THIS TRANSACTION OR ANY RELATED TRANSACTION. THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 

  
 22 

 11.2    Governing Law and Jurisdiction. 

(a)    THIS AGREEMENT, THE OTHER LOAN DOCUMENTS (EXCLUDING THOSE LOAN DOCUMENTS THAT BY THEIR OWN TERMS ARE EXPRESSLY
GOVERNED BY THE LAWS OF ANOTHER JURISDICTION) AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND THEREUNDER SHALL IN ALL RESPECTS BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO
THE CONFLICT OF LAWS PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAWS OTHER THAN THE LAWS OF THE STATE OF NEW YORK), INCLUDING ALL MATTERS OF CONSTRUCTION, VALIDITY AND PERFORMANCE, REGARDLESS OF THE LOCATION OF THE COLLATERAL,
PROVIDED, HOWEVER, THAT IF THE LAWS OF ANY JURISDICTION OTHER THAN NEW YORK SHALL GOVERN IN REGARD TO THE VALIDITY, PERFECTION OR EFFECT OF PERFECTION OF ANY LIEN OR IN REGARD TO PROCEDURAL MATTERS AFFECTING ENFORCEMENT OF ANY LIENS IN
COLLATERAL, SUCH LAWS OF SUCH OTHER JURISDICTIONS SHALL CONTINUE TO APPLY TO THAT EXTENT. 
 (b)    Submission to
Jurisdiction. Any legal action or proceeding with respect to the Loan Documents shall be brought exclusively in the courts of the State of New York located in the City of New York, Borough of Manhattan, or of the United States of America for the
Southern District of New York and, by execution and delivery of this Agreement, Borrower hereby accepts for itself and in respect of its Property, generally and unconditionally, the jurisdiction of the aforesaid courts. Notwithstanding the
foregoing, Collateral Agent and Lenders shall have the right to bring any action or proceeding against Borrower (or any property of Borrower) in the court of any other jurisdiction Collateral Agent or Lenders deem necessary or appropriate in order
to realize on the Collateral or other security for the Obligations. The parties hereto hereby irrevocably waive any objection, including any objection to the laying of venue or based on the grounds of forum non conveniens, that any of them
may now or hereafter have to the bringing of any such action or proceeding in such jurisdictions. 
 (c)    Service
of Process. Borrower irrevocably waives personal service of any and all legal process, summons, notices and other documents and other service of process of any kind and consents to such service in any suit, action or proceeding brought in the
United States of America with respect to or otherwise arising out of or in connection with any Loan Document by any means permitted by applicable requirements of law, including by the mailing thereof (by registered or certified mail, postage
prepaid) to the address of Borrower specified herein (and shall be effective when such mailing shall be effective, as provided therein). Borrower agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced
in other jurisdictions by suit on the judgment or in any other manner provided by law. 
 (d)    Non-exclusive Jurisdiction. Nothing contained in this Section 11.2 shall affect the right of Collateral Agent or Lenders to serve process in any other manner permitted by applicable requirements of law or
commence legal proceedings or otherwise proceed against Borrower in any other jurisdiction. 
  

	12.	 GENERAL PROVISIONS 

12.1    Successors and Assigns. This Agreement binds and is for the benefit of the successors and permitted
assigns of each party. Borrower may not transfer, pledge or assign this Agreement or any rights or obligations under it without Collateral Agent’s prior written consent (which may be granted or withheld in Collateral Agent’s discretion,
subject to Section 12.5). The Lenders have the right, without the consent of or notice to Borrower, to sell, transfer, assign, pledge, negotiate, or grant participation in (any such sale, transfer, assignment, negotiation, or
grant of a participation, a “Lender Transfer”) all or any part of, or any interest in, the Lenders’ obligations, rights, and benefits under this Agreement and the other Loan Documents; provided, however, so long as no
Event of Default has occurred and is continuing, no Lender Transfer shall be permitted, without Borrower’s consent, to any Person which is a direct competitor of Borrower or a vulture hedge fund, each as determined by Collateral Agent. 

12.2    Indemnification. Borrower agrees to indemnify, defend and hold Collateral Agent and the Lenders and
their respective directors, officers, employees, consultants, agents, attorneys, or any other Person affiliated with or representing Collateral Agent or the Lenders (each, an “Indemnified Person”) harmless against:

  
 23 

 
(a) all obligations, demands, claims, and liabilities (collectively, “Claims”) asserted by any other party in connection with; related to; following; or arising from, out of or
under, the transactions contemplated by the Loan Documents; and (b) all losses or Lenders’ Expenses incurred, or paid by Indemnified Person in connection with; related to; following; or arising from, out of or under, the transactions
contemplated by the Loan Documents between Collateral Agent, and/or the Lenders and Borrower (including reasonable attorneys’ fees and expenses), except for Claims and/or losses directly caused by such Indemnified Person’s gross negligence
or willful misconduct. Borrower hereby further indemnifies, defends and holds each Indemnified Person harmless from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, claims, costs, expenses and
disbursements of any kind or nature whatsoever (including the fees and disbursements of counsel for such Indemnified Person) in connection with any investigative, response, remedial, administrative or judicial matter or proceeding, whether or not
such Indemnified Person shall be designated a party thereto and including any such proceeding initiated by or on behalf of Borrower, and the reasonable expenses of investigation by engineers, environmental consultants and similar technical personnel
and any commission, fee or compensation claimed by any broker (other than any broker retained by Collateral Agent or Lenders) asserting any right to payment for the transactions contemplated hereby which may be imposed on, incurred by or asserted
against such Indemnified Person as a result of or in connection with the transactions contemplated hereby and the use or intended use of the proceeds of the loan proceeds except for liabilities, obligations, losses, damages, penalties, actions,
judgments, suits, claims, costs, expenses and disbursements directly caused by such Indemnified Person’s gross negligence or willful misconduct. 

12.3    Severability of Provisions. Each provision of this Agreement is severable from every other provision
in determining the enforceability of any provision. 
 12.4    Correction of Loan Documents. Collateral Agent may
correct patent errors and fill in any blanks in this Agreement and the other Loan Documents consistent with the agreement of the parties. 

12.5    Amendments in Writing; Integration. (a) No amendment, modification, termination or waiver of
any provision of this Agreement or any other Loan Document, no approval or consent thereunder, or any consent to any departure by Borrower or any of its Subsidiaries therefrom, shall in any event be effective unless the same shall be in writing and
signed by Borrower, Collateral Agent and the Required Lenders provided that: 
 (i)    no such amendment, waiver or
other modification that would have the effect of increasing or reducing a Lender’s Term Loan Commitment or Commitment Percentage shall be effective as to such Lender without such Lender’s written consent; 

(ii)    no such amendment, waiver or modification that would affect the rights and duties of Collateral Agent shall be
effective without Collateral Agent’s written consent or signature; and 
 (iii)    no such amendment, waiver or
other modification shall, unless signed by all the Lenders directly affected thereby, (A) reduce the principal of, rate of interest on or any fees with respect to any Term Loan or forgive any principal, interest (other than default interest) or
fees (other than late charges) with respect to any Term Loan (B) postpone the date fixed for, or waive, any payment of principal of any Term Loan or of interest on any Term Loan (other than default interest) or any fees provided for hereunder
(other than late charges or for any termination of any commitment); (C) change the definition of the term “Required Lenders” or the percentage of Lenders which shall be required for the Lenders to take any action hereunder;
(D) release all or substantially all of any material portion of the Collateral, authorize Borrower to sell or otherwise dispose of all or substantially all or any material portion of the Collateral or release any Guarantor of all or any portion
of the Obligations or its guaranty obligations with respect thereto, except, in each case with respect to this clause (D), as otherwise may be expressly permitted under this Agreement or the other Loan Documents (including in connection with any
disposition permitted hereunder); (E) amend, waive or otherwise modify this Section 12.5 or the definitions of the terms used in this Section 12.5 insofar as the definitions affect the substance of this Section 12.5; (F) consent to
the assignment, delegation or other transfer by Borrower of any of its rights and obligations under any Loan Document or release Borrower of its payment obligations under any Loan Document, except, in each case with respect to this clause (F),
pursuant to a merger or consolidation permitted pursuant to this Agreement; (G) amend any of the provisions of Section 9.4 or amend any of the definitions of Pro Rata Share, Term Loan Commitment, Commitment Percentage or that provide for
the Lenders to receive their Pro Rata Shares of any fees, payments, setoffs or proceeds of Collateral 

  
 24 

 
hereunder; (H) subordinate the Liens granted in favor of Collateral Agent securing the Obligations; or (I) amend any of the provisions of Section 12.5. It is hereby understood and
agreed that all Lenders shall be deemed directly affected by an amendment, waiver or other modification of the type described in the preceding clauses (C), (D), (E), (F), (G) and (H) of the immediately preceding sentence. 

(b)    Other than as expressly provided for in Section 12.5(a)(i)-(iii), Collateral Agent may, if requested by the
Required Lenders, from time to time designate covenants in this Agreement less restrictive by notification to a representative of Borrower. 

(c)    This Agreement and the Loan Documents represent the entire agreement about this subject matter and supersede prior
negotiations or agreements with respect to such subject matter. All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of this Agreement and the Loan Documents merge into this
Agreement and the Loan Documents. 
 12.6    Counterparts. This Agreement may be executed in any number of
counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. 

12.7    Survival. All covenants, representations and warranties made in this Agreement continue in full
force and effect until this Agreement has terminated pursuant to its terms and all Obligations (other than inchoate indemnity obligations and any other obligations which, by their terms, are to survive the termination of this Agreement) have been
satisfied. The obligation of Borrower in Section 12.2 to indemnify each Lender and Collateral Agent, as well as the confidentiality provisions in Section 12.8 below, shall survive until the statute of limitations with respect to such claim
or cause of action shall have run. 
 12.8    Confidentiality. In handling any confidential information of
Borrower, the Lenders and Collateral Agent shall exercise the same degree of care that it exercises for their own proprietary information, but disclosure of information may be made: (a) subject to the terms and conditions of this Agreement, to
the Lenders’ and Collateral Agent’s Subsidiaries or Affiliates; (b) to prospective transferees (other than those identified in (a) above) or purchasers of any interest in the Term Loan (provided, however, the Lenders and Collateral
Agent shall use best efforts to obtain such prospective transferee’s or purchaser’s agreement to the terms of this provision or to substantially similar confidentiality terms); (c) as required by law, regulation, subpoena, or other order;
(d) to Lenders’ or Collateral Agent’s regulators or as otherwise required in connection with an examination or audit; (e) as Collateral Agent reasonably considers appropriate in exercising remedies under the Loan Documents; and
(f) to third party service providers of the Lenders and/or Collateral Agent so long as such service providers have executed a confidentiality agreement or have agreed to similar confidentiality terms with the Lenders and Collateral Agent with
terms no less restrictive than those contained herein. Confidential information does not include information that either: (i) is in the public domain or in the Lenders’ and/or Collateral Agent’s possession when disclosed to the
Lenders and/or Collateral Agent, or becomes part of the public domain after disclosure to the Lenders and/or Collateral Agent at no fault of the Lenders or the Collateral Agent; or (ii) is disclosed to the Lenders and/or Collateral Agent by a
third party, if the Lenders and/or Collateral Agent does not know that the third party is prohibited from disclosing the information. Collateral Agent and the Lenders may use confidential information for any purpose solely related to their roles
under this Agreement or the Loan Documents, including, for the development of client databases, reporting purposes, and market analysis, in each case solely if such information is anonymous and does not disclose any confidential information as
otherwise required hereunder. The provisions of the immediately preceding sentence shall survive the termination of this Agreement. The agreements provided under this Section 12.8 supersede all prior agreements, understanding, representations,
warranties, and negotiations between the parties about the subject matter of this Section 12.8. 

12.9    Right of Set Off. Borrower hereby grants to Collateral Agent and to each Lender, a lien, security
interest and right of set off as security for all Obligations to Collateral Agent and each Lender hereunder, whether now existing or hereafter arising upon and against all deposits, credits, collateral and property, now or hereafter in the
possession, custody, safekeeping or control of Collateral Agent or the Lenders or any entity under the control of Collateral Agent or the Lenders (including a Collateral Agent affiliate) or in transit to any of them. At any time after the occurrence
and during the continuance of an Event of Default, without demand or notice, Collateral Agent or the Lenders may set off the same or any part thereof and apply the same to any liability or obligation of Borrower even

  
 25 

 
though unmatured and regardless of the adequacy of any other collateral securing the Obligations. ANY AND ALL RIGHTS TO REQUIRE COLLATERAL AGENT TO EXERCISE ITS RIGHTS OR REMEDIES WITH RESPECT TO
ANY OTHER COLLATERAL WHICH SECURES THE OBLIGATIONS, PRIOR TO EXERCISING ITS RIGHT OF SETOFF WITH RESPECT TO SUCH DEPOSITS, CREDITS OR OTHER PROPERTY OF BORROWER ARE HEREBY KNOWINGLY, VOLUNTARILY AND IRREVOCABLY WAIVED BY BORROWER. 

12.10    Cooperation of Borrower. If necessary, Borrower agrees to (i) execute any documents reasonably
required to effectuate and acknowledge each assignment of a Term Loan Commitment or Term Loan to an assignee in accordance with Section 12.1, (ii) make Borrower’s management available to meet with Collateral Agent and prospective
participants and assignees of Term Loan Commitments (which meetings shall be conducted no more often than once every twelve months unless an Event of Default has occurred and is continuing), and (iii) assist Collateral Agent or the Lenders in the
preparation of information relating to the financial affairs of Borrower as any prospective participant or assignee of a Term Loan Commitment or Term Loan reasonably may request. Subject to the provisions of Section 12.8, Borrower authorizes
each Lender to disclose to any prospective participant or assignee of a Term Loan Commitment, any and all information in such Lender’s possession concerning Borrower and its financial affairs which has been delivered to such Lender by or on
behalf of Borrower pursuant to this Agreement, or which has been delivered to such Lender by or on behalf of Borrower in connection with such Lender’s credit evaluation of Borrower prior to entering into this Agreement. 

12.11    Public Announcement. Borrower hereby agrees that Collateral Agent and Innovatus may make a public
announcement of the transactions contemplated by this Agreement, and may publicize the same in marketing materials, newspapers and other publications, and otherwise, and in connection therewith may use Borrower’s name, tradenames and logos, in
each case with the prior written consent of Borrower not to be unreasonably withheld, conditioned or delayed. 

12.12    Collateral Agent and Lender Agreement. Collateral Agent and each Lender hereby agree to the terms
and conditions set forth on Annex I attached hereto. Borrower acknowledges and agrees to the terms and conditions set forth on Annex I attached hereto. 
  

	13.	 DEFINITIONS 

As used in this Agreement, the following terms have the following meanings: 

“Account” is any “account” as defined in the Code with such additions to such term as may hereafter be made, and
includes, without limitation, all accounts receivable and other sums owing to Borrower. 
 “Account Debtor” is any
“account debtor” as defined in the Code with such additions to such term as may hereafter be made under the Code. 

“Affiliate” of any Person is a Person that owns or controls directly or indirectly the Person, any Person that controls or is
controlled by or is under common control with the Person, and each of that Person’s senior executive officers, directors, partners if such Person is a partnership and, for any Person that is a limited liability company, that Person’s
managers and members. 
 “Amortization Date” is the earliest of (i) the first Payment Date immediately following the
occurrence of an Event of Default that is continuing, (ii) the first Payment Date immediately following the date, if any, upon which the Interest-Only Milestones are not met and Borrower fails timely to achieve the Equity Cure (the earliest
such date in the foregoing clauses (i) and (ii), the “Early Amortization Date”) and (iii) the thirty-seventh (37th) Payment Date following the Effective Date. Notwithstanding the foregoing and for the avoidance of doubt,
any amortization payments that would have been due on the Payment Dates occurring after the Interest-Only Milestones are not met but for the Equity Cure period, shall be due and payable at the end of the Equity Cure period if the Borrower fails to
timely achieve the Equity Cure. 
 “Anti-Terrorism Laws” are any laws relating to terrorism or money laundering, including
without 

  
 26 

 
limitation Executive Order No. 13224 (effective September 24, 2001), the USA PATRIOT Act, the laws comprising or implementing the Bank Secrecy Act, and the laws administered by OFAC.

 “A/R Lender” is the lender providing Borrower the A/R Line. 

“A/R Line” means a credit facility made available to Borrower in an amount not to exceed Three Million Dollars
($3,000,000.00), repayment of which is secured by Borrower’s accounts receivable only, and which credit facility is subject to an intercreditor agreement between Collateral Agent and the A/R Lender in form and content reasonably acceptable to
Collateral Agent. 
 “Blocked Person” is any Person: (a) listed in the annex to, or is otherwise subject to the
provisions of, Executive Order No. 13224, (b) a Person owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224, (c) a Person
with which any Lender is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law, (d) a Person that commits, threatens or conspires to commit or supports “terrorism” as defined in Executive Order
No. 13224, or (e) a Person that is named a “specially designated national” or “blocked person” on the most current list published by OFAC or other similar list. 

“Borrower’s Books” are Borrower’s or any of its Subsidiaries’ books and records including ledgers, federal,
and state tax returns, records regarding Borrower’s or its Subsidiaries’ assets or liabilities, the Collateral, business operations or financial condition, and all computer programs or storage or any equipment containing such information.

 “Business Day” is any day that is not a Saturday, Sunday or a day on which Collateral Agent is closed. 

“Cash Equivalents” are (a) marketable direct obligations issued or unconditionally guaranteed by the United States or
any agency or any State thereof having maturities of not more than one (1) year from the date of acquisition; (b) commercial paper maturing no more than one (1) year after its creation and having the highest rating from either
Standard & Poor’s Ratings Group or Moody’s Investors Service, Inc.; and (c) certificates of deposit maturing no more than one (1) year after issue. 

“Code” is the Uniform Commercial Code, as the same may, from time to time, be enacted and in effect in the State of New York;
provided, that, to the extent that the Code is used to define any term herein or in any Loan Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9
shall govern; provided further, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection, or priority of, or remedies with respect to, Collateral Agent’s Lien on any Collateral is governed by
the Uniform Commercial Code in effect in a jurisdiction other than the State of New York, the term “Code” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions
thereof relating to such attachment, perfection, priority, or remedies and for purposes of definitions relating to such provisions. 

“Collateral” is any and all properties, rights and assets of Borrower described on Exhibit A. 

“Collateral Account” is any Deposit Account, Securities Account, or Commodity Account, or any other bank account maintained
by Borrower or any Subsidiary at any time (that is required to become either a co- Borrower hereunder or a secured guarantor with respect to the Obligations in accordance with Section 6.10). 

“Commitment Percentage” is set forth in Schedule 1.1, as amended from time to time. 

“Commodity Account” is any “commodity account” as defined in the Code with such additions to such term as may
hereafter be made under the Code. 
 “Compliance Certificate” is that certain certificate in substantially the form
attached hereto as Exhibit C. 
 “Contingent Obligation” is, for any Person, any direct or indirect liability,
contingent or not, of that 

  
 27 

 
Person for (a) any indebtedness, lease, dividend, letter of credit or other obligation of another Person such as an obligation directly or indirectly guaranteed, endorsed, co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable; (b) any obligations for undrawn letters of credit for the account of that Person; and
(c) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange
rates or commodity prices; but “Contingent Obligation” does not include endorsements in the ordinary course of business. The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the
Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support
arrangement. 
 “Control Agreement” is any control agreement entered into among the depository institution at which
Borrower or any of its domestic U.S. Subsidiaries maintains a Deposit Account or the securities intermediary or commodity intermediary at which Borrower or any of its domestic U.S. Subsidiaries maintains a Securities Account or a Commodity Account,
Borrower and such Subsidiary, and Collateral Agent pursuant to which Collateral Agent, for the benefit of the Lenders, obtains “control” (within the meaning of the Code) over such Deposit Account, Securities Account, or Commodity Account.

 “Copyrights” are any and all copyright rights, copyright applications, copyright registrations and like protections in
each work of authorship and derivative work thereof, whether published or unpublished and whether or not the same also constitutes a trade secret. 

“CRP” means, collectively, Capital Royalty Partners II, L.P., Capital Royalty Partners II – Parallel Fund “A”
L.P., Parallel Investment Opportunities Partners II L.P. and Capital Royalty Partners II (Cayman) L.P. 
 “Deposit Account”
is any “deposit account” as defined in the Code with such additions to such term as may hereafter be made. 

“Disbursement Letter” is that certain form attached hereto as Exhibit B-2.

 “DOJ” means the U.S. Department of Justice or any successor thereto or any other comparable Governmental Authority. 

“Dollars,” “dollars” and “$” each mean lawful money of the United States. 

“Equipment” is all “equipment” as defined in the Code with such additions to such term as may hereafter be made,
and includes without limitation all machinery, fixtures, goods, vehicles (including motor vehicles and trailers), and any interest in any of the foregoing. 

“Equity Cure” means Borrower’s receipt, within sixty (60) days of any failure to achieve the Interest-Only
Milestones, of gross proceeds from the sale and issuance of Borrower’s equity securities or Subordinated Debt, which in each case will not have any redemption, clawback, escrow or similar terms of at least Ten Million Dollars ($10,000,000.00);
provided that (i) the net proceeds thereof are no less than Nine Million Five Hundred Thousand Dollars ($9,500,000.00); and (ii) in the event any portion of the Equity Cure is raised in the form of Subordinated Debt, at least fifty percent
(50.00%) of such Subordinated Debt must be from Borrower’s investors as of the Effective Date. 
 “ERISA” is the
Employee Retirement Income Security Act of 1974, as amended, and its regulations. 
 “Excluded Taxes” means any of the
following Taxes imposed on or with respect to a Recipient or required to be withheld or deducted from a payment to a Recipient, (a) Taxes imposed on or measured by net income (however denominated), franchise Taxes, and branch profits Taxes, in
each case, (i) imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in the case of any Lender, its applicable lending office located in, the jurisdiction imposing such Tax (or any political
subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts 

  
 28 

 
payable to or for the account of such Lender with respect to an applicable interest in a Term Loan or Commitment pursuant to a law in effect on the date on which (i) such Lender acquires
such interest in a Loan or Commitment or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 2.5, amounts with respect to such Taxes were payable either to such Lender’s assignor
immediately before such Lender became a party hereto or to such Lender immediately before it changed its lending office, (c) Taxes attributable to such Recipient’s failure to comply with Section 2.5(e) and (d) any U.S. federal
withholding Taxes imposed under FATCA. 
 “Exigent Circumstance” means any event or circumstance that, in
the reasonable judgment of Collateral Agent, imminently threatens the ability of Collateral Agent to realize upon all or any material portion of the Collateral, such as, without limitation, fraudulent removal, concealment, or abscondment thereof,
destruction or material waste thereof, or failure of Borrower or any of its Subsidiaries after reasonable demand to maintain or reinstate adequate casualty insurance coverage, or which, in the judgment of Collateral Agent, could reasonably be
expected to result in a material diminution in value of the Collateral. 
 “Existing Indebtedness” is the
indebtedness of Borrower to CRP in the aggregate principal outstanding amount as of the Effective Date of approximately Seventeen Million Two Hundred Ninety Seven Thousand Nine Hundred Ninety Nine and Three
One-Hundredths Dollars ($17,297,999.03) pursuant to that certain Term Loan Agreement, dated as of October 10, 2013, as amended from time to time, entered into by and between CRP and Borrower. 

“Facility Fee” is a fee due on the Effective Date equal to Two Hundred Fifty Thousand Dollars ($250,000.00).

 “FATCA” means Sections 1471 through 1474 of the IRC, as of the date of this Agreement (or any amended or
successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof and any agreements entered into pursuant to Section 1471(b)(1) of the IRC,
any intergovernmental agreement entered into in connection with the implementation of such Sections of the IRC and any fiscal or regulatory legislation, rules or practices adopted pursuant to such intergovernmental agreement. 

“FDA” means the U.S. Food and Drug Administration or any successor thereto or any other comparable
Governmental Authority. 
 “Final Fee” is a payment (in addition to and not a substitution for the regular
monthly payments of principal plus accrued interest or any other fee payable hereunder) due on the earliest to occur of (a) the Maturity Date, or (b) the acceleration of any Term Loan, or (c) the prepayment of the Term Loan pursuant
to Section 2.2(c), in each case equal to four percent (4.00%) multiplied by the Term Loan funded under this Agreement, payable to Lenders in accordance with their respective Pro Rata Shares. 

“Foreign Subsidiary” is a Subsidiary that is not an entity organized under the laws of the United States or
any state thereof. 
 “Funding Date” is any date on which the Term Loan is made to or on account of
Borrower, which shall be a Business Day. 
 “GAAP” is generally accepted accounting principles set forth in
the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other
Person as may be approved by a significant segment of the accounting profession in the United States, which are applicable to the circumstances as of the date of determination. 

“General Intangibles” are all “general intangibles” as defined in the Code in effect on the date
hereof with such additions to such term as may hereafter be made. 

  
 29 

 “Governmental Approval” is any consent, authorization, approval, order,
license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority. 

“Governmental Authority” is any nation or government, any state or other political subdivision thereof, any agency,
authority, instrumentality, regulatory body (including, without limitation, the FDA and any state board of pharmacy or state pharmacy licensing authority), court, central bank or other entity exercising executive, legislative, judicial, taxing,
regulatory or administrative functions of or pertaining to government, any securities exchange and any self-regulatory organization. 

“Guarantor” is any Person providing a Guaranty in favor of Collateral Agent for the benefit of the Lenders. 

“Guaranty” is any guarantee of all or any part of the Obligations, as the same may from time to time be amended, restated,
modified or otherwise supplemented. 
 “Gross Margin” is the ratio, expressed as a percentage, of Gross Profit to revenues
under GAAP. 
 “Gross Profit” is revenues minus the cost of sales, in each case computed in accordance with
GAAP. 
 “Indebtedness” is (a) indebtedness for borrowed money or the deferred price of property or services,
such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease obligations, and (d) Contingent Obligations. 

“Indemnified Taxes” means (a) Taxes, other than Excluded Taxes, imposed on or with respect to any payment made by or on
account of any obligation of Borrower under any Loan Document and (b) to the extent not otherwise described in (a), Other Taxes. 

“Insolvency Proceeding” is any proceeding by or against any Person under the United States Bankruptcy Code, or any other
bankruptcy or insolvency law, including assignments for the benefit of creditors, compositions or proceedings seeking reorganization, arrangement, or other relief. 

“Insolvent” means not Solvent. 

“Intellectual Property” means all of Borrower’s or any of its Subsidiaries’ right, title and interest in and to the
following: 
 (a)    its Copyrights, Trademarks and Patents; 

(b)    any and all trade secrets and trade secret rights, including, without limitation, any rights to unpatented
inventions, know-how, operating manuals; 
 (c)    any and all source code; 

(d)    any and all design rights which may be available to Borrower; 

(e)    any and all claims for damages by way of past, present and future infringement of any of the foregoing, with the
right, but not the obligation, to sue for and collect such damages for said use or infringement of the Intellectual Property rights identified above; 

(f)    all amendments, renewals and extensions of any of the Copyrights, Trademarks or Patents; and 

(g)    all licenses, sublicenses or other contracts under which Borrower or any Subsidiary is granted rights by third
parties in any Intellectual Property asset. 

  
 30 

 “Interest-Only Milestones” means achievement of each of the following:
(i) the I/O Revenue Milestone; and (ii) (x) the I/O Gross Margin Milestone or (y) the I/O Gross Profit Milestone; in each case, written evidence of which is provided, and is in form and content reasonably acceptable, to Collateral
Agent and the Lenders. Notwithstanding the foregoing, Borrower’s failure to achieve the Interest-Only Milestones may be cured by, at Borrower’s election, either: (i) an increase in the interest rate set forth in Section 2.3(c) by
8.0% from the date of any such failure until (A) the I/O Revenue Milestone and (B) either (x) the I/O Gross Margin Milestone or (y) the I/O Gross Profit Milestone have been achieved; or (ii) the Equity Cure; such election to be
made in writing to Collateral Agent and the Lenders no later than forty-five (45) days after the failure to achieve the Interest-Only Milestones (or any of them). 

“Inventory” is all “inventory” as defined in the Code in effect on the date hereof with such additions to such term
as may hereafter be made under the Code, and includes without limitation all merchandise, raw materials, parts, supplies, packing and shipping materials, work in process and finished products, including without limitation such inventory as is
temporarily out of any Person’s custody or possession or in transit and including any returned goods and any documents of title representing any of the above. 

“Investment” is any beneficial ownership interest in any Person (including stock, partnership interest or other securities),
and any loan, advance or capital contribution to any Person. 
 “I/O Gross Margin Milestone” means actual minimum trailing
twelve (12) month Gross Margin, measured at the end of each calendar quarter commencing with the quarter ending December 31, 2017, greater than forty-five percent (45.00%); written evidence of which is provided, and is in form and content
reasonably acceptable, to Collateral Agent and Innovatus; provided that Borrower shall have thirty (30) calendar days from the last day of the applicable quarter to present unaudited financial statements to Collateral Agent and Innovatus for
review, to determine compliance with the I/O Gross Margin Milestone. 
 “I/O Gross Profit Milestone” means actual minimum
trailing twelve (12) month Gross Profit, measured at the end of each calendar quarter commencing with the quarter ending December 31, 2017, greater than seventy-five percent (75.00%) of projected Gross Profit (such projections attached
hereto as Annex Q (the “Management Plan”)); written evidence of which is provided, and is in form and content reasonably acceptable, to Collateral Agent and Innovatus; provided that Borrower shall have thirty
(30) calendar days from the last day of the applicable quarter to present unaudited financial statements to Collateral Agent and Innovatus for review, to determine compliance with the I/O Gross Profit Milestone 

“I/O Revenue Milestone” means actual minimum trailing twelve (12) month revenue under GAAP, measured at the end of each
calendar quarter commencing with the quarter ending December 31, 2017, greater than seventy-five percent (75.00%) of revenue under GAAP projected in the Management Plan; written evidence of which is provided, and is in form and content
reasonably acceptable, to Collateral Agent and Innovatus; provided that Borrower shall have thirty (30) calendar days from the last day of the applicable quarter to present unaudited financial statements to Collateral Agent and Innovatus for
review, to determine compliance with the I/O Revenue Milestone. 
 “IP Security Agreement” is that certain Intellectual
Property Security Agreement executed and delivered by Borrower to Collateral Agent and dated as of the Effective Date, as may be amended, restated, or otherwise modified or supplemented from time to time. 

“IRC” means the Internal Revenue Code of 1986, as amended, and the Treasury Regulations adopted thereunder. 

“Key Person” is each of Borrower’s (i) President and Chief Executive Officer, who is Ron Rocca as of the Effective
Date, (ii) Chief Financial Officer, who is Kamal Adawi as of the Effective Date, (iii) Chief Scientific Officer, who is Thierry Dervieux as of the Effective Date and (iv) Claudia Ibarra, who is Senior Vice President, Laboratory
Operations as of the Effective Date. 
 “Knowledge” means to the “best of” Borrower’s knowledge, or with a
similar qualification, knowledge or 

  
 31 

 
awareness means the actual knowledge, after reasonable investigation, of the Responsible Officers. 

“Lender” is any one of the Lenders. 

“Lenders” are the Persons identified on Schedule 1.1 hereto and each assignee that becomes a party to this Agreement
pursuant to Section 12.1. 
 “Lenders’ Expenses” are all reasonable and actual audit fees and expenses, costs,
and expenses (including reasonable attorneys’ fees and expenses, as well as appraisal fees, fees incurred on account of lien searches, inspection fees, and filing fees) for preparing, amending, negotiating, administering, defending and
enforcing the Loan Documents (including, without limitation, those incurred in connection with appeals or Insolvency Proceedings) or otherwise incurred by Collateral Agent and/or the Lenders in connection with the Loan Documents. 

“Lien” is a claim, mortgage, deed of trust, levy, charge, pledge, security interest, or other encumbrance of any kind,
whether voluntarily incurred or arising by operation of law or otherwise against any property. 
 “Loan Documents” are,
collectively, this Agreement, the IP Security Agreement, each Secured Promissory Note, each Warrant, the Perfection Certificate(s), each Control Agreement, each Compliance Certificate, each Loan Payment Request Form, each Disbursement Letter, any
subordination agreements, any note, or notes or guaranties executed by Borrower or any other Person, and any other present or future agreement entered into by Borrower, any Guarantor or any other Person for the benefit of the Lenders and Collateral
Agent in connection with this Agreement; all as amended, restated, or otherwise modified or supplemented from time to time. 
 “Loan
Payment Request Form” is that certain form attached hereto as Exhibit B-1. 

“Material Adverse Change” is (a) a material adverse change in the business, operations or financial condition of
Borrower or any Subsidiary, taken as a whole; (b) a material impairment of the prospect of repayment of any portion of the Obligations, or (c) a material adverse effect on the Collateral. 

“Material Agreement” is any license, agreement or other contractual arrangement with a Person or Governmental Authority
whereby Borrower or any of its Subsidiaries is reasonably likely to be required to transfer, either in-kind or in cash, prior to the Maturity Date, assets or property valued (book or market) at more than Five
Hundred Thousand Dollars ($500,000.00) in the aggregate or any license, agreement or other contractual arrangement conveying rights in or to any material Intellectual Property necessary to make, use or sell any Inventory, products or services of
Borrower or any Subsidiary. As used herein, “material Intellectual Property” includes but is not limited to U.S. Patent No.s 7,585,640 and 7,390,631, and U.S. Patent Application No.s 13/992,086 and 14/767,461. 

“Maturity Date” is the earlier of (i) September 7, 2022 and (ii) eighteen (18)) months following the Early
Amortization Date, if applicable. 
 “Obligations” are all of Borrower’s obligations to pay when due any debts,
principal, interest, Lenders’ Expenses, the Prepayment Fee, the Final Fee, and other amounts Borrower owes the Lenders now or later, in connection with, related to, following, or arising from, out of or under, this Agreement or, the other Loan
Documents, or otherwise (other than the Warrant or any equity investment related thereto), and including interest accruing after Insolvency Proceedings begin (whether or not allowed) and debts, liabilities, or obligations of Borrower assigned to the
Lenders and/or Collateral Agent, and the performance of Borrower’s duties under the Loan Documents (other than the Warrant or any equity investment related thereto). 

“OFAC” is the U.S. Department of Treasury Office of Foreign Assets Control. 

“OFAC Lists” are, collectively, the Specially Designated Nationals and Blocked Persons List maintained by OFAC pursuant to
Executive Order No. 13224, 66 Fed. Reg. 49079 (Sept. 25, 2001) and/or any other list of terrorists or other restricted Persons maintained pursuant to any of the rules and regulations of OFAC or pursuant to any other applicable Executive Orders.

  
 32 

 “Operating Documents” are, for any Person, such Person’s formation
documents, as certified by the Secretary of State (or equivalent agency) of such Person’s jurisdiction of organization on a date that is no earlier than thirty (30) days prior to the Effective Date, and, (a) if such Person is a
corporation, its bylaws in current form, (b) if such Person is a limited liability company, its limited liability company agreement (or similar agreement), and (c) if such Person is a partnership, its partnership agreement (or similar agreement),
each of the foregoing with all current amendments or modifications thereto. 
 “Other Connection Taxes” means, with respect
to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such Tax (other than connections arising from such Recipient having executed, delivered, become a party to, performed
its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in any Loan Document or pursuant to any
Lender Transfer). 
 “Other Taxes” means all present or future stamp, court or documentary, intangible, recording, filing
or similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except
any such Taxes that are Other Connection Taxes imposed with respect to an assignment. 
 “Patents” means all patents,
patent applications and like protections including without limitation improvements, divisions, continuations, renewals, reissues, re-examination certificates, utility models, extensions and continuations-in-part of the same. 
 “Payment
Date” is the first (1st) calendar day of each calendar month, commencing on October 1, 2017. 
 “Permitted
Indebtedness” is: 
 (a)    Borrower’s Indebtedness to the Lenders and Collateral Agent under this
Agreement and the other Loan Documents; 
 (b)    Indebtedness existing on the Effective Date and disclosed on the
Perfection Certificate(s); 
 (c)    Indebtedness consisting of the A/R Line; 

(d)    Subordinated Debt; 

(e)    unsecured Indebtedness to trade creditors and Indebtedness in connection with credit cards incurred in the ordinary
course of business; 
 (f)    Indebtedness consisting of capitalized lease obligations, equipment financings and
purchase money Indebtedness, in each case incurred by Borrower or any of its Subsidiaries to finance the acquisition, repair, improvement or construction of fixed or capital assets of such Person, provided that (i) the aggregate outstanding
principal amount of all such Indebtedness does not exceed Five Hundred Thousand Dollars ($500,000.00) at any time and (ii) the principal amount of such Indebtedness does not exceed the lower of the cost or fair market value of the property so
acquired or built or of such repairs or improvements financed with such Indebtedness (each measured at the time of such acquisition, repair, improvement or construction is made); 

(g)    Indebtedness consisting of letters of credit securing real property leases and/or subleases entered into in the
ordinary course of business, not to exceed the face amount of Five Hundred Thousand Dollars ($500,000.00) (or such greater amount as may be approved by the Collateral Agent in it reasonable discretion); 

(h)    [Reserved]; 

  
 33 

 (i)    Indebtedness in the notional amount not to exceed One Hundred
Thousand Dollars ($100,000.00) incurred in connection with the hedges and similar agreements entered into the ordinary course of Borrower’s business; 

(j)    Indebtedness incurred as a result of endorsing negotiable instruments received in the ordinary course of
Borrower’s business; and 
 (k)    extensions, refinancings, modifications, amendments and restatements of any
items of Permitted Indebtedness (a) through (h) above, provided that the principal amount thereof is not increased or the terms thereof are not modified to impose materially more burdensome terms upon Borrower, or its Subsidiary, as the case
may be. 
 “Permitted Investments” are: 

(a)    Investments disclosed on the Perfection Certificate(s) and existing on the Effective Date; 

(b)    Investments consisting of cash and Cash Equivalents, and (ii) any Investments permitted by Borrower’s
investment policy, as amended from time to time, provided that such investment policy (and any such amendment thereto) has been approved in writing by Collateral Agent, which such investment policy submitted to Collateral Agent by Borrower prior to
the Effective Date is deemed approved; 
 (c)    Investments consisting of the endorsement of negotiable instruments for
deposit or collection or similar transactions in the ordinary course of Borrower; 
 (d)    Investments consisting of
Deposit Accounts in which Collateral Agent has a perfected security interest as required hereunder; 

(e)    Investments in connection with Transfers permitted by Section 7.1 and Permitted Indebtedness and Permitted
Liens to the extent such transaction constitutes an Investment; 
 (f)    Investments consisting of (i) travel
advances and employee relocation loans and other employee loans and advances in the ordinary course of business, and (ii) loans to employees, officers or directors relating to the purchase of equity securities of Borrower or its Subsidiaries
pursuant to employee stock purchase plans or agreements approved by Borrower’s board of directors, not to exceed Two Hundred Fifty Thousand Dollars ($250,000.00) in the aggregate for (i) and (ii) in any fiscal year; 

(g)    Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers
or suppliers and in settlement of delinquent obligations of, and other disputes with, customers or suppliers arising in the ordinary course of business; 

(h)    Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and
suppliers who are not Affiliates, in the ordinary course of business; provided that this paragraph (h) shall not apply to Investments of Borrower in any Subsidiary; 

(i)    Investments in (A) Subsidiaries that are co-borrowers of the
Obligations or Guarantors, and (B) other Subsidiaries not to exceed Three Hundred Fifty Thousand Dollars ($350,000.00) in the aggregate per fiscal year; and 

(j)    Investments in joint ventures or strategic alliances in the ordinary course of Borrower’s business consisting
of the licensing of technology, the development of technology or the providing of technical support, as otherwise permitted hereunder, and in which Borrower may invest cash in an amount not greater than Five Hundred Thousand Dollars ($500,000.00)
per fiscal year of Borrower. 
 “Permitted Licenses” are (A) licenses of over-the-counter software that is commercially available to the public, and (B) non-exclusive and exclusive licenses for the use of the Intellectual Property of
Borrower or any of its 

  
 34 

 
Subsidiaries entered into in the ordinary course of business, provided, that, with respect to each such license described in clause (B), (i) no Event of Default has occurred or is
continuing at the time of such license; (ii) the license constitutes an arms-length transaction, the terms of which, on their face, do not provide for a sale or assignment of any Intellectual Property and do not restrict the ability of Borrower
or any of its Subsidiaries, as applicable, to pledge, grant a security interest in or lien on, or assign or otherwise Transfer any Intellectual Property; (iii) in the case of any exclusive license, (x) Borrower delivers ten (10) days’
prior written notice and a brief summary of the terms of the proposed license to Collateral Agent and the Lenders and delivers to Collateral Agent and the Lenders copies of the final executed licensing documents in connection with the exclusive
license promptly upon consummation thereof, and (y) any such license could not result in a legal transfer of title of the licensed property but may be exclusive in respects other than territory and may be exclusive as to territory only as to
discrete geographical areas outside of the United States [unless such license is with respect to any specific field of use,, and identified in writing to Collateral Agent as such, in which case it may be exclusive as to territory globally] and
(iv) all upfront payments, royalties, milestone payments or other proceeds arising from the licensing agreement that are payable to Borrower or any of its Subsidiaries are paid to a Deposit Account that is governed by a Control Agreement. 

“Permitted Liens” are: 

(a)    Liens existing on the Effective Date and disclosed on the Perfection Certificates or arising under this Agreement
and the other Loan Documents; 
 (b)    Liens for taxes, fees, assessments or other government charges or levies, either
(i) not due and payable or (ii) being contested in good faith and for which Borrower maintains adequate reserves on its Books, provided that no notice of any such Lien has been filed or recorded under the Internal Revenue Code of 1986, as
amended, and the Treasury Regulations adopted thereunder; 
 (c)    Liens securing Indebtedness permitted under clause
(e) of the definition of “Permitted Indebtedness,” provided that (i) such liens exist prior to the acquisition of, or attach substantially simultaneous with, or within twenty (20) days after the, acquisition, lease, repair,
improvement or construction of, such property financed or leased by such Indebtedness and (ii) such liens do not extend to any property of Borrower other than the property (and proceeds thereof) acquired, leased or built, or the improvements or
repairs, financed by such Indebtedness; 
 (d)    Liens of carriers, warehousemen, suppliers, or other Persons that are
possessory in nature arising in the ordinary course of business so long as such Liens attach only to Inventory, securing liabilities in the aggregate amount not to exceed One Hundred Fifty Thousand Dollars ($150,000.00), and which are not delinquent
or remain payable without penalty or which are being contested in good faith and by appropriate proceedings which proceedings have the effect of preventing the forfeiture or sale of the property subject thereto; 

(e)    Liens to secure payment of workers’ compensation, employment insurance,
old-age pensions, social security and other like obligations incurred in the ordinary course of business (other than Liens imposed by ERISA); 

(f)    Liens incurred in the extension, renewal or refinancing of the indebtedness secured by Liens described in
(a) through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the indebtedness may not increase; 

(g)    leases or subleases of real property granted in the ordinary course of Borrower’s business (or, if referring
to another Person, in the ordinary course of such Person’s business), and leases, subleases, non-exclusive licenses or sublicenses of personal property (other than Intellectual Property) granted in the
ordinary course of Borrower’s business (or, if referring to another Person, in the ordinary course of such Person’s business), if the leases, subleases, licenses and sublicenses do not prohibit granting Collateral Agent or any Lender a
security interest therein; 

  
 35 

 (h)    banker’s liens, rights of setoff and Liens in favor of
financial institutions incurred in the ordinary course of business arising in connection with Borrower’s deposit accounts or securities accounts held at such institutions solely to secure payment of fees and similar costs and expenses and
provided such accounts are maintained in compliance with Section 6.6 hereof; 
 (i)    Liens to secure the A/R
Line; 
 (j)    Liens arising from judgments, decrees or attachments in circumstances not constituting an Event of
Default under Section 8.4 or 8.7; 
 (k)    Permitted Licenses and deposits to secure Permitted Indebtedness under
clauses (f) and (h) thereunder; and 
 (l)    Liens incurred in the extension, renewal or refinancing of the
indebtedness secured by Liens described in (a) through (c), but any extension, renewal or replacement Lien must be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness may not increase. 

“Permitted Prepayment Mandatory Warrant” means an additional warrant in form and substance substantially similar to the
Warrant issued to Innovatus on the Closing Date, for 3,000,000 shares at an exercise price of $0.078 per share. 
 “Permitted
Prepayment Reason” is any of the following occurrences after the first anniversary of the Effective Date but prior to the second anniversary of the Effective Date: (a) any equity event or similar capital raise that would not constitute
a Change of Control, (b) entry by Borrower into any joint ventures, licensing, corporate collaboration or similar transactions, whether or not permitted by this Agreement, (c) consummation of a reverse merger, alternative public offering
or similar capital market transaction, (d) incurrence of Indebtedness that has a weighted average life (as customarily defined and calculated) lower than the Indebtedness under this Agreement, whether or not permitted by this Agreement,
(e) any merger that would not constitute a Change of Control but where the equity interest of Borrower being transferred, exchanged or tendered in connection thereto is greater than twenty percent (20%), (f) the occurrence of an Event of
Default, or (g) the occurrence of the Amortization Date. 
 “Person” is any individual, sole proprietorship,
partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency. 

“Prepayment Fee” is, with respect to any Term Loan subject to prepayment prior to the Maturity Date, whether by mandatory or
voluntary prepayment, acceleration or otherwise, as indicated, an additional fee payable to the Lenders in amount equal to: 

(i)    for any voluntary prepayment made on or after the first anniversary of the Effective Date but prior to the second
anniversary of the Effective Date, which voluntary prepayment during such period is permitted solely in connection with a Permitted Prepayment Reason, the Prepayment Mandatory Fee plus issuance to Lender on such date of prepayment of the Permitted
Prepayment Mandatory Warrant; 
 (ii)    for any prepayment made on or after the second anniversary of the Effective
Date through and including the third anniversary of the Effective Date, three percent (3.00%) of the principal amount of the Term Loan prepaid; 

(iii)    for any prepayment made after the date which is the third anniversary of the Effective Date through and
including the date which is the fourth anniversary of the Effective Date, two percent (2.00%) of the principal amount of the Term Loan prepaid; and 

(iv)    for any prepayment made after the date which is the fourth anniversary of the Effective Date and prior to the
Maturity Date, one percent (1.00%) of the principal amount of the Term Loan prepaid; 

  
 36 

 
provided that, for a mandatory prepayment made on or after the Effective Date through and including the second anniversary of the Effective Date, the Prepayment Fee shall be the Prepayment
Mandatory Fee. 
 “Prepayment Mandatory Fee” means the amount shown next to the applicable period on Schedule I (Prepayment
Mandatory Fee) attached hereto. 
 “Property” means any interest in any kind of property or asset, whether real, personal
or mixed, and whether tangible or intangible. 
 “Pro Rata Share” is, as of any date of determination, with respect to each
Lender, a percentage (expressed as a decimal, rounded to the ninth decimal place) determined by dividing the outstanding principal amount of the Term Loan held by such Lender by the aggregate outstanding principal amount of the Term Loan. 

“Recipient” means Collateral Agent or any Lender, as applicable. 

“Registered Organization” is any “registered organization” as defined in the Code with such additions to such term
as may hereafter be made under the Code. 
 “Registration” means any registration, authorization, approval, license,
permit, clearance, certificate, and exemption issued or allowed by the FDA or state pharmacy licensing authorities (including, without limitation, new drug applications, abbreviated new drug applications, biologics license applications,
investigational new drug applications, over-the-counter drug monograph, device pre-market approval applications, device pre-market notifications, investigational device exemptions, product recertifications, manufacturing approvals, registrations and authorizations, CE Marks, pricing and reimbursement approvals, labeling approvals or
their foreign equivalent, controlled substance registrations, and wholesale distributor permits). 
 “Regulatory Action”
means an administrative, regulatory, or judicial enforcement action, proceeding, investigation or inspection, FDA Form 483 notice of inspectional observation, warning letter, untitled letter, other notice of violation letter, recall, seizure,
Section 305 notice or other similar written communication, injunction or consent decree, issued by the FDA or a federal or state court. 

“Related Persons” means, with respect to any Person, each Affiliate of such Person and each director, officer, employee,
agent, trustee, representative, attorney, accountant and each insurance, environmental, legal, financial and other advisor and other consultants and agents of or to such Person or any of its Affiliates. 

“Required Lenders” means (i) for so long as all of the Persons that are Lenders on the Effective Date (each an
“Original Lender”) have not assigned or transferred any of their interests in the Term Loan, Lenders holding one hundred percent (100%) of the aggregate outstanding principal balance of the Term Loan, or (ii) at any time from
and after any Original Lender has assigned or transferred any interest in its Term Loan, Lenders holding at least fifty one percent (51%) of the aggregate outstanding principal balance of the Term Loan. 

“Requirement of Law” is as to any Person, the organizational or governing documents of such Person, and any law (statutory or
common), treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is
subject. 
 “Responsible Officer” is any of the President, Chief Executive Officer, or Chief Financial Officer of Borrower
acting alone. 
 “Second Draw Period” is the period commencing on the date of the occurrence of the Term B Funding
Milestones and ending on the earlier of (i) December 31, 2018 and (ii) the occurrence of an Event of Default; provided, however, that the Second Draw Period shall not commence if on the date of the occurrence of the Term B Funding
Milestones an Event of Default has occurred. 
 “Secured Promissory Note” is defined in Section 2.6. 

  
 37 

 “Secured Promissory Note Record” is a record maintained by each Lender with
respect to the outstanding Obligations owed by Borrower to Lender and credits made thereto. 
 “Securities Account” is any
“securities account” as defined in the Code with such additions to such term as may hereafter be made under the Code. 

“Shares” is (a) one hundred percent (100%) of the issued and outstanding capital stock, membership units or other
securities owned or held of record by Borrower or Borrower’s Subsidiary, in any Subsidiary or (b) sixty-five percent (65%) of the issued and outstanding capital stock, membership units or other securities owned or held of record by
Borrower or Borrower’s Subsidiary in any Foreign Subsidiary. 
 “Solvent” is, with respect to any Person: the fair
salable value of such Person’s consolidated assets (including goodwill minus disposition costs) exceeds the fair value of such Person’s liabilities; such Person is not left with unreasonably small capital after the transactions in this
Agreement; and such Person is able to pay its debts (including trade debts) as they mature in the ordinary course (without taking into account any forbearance and extensions related thereto). 

“Subordinated Debt” is indebtedness incurred by Borrower or any of its Subsidiaries subordinated to all Indebtedness of
Borrower and/or its Subsidiaries to the Lenders (pursuant to a subordination, intercreditor, or other similar agreement in form and substance reasonably satisfactory to Collateral Agent and the Lenders entered into between Collateral Agent,
Borrower, and/or any of its Subsidiaries, and the other creditor (each, a “Subordination Agreement”)), on terms reasonably acceptable to Collateral Agent and the Lenders. Among other things, the Subordination Agreement shall include an
acknowledgement by the holder of Subordinated Debt of the first in priority, senior secured Lien and security interest in all assets of Borrower granted in favor of, and held by, Collateral Agent. 

“Subsidiary” is, with respect to any Person, any Person of which more than fifty percent (50%) of the voting stock or other
equity interests (in the case of Persons other than corporations) is owned or controlled, directly or indirectly, by such Person or through one or more intermediaries. Unless otherwise specified, references herein to a Subsidiary means a Subsidiary
of Borrower. 
 “Taxes” is all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup
withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto. 

“Term A Loan” is defined in Section 2.2(a)(i) hereof. 

“Term B Loan” is defined in Section 2.2(a)(ii) hereof. 

“Term B Funding Milestones” means the date upon which both of the following has occurred: (i) the Term B Revenue
Milestone; and (ii) the Term B Gross Margin Milestone. 
 “Term B Gross Margin Milestone” means actual minimum
trailing twelve (12) month gross margin, measured as of the last day of the month ending immediately prior to the Funding Date of the Term B Loan, greater than fifty percent (50.00%); written evidence of which (including Borrower’s
unaudited financial statements) is provided, and is in form and content reasonably acceptable, to Collateral Agent and the Lenders prior to the Funding Date of the Term B Loan. 

“Term B Revenue Milestone” means actual minimum trailing twelve (12) month revenue under GAAP, measured as of the last
day of the month ending immediately prior to the Funding Date of the Term B Loan, greater than Thirty Million Dollars ($30,000,000.00); written evidence of which (including Borrower’s unaudited financial statements) is provided, and is in form
and content reasonably acceptable, to Collateral Agent and the Lenders prior to the Funding Date of the Term B Loan. 
 “Term
Loan” is defined in Section 2.2(a)(ii) hereof. 

  
 38 

 “Term Loan Commitment” is, for any Lender, the obligation of such Lender to
make the Term Loan, up to the principal amount shown on Schedule 1.1. “Term Loan Commitments” means the aggregate amount of such commitments of all Lenders. 

“Trademarks” means any trademark and servicemark rights, whether registered or not, applications to register and
registrations of the same and like protections, and the entire goodwill of the business of Borrower and each of its Subsidiaries connected with and symbolized by such trademarks. 

“U.S. Person” shall mean any Person that is a “United States person” as defined in Section 7701(a)(30) of the
IRC. 
 “Withholding Agent” is Borrower or Collateral Agent, as the context dictates. 

“Warrant” means any of that certain Warrant to Purchase Stock dated the Effective Date issued by Borrower in favor of each
Lender or such Lender’s Affiliates or any other warrant entered into in connection with the Term Loan, all as may be amended, restated, or otherwise modified or supplemented from time to time. 

[Balance of Page Intentionally Left Blank] 

  
 39 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as
of the Effective Date. 
 BORROWER: 
 EXAGEN
DIAGNOSTICS, INC. 
  

	
	/s/ Kamal Adawi
	 Name: Kamal Adawi
 Title: CFO

  
 [Signature Page to
Loan and Security Agreement] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as
of the Effective Date. 
 COLLATERAL AGENT AND LENDER: 

INNOVATUS LIFE SCIENCES LENDING FUND I, LP 
  

	
	 By: Innovatus Life Sciences GP, LP
 Its: General
Partner

	
	/s/ Andrew Hobson
	Name: Andrew Hobson
	Title: Authorized Signatory

  
 [Signature Page to
Loan and Security Agreement] 

 SCHEDULE 1.1 

Lenders and Commitments 

Term A Loans 
  

									
	 Lender
	  	 Term
Loan
Commitment
	 	  	
Commitment
Percentage
	 
	 INNOVATUS LIFE SCIENCES LENDING FUND I, LP
	  	$	20,000,000.00	 	  	 	100.00	% 
	 TOTAL
	  	$	20,000,000.00	 	  	 	100.00	% 

 Term B Loans 
  

									
	 Lender
	  	 Term
Loan
Commitment
	 	  	
Commitment
Percentage
	 
	 INNOVATUS LIFE SCIENCES LENDING FUND I, LP
	  	$	5,000,000.00	 	  	 	100.00	% 
	 TOTAL
	  	$	5,000,000.00	 	  	 	100.00	% 

 Aggregate (all Term Loans) 
  

									
	 Lender
	  	 Term
Loan
Commitment
	 	  	
Commitment
Percentage
	 
	 INNOVATUS LIFE SCIENCES LENDING FUND I, LP
	  	$	25,000,000.00	 	  	 	100.00	% 
	 TOTAL
	  	$	25,000,000.00	 	  	 	100.00	% 

 EXHIBIT A 

Description of Collateral 
 The
Collateral consists of all of Borrower’s right, title and interest in and to the following property: 
 All goods, Accounts (including
health-care receivables), Equipment, Inventory, contract rights or rights to payment of money, leases, license agreements, franchise agreements, General Intangibles (including Intellectual Property), commercial tort claims, documents, instruments
(including any promissory notes), chattel paper (whether tangible or electronic), cash, deposit accounts and other Collateral Accounts, all certificates of deposit, fixtures, letters of credit rights (whether or not the letter of credit is evidenced
by a writing), securities, and all other investment property, supporting obligations, and financial assets, whether now owned or hereafter acquired, wherever located; and 

All Borrower’s Books relating to the foregoing, and any and all claims, rights and interests in any of the above and all substitutions
for, additions, attachments, accessories, accessions and improvements to and replacements, products, proceeds and insurance proceeds of any or all of the foregoing. 

Notwithstanding the foregoing, the Collateral does not include (i) more than sixty five percent (65%) of the total combined voting power
of all classes of stock entitled to vote the shares of capital stock (the “Shares”) of any Foreign Subsidiary, if Borrower demonstrates to Collateral Agent’s reasonable satisfaction that a pledge of more than sixty five percent (65%)
of the Shares of such Subsidiary creates a present and existing adverse tax consequence to Borrower under the U.S. Internal Revenue Code; (ii) any license or contract, in each case if the granting of a Lien in such license or contract is
prohibited by or would constitute a default under the agreement governing such license or contract (but (A) only to the extent such prohibition is enforceable under applicable law and (B) other than to the extent that any such term would
be rendered ineffective pursuant to Sections 9-406, 9-408 or 9-409 (or any other Section) of Division 9 of the Code); provided
that upon the termination, lapsing or expiration of any such prohibition, such license or contract, as applicable, shall automatically be subject to the security interest granted in favor of Collateral Agent hereunder and become part of the
“Collateral;” or (iii) intent-to-use trademarks or service mark applications, to the extent that, and solely during the period in which, the grant of a
security interest therein would impair the validity or enforceability of such intent-to-use trademarks or service mark applications under applicable law. 

 ANNEX I 

Collateral Agent and Lender Terms 
  

1.    Appointment of Collateral Agent. 

(a)    Each Lender hereby appoints INNOVATUS LIFE SCIENCES LENDING FUND I, LP (together with any successor Collateral
Agent pursuant to Section 7 of this Annex I) as Collateral Agent under the Loan Documents and authorizes Collateral Agent to (i) execute and deliver the Loan Documents and accept delivery thereof on its behalf from Borrower, (ii) take
such action on its behalf and to exercise all rights, powers and remedies and perform the duties as are expressly delegated to Collateral Agent under such Loan Documents and (iii) exercise such powers as are reasonably incidental thereto. 

(b)    Without limiting the generality of clause (a) above, Collateral Agent shall have the sole and exclusive right
and authority (to the exclusion of the Lenders), and is hereby authorized, to (i) act as the disbursing and collecting agent for the Lenders with respect to all payments and collections arising in connection with the Loan Documents (including
in any other bankruptcy, insolvency or similar proceeding), and each Person making any payment in connection with any Loan Document to any Lender is hereby authorized to make such payment to Collateral Agent, (ii) file and prove claims and file
other documents necessary or desirable to allow the claims of Collateral Agent and Lenders with respect to any Obligation in any bankruptcy, insolvency or similar proceeding (but not to vote, consent or otherwise act on behalf of such Lender), (iii)
act as collateral agent for Collateral Agent and each Lender for purposes of the perfection of all Liens created by the Loan Documents and all other purposes stated therein, (iv) manage, supervise and otherwise deal with the Collateral,
(v) take such other action as is necessary or desirable to maintain the perfection and priority of the Liens created or purported to be created by the Loan Documents, (vi) except as may be otherwise specified in any Loan Document, exercise
all remedies given to Collateral Agent and the other Lenders with respect to the Borrower and/or the Collateral, whether under the Loan Documents, applicable Requirements of Law or otherwise and (vii) execute any amendment, consent or waiver
under the Loan Documents on behalf of any Lender that has consented in writing to such amendment, consent or waiver; provided, however, that Collateral Agent hereby appoints, authorizes and directs each Lender to act as collateral sub-agent for Collateral Agent and the Lenders for purposes of the perfection of all Liens with respect to the Collateral, including any Deposit Account maintained by Borrower with, and cash and Cash Equivalents
held by, such Lender, and may further authorize and direct the Lenders to take further actions as collateral sub-agents for purposes of enforcing such Liens or otherwise to transfer the Collateral subject
thereto to Collateral Agent, and each Lender hereby agrees to take such further actions to the extent, and only to the extent, so authorized and directed. Collateral Agent may, upon any term or condition it specifies, delegate or exercise any of its
rights, powers and remedies under, and delegate or perform any of its duties or any other action with respect to, any Loan Document by or through any trustee, co-agent, employee,
attorney-in-fact and any other Person (including any Lender). Any such Person shall benefit from this Annex I to the extent provided by Collateral Agent. 

(c)    Under the Loan Documents, Collateral Agent (i) is acting solely on behalf of the Lenders, with duties that are
entirely administrative in nature, notwithstanding the use of the defined term “Collateral Agent”, the terms “agent”, “Collateral Agent” and “collateral agent” and similar terms in any Loan Document to refer
to Collateral Agent, which terms are used for title purposes only, (ii) is not assuming any obligation under any Loan Document other than as expressly set forth therein or any role as agent, fiduciary or trustee of or for any Lender or any
other Person and (iii) shall have no implied functions, responsibilities, duties, obligations or other liabilities under any Loan Document, and each Lender, by accepting the benefits of the Loan Documents, hereby waives and agrees not to assert
any claim against Collateral Agent based on the roles, duties and legal relationships expressly disclaimed in clauses (i) through (iii) above. Except as expressly set forth in the Loan Documents, Collateral Agent shall not have any duty to
disclose, and shall not be liable for failure to disclose, any information relating to Borrower or any of its Subsidiaries that is communicated to or obtained by any other Lender or any of its Affiliates in any capacity. 

2.    Binding Effect; Use of Discretion; E-Systems. 

(a)    Each Lender, by accepting the benefits of the Loan Documents, agrees that (i) any action taken by Collateral
Agent or Required Lenders (or, if expressly required in any Loan Document, a greater proportion 

 
of the Lenders) in accordance with the provisions of the Loan Documents, (ii) any action taken by Collateral Agent in reliance upon the instructions of Required Lenders (or, where so
required, such greater proportion) and (iii) the exercise by Collateral Agent or Required Lenders (or, where so required, such greater proportion) of the powers set forth herein or therein, together with such other powers as are reasonably
incidental thereto, shall be authorized and binding upon all of Lenders. 
 (b)    If Collateral Agent shall request
instructions from Required Lenders or all affected Lenders with respect to any act or action (including failure to act) in connection with any Loan Document, then Collateral Agent shall be entitled to refrain from such act or taking such action
unless and until Collateral Agent shall have received instructions from Required Lenders or all affected Lenders, as the case may be, and Collateral Agent shall not incur liability to any Person by reason of so refraining. Collateral Agent shall be
fully justified in failing or refusing to take any action under any Loan Document (i) if such action would, in the opinion of Collateral Agent, be contrary to any Requirement of Law or any Loan Document, (ii) if such action would, in the
opinion of Collateral Agent, expose Collateral Agent to any potential liability under any Requirement of Law or (iii) if Collateral Agent shall not first be indemnified to its satisfaction against any and all liability and expense which may be
incurred by it by reason of taking or continuing to take any such action. Without limiting the foregoing, no Lender shall have any right of action whatsoever against Collateral Agent as a result of Collateral Agent acting or refraining from acting
under any Loan Document in accordance with the instructions of Required Lenders or all affected Lenders, as applicable. 

(c)    Collateral Agent is hereby authorized by Borrower and each Lender to establish procedures (and to amend such
procedures from time to time) to facilitate administration and servicing of the Term Loan and other matters incidental thereto. Without limiting the generality of the foregoing, Collateral Agent is hereby authorized to establish procedures to make
available or deliver, or to accept, notices, documents (including, without limitation, borrowing base certificates) and similar items on, by posting to or submitting and/or completion, on E-Systems. Borrower
and each Lender acknowledges and agrees that the use of transmissions via an E-System or electronic mail is not necessarily secure and that there are risks associated with such use, including risks of
interception, disclosure and abuse, and Borrower and each Lender assumes and accepts such risks by hereby authorizing the transmission via E-Systems or electronic mail. Each
“e-signature” on any such posting shall be deemed sufficient to satisfy any requirement for a “signature”, and each such posting shall be deemed sufficient to satisfy any requirement for a
“writing”, in each case including pursuant to any Loan Document, any applicable provision of any Code, the federal Uniform Electronic Transactions Act, the Electronic Signatures in Global and National Commerce Act and any substantive or
procedural Requirement of Law governing such subject matter. All uses of an E-System shall be governed by and subject to, in addition to this Section, the separate terms, conditions and privacy policy posted
or referenced in such E-System (or such terms, conditions and privacy policy as may be updated from time to time, including on such E-System) and related contractual
obligations executed by Collateral Agent, Borrower and/or Lenders in connection with the use of such E-System. ALL E-SYSTEMS AND ELECTRONIC TRANSMISSIONS SHALL BE
PROVIDED “AS IS” AND “AS AVAILABLE”. NO REPRESENTATION OR WARRANTY OF ANY KIND IS MADE BY AGENT, ANY LENDER OR ANY OF THEIR RELATED PERSONS IN CONNECTION WITH ANY E-SYSTEMS. 

3.    Collateral Agent’s Reliance, Etc. Collateral Agent may, without incurring any liability
hereunder, (a) consult with any of its Related Persons and, whether or not selected by it, any other advisors, accountants and other experts (including advisors to, and accountants and experts engaged by, Borrower) and (b) rely and act upon any
document and information (including those transmitted by electronic transmission) and any telephone message or conversation, in each case believed by it to be genuine and transmitted, signed or otherwise authenticated by the appropriate parties.
None of Collateral Agent and its Related Persons shall be liable for any action taken or omitted to be taken by any of them under or in connection with any Loan Document, and each Lender and Borrower hereby waives and shall not assert (and Borrower
shall cause its Subsidiaries to waive and agree not to assert) any right, claim or cause of action based thereon, except to the extent of liabilities resulting from the gross negligence or willful misconduct of Collateral Agent or, as the case may
be, such Related Person (each as determined in a final, non-appealable judgment of a court of competent jurisdiction) in connection with the duties of Collateral Agent expressly set forth herein. Without
limiting the foregoing, Collateral Agent: (i) shall not be responsible or otherwise incur liability for any action or omission taken in reliance upon the instructions of the Required Lenders or for the actions or omissions of any of its Related
Persons, except to the extent that a court of competent jurisdiction determines in a final non-appealable judgment that Collateral Agent acted with gross 

 
negligence or willful misconduct in the selection of such Related Person; (ii) shall not be responsible to any Lender or other Person for the due execution, legality, validity,
enforceability, effectiveness, genuineness, sufficiency or value of, or the attachment, perfection or priority of any Lien created or purported to be created under or in connection with, any Loan Document; (iii) makes no warranty or
representation, and shall not be responsible, to any Lender or other Person for any statement, document, information, representation or warranty made or furnished by or on behalf of Borrower or any Related Person of Borrower in connection with any
Loan Document or any transaction contemplated therein or any other document or information with respect to Borrower, whether or not transmitted or (except for documents expressly required under any Loan Document to be transmitted to the Lenders)
omitted to be transmitted by Collateral Agent, including as to completeness, accuracy, scope or adequacy thereof, or for the scope, nature or results of any due diligence performed by Collateral Agent in connection with the Loan Documents; and
(iv) shall not have any duty to ascertain or to inquire as to the performance or observance of any provision of any Loan Document, whether any condition set forth in any Loan Document is satisfied or waived, as to the financial condition of
Borrower or as to the existence or continuation or possible occurrence or continuation of any Event of Default, and shall not be deemed to have notice or Knowledge of such occurrence or continuation unless it has received a notice from Borrower or
any Lender describing such Event of Default that is clearly labeled “notice of default” (in which case Collateral Agent shall promptly give notice of such receipt to all Lenders, provided that Collateral Agent shall not be liable to
any Lender for any failure to do so, except to the extent that such failure is attributable to Collateral Agent’s gross negligence or willful misconduct as determined by a final non- appealable judgment
of a court of competent jurisdiction); and, for each of the items set forth in clauses (i) through (iv) above, each Lender and Borrower hereby waives and agrees not to assert (and Borrower shall cause its Subsidiaries to waive and agree not to
assert) any right, claim or cause of action it might have against Collateral Agent based thereon. 

4.    Collateral Agent Individually. Collateral Agent and its Affiliates may make loans and other extensions
of credit to, acquire stock and stock equivalents of, engage in any kind of business with, Borrower or any Affiliate of Borrower as though it were not acting as Collateral Agent and may receive separate fees and other payments therefor. To the
extent Collateral Agent or any of its Affiliates makes the Term Loan or otherwise becomes a Lender hereunder, it shall have and may exercise the same rights and powers hereunder and shall be subject to the same obligations and liabilities as any
other Lender and the terms “Lender”, “Required Lender” and any similar terms shall, except where otherwise expressly provided in any Loan Document, include, without limitation, Collateral Agent or such Affiliate, as the case may
be, in its individual capacity as Lender, or as one of the Required Lenders. 
 5.    Lender Credit Decision;
Collateral Agent Report. Each Lender acknowledges that it shall, independently and without reliance upon Collateral Agent, any Lender or any of their Related Persons or upon any document solely or in part because such document was transmitted by
Collateral Agent or any of its Related Persons, conduct its own independent investigation of the financial condition and affairs of Borrower and make and continue to make its own credit decisions in connection with entering into, and taking or not
taking any action under, any Loan Document or with respect to any transaction contemplated in any Loan Document, in each case based on such documents and information as it shall deem appropriate. Except for documents expressly required by any Loan
Document to be transmitted by Collateral Agent to the Lenders, Collateral Agent shall not have any duty or responsibility to provide any Lender with any credit or other information concerning the business, prospects, operations, Property, financial
and other condition or creditworthiness of Borrower or any Affiliate of Borrower that may come in to the possession of Collateral Agent or any of its Related Persons. Each Lender agrees that is shall not rely on any field examination, audit or other
report provided by Collateral Agent or its Related Persons (a “Collateral Agent Report”). Each Lender further acknowledges that any Collateral Agent Report (a) is provided to the Lenders solely as a courtesy, without
consideration, and based upon the understanding that such Lender will not rely on such Collateral Agent Report, (b) was prepared by Collateral Agent or its Related Persons based upon information provided by Borrower solely for Collateral
Agent’s own internal use, and (c) may not be complete and may not reflect all information and findings obtained by Collateral Agent or its Related Persons regarding the operations and condition of Borrower. Neither Collateral Agent nor any
of its Related Persons makes any representations or warranties of any kind with respect to (i) any existing or proposed financing, (ii) the accuracy or completeness of the information contained in any Collateral Agent Report or in any
related documentation, (iii) the scope or adequacy of Collateral Agent’s and its Related Persons’ due diligence, or the presence or absence of any errors or omissions contained in any Collateral Agent Report or in any related
documentation, and (iv) any work performed by Collateral Agent or Collateral Agent’s Related Persons in connection with or using any Collateral 

 
Agent Report or any related documentation. Neither Collateral Agent nor any of its Related Persons shall have any duties or obligations in connection with or as a result of any Lender receiving a
copy of any Collateral Agent Report. Without limiting the generality of the forgoing, neither Collateral Agent nor any of its Related Persons shall have any responsibility for the accuracy or completeness of any Collateral Agent Report, or the
appropriateness of any Collateral Agent Report for any Lender’s purposes, and shall have no duty or responsibility to correct or update any Collateral Agent Report or disclose to any Lender any other information not embodied in any Collateral
Agent Report, including any supplemental information obtained after the date of any Collateral Agent Report. Each Lender releases, and agrees that it will not assert, any claim against Collateral Agent or its Related Persons that in any way relates
to any Collateral Agent Report or arises out of any Lender having access to any Collateral Agent Report or any discussion of its contents, and agrees to indemnify and hold harmless Collateral Agent and its Related Persons from all claims,
liabilities and expenses relating to a breach by any Lender arising out of such Lender’s access to any Collateral Agent Report or any discussion of its contents. 

6.    Indemnification. Each Lender agrees to reimburse Collateral Agent and each of its Related Persons (to
the extent not reimbursed by Borrower as required under the Loan Documents) promptly upon demand for its Pro Rata Share of any out-of-pocket costs and expenses
(including, without limitation, fees, charges and disbursements of financial, legal and other advisors and any taxes or insurance paid in the name of, or on behalf of, Borrower) incurred by Collateral Agent or any of its Related Persons in
connection with the preparation, syndication, execution, delivery, administration, modification, amendment, consent, waiver or enforcement of, or the taking of any other action (whether through negotiations, through any work-out, bankruptcy, restructuring or other legal or other proceeding (including, without limitation, preparation for and/or response to any subpoena or request for document production relating thereto) or
otherwise) in respect of, or legal advice with respect to, its rights or responsibilities under, any Loan Document. Each Lender further agrees to indemnify Collateral Agent and each of its Related Persons (to the extent not reimbursed by Borrower as
required under the Loan Documents), ratably according to its Pro Rata Share, from and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature
whatsoever (including, to the extent not indemnified by the applicable Lender, taxes, interests and penalties imposed for not properly withholding or backup withholding on payments made to or for the account of any Lender) that may be imposed on,
incurred by, or asserted against Collateral Agent or any of its Related Persons in any matter relating to or arising out of, in connection with or as a result of any Loan Document or any other act, event or transaction related, contemplated in or
attendant to any such document, or, in each case, any action taken or omitted to be taken by Collateral Agent or any of its Related Persons under or with respect to the foregoing; provided that no Lender shall be liable to Collateral Agent or
any of its Related Persons under this Section 6 of this Annex I to the extent such liability has resulted from the gross negligence or willful misconduct of Collateral Agent or, as the case may be, such Related Person, as determined by a final non-appealable judgment of a court of competent jurisdiction. To the extent required by any applicable Requirement of Law, Collateral Agent may withhold from any payment to any Lender under a Loan Document an amount
equal to any applicable withholding tax. If the Internal Revenue Service or any other Governmental Authority asserts a claim that Collateral Agent did not properly withhold tax from amounts paid to or for the account of any Lender for any reason, or
if Collateral Agent reasonably determines that it was required to withhold taxes from a prior payment to or for the account of any Lender but failed to do so, such Lender shall promptly indemnify Collateral Agent fully for all amounts paid, directly
or indirectly, by Collateral Agent as tax or otherwise, including penalties and interest, and together with all expenses incurred by Collateral Agent. Collateral Agent may offset against any payment to any Lender under a Loan Document, any
applicable withholding tax that was required to be withheld from any prior payment to such Lender but which was not so withheld, as well as any other amounts for which Collateral Agent is entitled to indemnification from such Lender under the
immediately preceding sentence of this Section 6 of this Annex I. 
 7.    Successor Collateral Agent.
Collateral Agent may resign at any time by delivering notice of such resignation to the Lenders and Borrower, effective on the date set forth in such notice or, if no such date is set forth therein, upon the date such notice shall be effective,
in accordance with the terms of this Section 7 of this Annex I. If Collateral Agent delivers any such notice, the Required Lenders shall have the right to appoint a successor Collateral Agent. If, after 30 days after the date of the retiring
Collateral Agent’s notice of resignation, no successor Collateral Agent has been appointed by the Required Lenders that has accepted such appointment, then the retiring Collateral Agent may, on behalf of the Lenders, appoint a successor
Collateral Agent from among the Lenders. Effective immediately upon its resignation, (a) the retiring Collateral Agent shall be discharged from its duties and obligations under the Loan Documents, (b) the Lenders shall assume and perform
all of the duties of 

 
Collateral Agent until a successor Collateral Agent shall have accepted a valid appointment hereunder, (c) the retiring Collateral Agent and its Related Persons shall no longer have the
benefit of any provision of any Loan Document other than with respect to any actions taken or omitted to be taken while such retiring Collateral Agent was, or because such Collateral Agent had been, validly acting as Collateral Agent under the Loan
Documents, and (iv) subject to its rights under Section 2(b) of this Annex I, the retiring Collateral Agent shall take such action as may be reasonably necessary to assign to the successor Collateral Agent its rights as Collateral Agent under
the Loan Documents. Effective immediately upon its acceptance of a valid appointment as Collateral Agent, a successor Collateral Agent shall succeed to, and become vested with, all the rights, powers, privileges and duties of the retiring Collateral
Agent under the Loan Documents. 
 8.    Release of Collateral. Each Lender hereby consents to the release
and hereby directs Collateral Agent to release (or in the case of clause (b)(ii) below, release or subordinate) the following: 

(a)    any Guarantor or Subsidiary “co-Borrower” if all of the stock of
such Subsidiary owned by Borrower is sold or transferred in a transaction permitted under the Loan Documents (including pursuant to a valid waiver or consent), to the extent that, after giving effect to such transaction, such Subsidiary would not be
required to guaranty any Obligations pursuant to any Loan Document; and 
 (b)    any Lien held by Collateral Agent for
the benefit of itself and the Lenders against (i) any Collateral that is sold or otherwise disposed of by Borrower in a transaction permitted by the Loan Documents (including pursuant to a valid waiver or consent), (ii) any Collateral subject
to a Lien that is expressly permitted under clause (c) of the definition of the term “Permitted Lien” and (iii) all of the Collateral and Borrower, upon (A) termination of all of the Commitments, (B) payment in full in
cash of all of the Obligations that Collateral Agent has theretofore been notified in writing by the holder of such Obligation are then due and payable, and (C) to the extent requested by Collateral Agent, receipt by Collateral Agent and
Lenders of liability releases from Borrower in form and substance acceptable to Collateral Agent (the satisfaction of the conditions in this clause (iii), the “Termination Date”). 

9.    Setoff and Sharing of Payments. In addition to any rights now or hereafter granted under any
applicable requirement of law and not by way of limitation of any such rights, upon the occurrence and during the continuance of any Event of Default and subject to Section 10(d) of this Annex I, each Lender is hereby authorized at any time or
from time to time upon the direction of Collateral Agent, without notice to Borrower or any other Person, any such notice being hereby expressly waived, to setoff and to appropriate and to apply any and all balances held by it at any of its offices
for the account of Borrower (regardless of whether such balances are then due to Borrower) and any other properties or assets at any time held or owing by that Lender or that holder to or for the credit or for the account of Borrower against and on
account of any of the Obligations that are not paid when due. Any Lender exercising a right of setoff or otherwise receiving any payment on account of the Obligations in excess of its Pro Rata Share thereof shall purchase for cash (and the other
Lenders or holders shall sell) such participations in each such other Lender’s or holder’s Pro Rata Share of the Obligations as would be necessary to cause such Lender to share the amount so offset or otherwise received with each other
Lender or holder in accordance with their respective Pro Rata Shares of the Obligations. Borrower agrees, to the fullest extent permitted by law, that (a) any Lender may exercise its right to offset with respect to amounts in excess of its Pro
Rata Share of the Obligations and may purchase participations in accordance with the preceding sentence and (b) any Lender so purchasing a participation in the Term Loan made or other Obligations held by other Lenders or holders may exercise
all rights of offset, bankers’ lien, counterclaim or similar rights with respect to such participation as fully as if such Lender or holder were a direct holder of the Term Loan and the other Obligations in the amount of such participation.
Notwithstanding the foregoing, if all or any portion of the offset amount or payment otherwise received is thereafter recovered from the Lender that has exercised the right of offset, the purchase of participations by that Lender shall be rescinded
and the purchase price restored without interest. 
 10.    Advances; Payments;
Non-Funding Lenders; Actions in Concert. 
 (a)    Advances; Payments. If
Collateral Agent receives any payment with respect to the Term Loan for the account of Lenders on or prior to 2:00 p.m. (New York time) on any Business Day, Collateral Agent shall pay to each applicable Lender such Lender’s Pro Rata Share of
such payment on such Business Day. If Collateral Agent receives any payment with respect to the Term Loan for the account of Lenders after 2:00 p.m. 

 
(New York time) on any Business Day, Collateral Agent shall pay to each applicable Lender such Lender’s Pro Rata Share of such payment on the next Business Day. 

(b)    Return of Payments. 

(i)    If Collateral Agent pays an amount to a Lender under this Agreement in the belief or expectation that a related
payment has been or will be received by Collateral Agent from Borrower and such related payment is not received by Collateral Agent, then Collateral Agent will be entitled to recover such amount (including interest accruing on such amount at the
rate otherwise applicable to such Obligation) from such Lender on demand without setoff, counterclaim or deduction of any kind. 

(ii)    If Collateral Agent determines at any time that any amount received by Collateral Agent under any Loan Document
must be returned to Borrower or paid to any other Person pursuant to any insolvency law or otherwise, then, notwithstanding any other term or condition of any Loan Document, Collateral Agent will not be required to distribute any portion thereof to
any Lender. In addition, each Lender will repay to Collateral Agent on demand any portion of such amount that Collateral Agent has distributed to such Lender, together with interest at such rate, if any, as Collateral Agent is required to pay to
Borrower or such other Person, without setoff, counterclaim or deduction of any kind and Collateral Agent will be entitled to set off against future distributions to such Lender any such amounts (with interest) that are not repaid on demand. 

(c)    Non-Funding Lenders. 

(i)    Unless Collateral Agent shall have received notice from a Lender prior to the date of any Term Loan that such
Lender will not make available to Collateral Agent such Lender’s Pro Rata Share of such Term Loan, Collateral Agent may assume that such Lender will make such amount available to it on the date of such Term Loan in accordance with
Section 2(b) of this Annex I, and Collateral Agent may (but shall not be obligated to), in reliance upon such assumption, make available a corresponding amount for the account of Borrower on such date. If and to the extent that such Lender
shall not have made such amount available to Collateral Agent, such Lender and Borrower severally agree to repay to Collateral Agent forthwith on demand such corresponding amount together with interest thereon, for each day from the day such amount
is made available to Borrower until the day such amount is repaid to Collateral Agent, at a rate per annum equal to the interest rate applicable to the Obligation that would have been created when Collateral Agent made available such amount to
Borrower had such Lender made a corresponding payment available. If such Lender shall repay such corresponding amount to Collateral Agent, the amount so repaid shall constitute such Lender’s portion of such Term Loan for purposes of this
Agreement. 
 (ii)    To the extent that any Lender has failed to fund any Term Loan or any other payments required to
be made by it under the Loan Documents after any such Term Loan is required to be made or such payment is due (a “Non-Funding Lender”), Collateral Agent shall be entitled to set off the
funding short-fall against that Non-Funding Lender’s Pro Rata Share of all payments received from Borrower. The failure of any Non-Funding Lender to make any Term
Loan or any payment required by it hereunder shall not relieve any other Lender (each such other Lender, an “Other Lender”) of its obligations to make such Term Loan, but neither any Other Lender nor Collateral Agent shall be
responsible for the failure of any Non-Funding Lender to make such Term Loan or make any other payment required hereunder. Notwithstanding anything set forth herein to the contrary, a Non-Funding Lender shall not have any voting or consent rights under or with respect to any Loan Document or constitute a “Lender” (or be included in the calculation of “Required Lender”
hereunder) for any voting or consent rights under or with respect to any Loan Document. At Borrower’s request, Collateral Agent or a Person reasonably acceptable to Collateral Agent shall have the right with Collateral Agent’s consent and
in Collateral Agent’s sole discretion (but Collateral Agent or any such Person shall have no obligation) to purchase from any Non-Funding Lender, and each Lender agrees that if it becomes a Non-Funding Lender it shall, at Collateral Agent’s request, sell and assign to Collateral Agent or such Person, all of the Term Loan Commitment (if any), and all of the outstanding Term Loan of that Non-Funding Lender for an amount equal to the aggregate outstanding principal balance of the Term Loan held by such Non-Funding Lender and all accrued interest with respect
thereto through the date of sale, such purchase and sale to be consummated pursuant to an executed assignment agreement in form and substance reasonably satisfactory to, and acknowledged by, Collateral Agent. 

 (d)    Actions in Concert. Anything in this Agreement to the
contrary notwithstanding, each Lender hereby agrees with each other Lender that no Lender shall take any action to protect or enforce its rights arising out of any Loan Document (including exercising any rights of setoff) without first obtaining the
prior written consent of Collateral Agent or Required Lenders, it being the intent of Lenders that any such action to protect or enforce rights under any Loan Document shall be taken in concert and at the direction or with the consent of Collateral
Agent or Required Lenders.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]